{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "b7eaf947-66d7-4763-b80c-5ab332ba9bd7",
   "metadata": {},
   "source": [
    "# OCR Text Extraction and Evaluation Script\n",
    "\n",
    "This script performs the following tasks:\n",
    "1. Extracts text from images using Tesseract OCR.\n",
    "2. Generates a ground truth dataset if not already available.\n",
    "3. Compares extracted text with the ground truth.\n",
    "4. Calculates similarity scores to evaluate OCR accuracy.\n",
    "5. Saves results to CSV files and visualizes the performance."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "e07ba826-101c-4741-acb8-2328e92efa15",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Import necessary libraries\n",
    "import pandas as pd\n",
    "import difflib\n",
    "import os\n",
    "import cv2\n",
    "import pytesseract\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "435f029c-a2ab-4e04-9570-47111c53f54f",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Define paths for storing data\n",
    "GROUND_TRUTH_CSV = r\"C:\\Users\\hp\\project 10\\ground_truth.csv\"\n",
    "EXTRACTED_TEXT_CSV = r\"C:\\Users\\hp\\project 10\\output.csv\"\n",
    "RAW_IMAGE_DIR = r\"C:\\Users\\hp\\project 10\\raw_images\"\n",
    "EVALUATION_CSV = r\"C:\\Users\\hp\\project 10\\evaluation_results.csv\""
   ]
  },
  {
   "cell_type": "markdown",
   "id": "db5d40d5-1e85-4524-84cd-aca3df6b5832",
   "metadata": {},
   "source": [
    "# Step 1: Generate Ground Truth Dataset"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "915f2ed4-e189-4854-90a7-b5171c0f1095",
   "metadata": {},
   "outputs": [],
   "source": [
    "def generate_ground_truth():\n",
    "    \"\"\"Generates a ground truth dataset by extracting text from images and saving it to a CSV file.\"\"\"\n",
    "    if not os.path.exists(GROUND_TRUTH_CSV) or os.stat(GROUND_TRUTH_CSV).st_size == 0:\n",
    "        print(\"Generating ground truth data...\")\n",
    "        data = []\n",
    "        for filename in os.listdir(RAW_IMAGE_DIR):\n",
    "            if filename.lower().endswith(('png', 'jpg', 'jpeg')):\n",
    "                image_path = os.path.join(RAW_IMAGE_DIR, filename)\n",
    "                image = cv2.imread(image_path)\n",
    "                extracted_text = pytesseract.image_to_string(image).strip()\n",
    "                data.append([filename, extracted_text])\n",
    "        \n",
    "        if data:\n",
    "            df = pd.DataFrame(data, columns=[\"Filename\", \"Extracted Text\"])\n",
    "            df.to_csv(GROUND_TRUTH_CSV, index=False)\n",
    "            print(\"Ground truth generated successfully.\")\n",
    "        else:\n",
    "            print(\"Warning: No images found in raw_images to generate ground truth.\")\n",
    "    else:\n",
    "        print(\"Ground truth file already exists but checking for empty content...\")\n",
    "        df_check = pd.read_csv(GROUND_TRUTH_CSV)\n",
    "        if df_check.empty:\n",
    "            print(\"Ground truth file is empty. Regenerating...\")\n",
    "            os.remove(GROUND_TRUTH_CSV)\n",
    "            generate_ground_truth()\n",
    "        else:\n",
    "            print(\"Ground truth file is valid.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3466cb8d-ff75-414d-bf69-f9144fc88bd0",
   "metadata": {},
   "source": [
    "# Step 2: Load Data from CSV Files"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "a019f5d2-f754-471f-8759-274eca8e3b09",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ground truth file already exists but checking for empty content...\n",
      "Ground truth file is valid.\n"
     ]
    }
   ],
   "source": [
    "def load_csv_data(file_path):\n",
    "    \"\"\"Loads OCR results or ground truth data from a CSV file.\"\"\"\n",
    "    data = {}\n",
    "    try:\n",
    "        df = pd.read_csv(file_path, dtype=str).fillna(\"\")  # Convert all data to strings\n",
    "        if \"Filename\" not in df.columns or \"Extracted Text\" not in df.columns:\n",
    "            print(f\"Error: {file_path} does not have the required columns.\")\n",
    "            return {}\n",
    "        for index, row in df.iterrows():\n",
    "            filename = row[\"Filename\"].strip().lower()\n",
    "            extracted_text = str(row[\"Extracted Text\"]).strip()\n",
    "            data[filename] = extracted_text\n",
    "    except Exception as e:\n",
    "        print(f\"Error loading {file_path}: {e}\")\n",
    "    return data\n",
    "\n",
    "# Generate ground truth if missing\n",
    "generate_ground_truth()\n",
    "\n",
    "ground_truth_data = load_csv_data(GROUND_TRUTH_CSV)\n",
    "extracted_data = load_csv_data(EXTRACTED_TEXT_CSV)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3b29cc75-4be5-4889-8d69-d3ef720c9163",
   "metadata": {},
   "source": [
    "# Step 3: Identify Missing OCR Results"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "0bd47191-24a2-4c98-b1eb-4d2aa9a3b8dc",
   "metadata": {},
   "outputs": [],
   "source": [
    "missing_files = set(ground_truth_data.keys()) - set(extracted_data.keys())\n",
    "if missing_files:\n",
    "    print(f\"Warning: The following files are missing from the extracted OCR results: {missing_files}\")\n",
    "    for filename in missing_files:\n",
    "        image_path = os.path.join(RAW_IMAGE_DIR, filename)\n",
    "        if os.path.exists(image_path):\n",
    "            try:\n",
    "                image = cv2.imread(image_path)\n",
    "                extracted_text = pytesseract.image_to_string(image).strip()\n",
    "                if extracted_text:\n",
    "                    extracted_data[filename] = extracted_text\n",
    "                else:\n",
    "                    print(f\"Warning: No text extracted from {filename}.\")\n",
    "            except Exception as e:\n",
    "                print(f\"Error processing {filename}: {e}\")\n",
    "        else:\n",
    "            print(f\"Error: Image file {filename} not found in raw images folder.\")\n",
    "\n",
    "# Save updated extracted data\n",
    "if extracted_data:\n",
    "    output_df = pd.DataFrame(list(extracted_data.items()), columns=[\"Filename\", \"Extracted Text\"])\n",
    "    output_df.to_csv(EXTRACTED_TEXT_CSV, index=False)\n",
    "else:\n",
    "    print(\"Warning: No extracted data available to save.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "834a84dc-6309-4e42-8dcf-55084e95410c",
   "metadata": {},
   "source": [
    "# Step 4: Evaluate OCR Performance"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "d2e9955c-6883-4067-b9a7-3579ea006fa9",
   "metadata": {},
   "outputs": [],
   "source": [
    "def normalize_text(text):\n",
    "    \"\"\"Normalizes text by converting it to lowercase and removing extra spaces.\"\"\"\n",
    "    return \" \".join(str(text).lower().strip().split())\n",
    "\n",
    "def calculate_similarity(text1, text2):\n",
    "    \"\"\"Calculates the similarity ratio between two strings using difflib.\"\"\"\n",
    "    return difflib.SequenceMatcher(None, normalize_text(text1), normalize_text(text2)).ratio()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c9bca339-87cb-47b7-86a6-2408718eb727",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Step 5: Compute Similarity Scores"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "2f1c7a7a-4f60-40a5-9b2f-e389912fa077",
   "metadata": {},
   "outputs": [],
   "source": [
    "results = []\n",
    "similarity_scores = []\n",
    "filenames = []\n",
    "for filename, true_text in ground_truth_data.items():\n",
    "    extracted_text = extracted_data.get(filename, \"\")\n",
    "    similarity_score = calculate_similarity(true_text, extracted_text)\n",
    "    results.append([filename, true_text, extracted_text, similarity_score])\n",
    "    similarity_scores.append(similarity_score)\n",
    "    filenames.append(filename)\n",
    "\n",
    "# Save evaluation results\n",
    "df_results = pd.DataFrame(results, columns=[\"Filename\", \"Ground Truth\", \"Extracted Text\", \"Similarity Score\"])\n",
    "df_results.to_csv(EVALUATION_CSV, index=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "077e3ed0-4820-4265-8325-69cd2fdfb15e",
   "metadata": {},
   "source": [
    "# Step 6: Print Evaluation Summary"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "43ad2f0f-c0c7-49f8-8a15-6524bf6e4cb9",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OCR Evaluation Summary:\n",
      "Total Files Evaluated: 98\n",
      "Average Similarity Score: 0.13\n",
      "Minimum Similarity Score: 0.00\n",
      "Maximum Similarity Score: 0.47\n",
      "Files with Similarity Below 0.8: 98\n"
     ]
    }
   ],
   "source": [
    "print(\"OCR Evaluation Summary:\")\n",
    "print(f\"Total Files Evaluated: {len(results)}\")\n",
    "if similarity_scores:\n",
    "    print(f\"Average Similarity Score: {sum(similarity_scores) / len(similarity_scores):.2f}\")\n",
    "    print(f\"Minimum Similarity Score: {min(similarity_scores):.2f}\")\n",
    "    print(f\"Maximum Similarity Score: {max(similarity_scores):.2f}\")\n",
    "    print(f\"Files with Similarity Below 0.8: {sum(1 for s in similarity_scores if s < 0.8)}\")\n",
    "else:\n",
    "    print(\"No valid similarity scores computed.\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2d01979a-a1e9-4322-93d8-cd05b86e8b62",
   "metadata": {},
   "source": [
    "# Step 7: Visualize OCR Accuracy"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "962b9faa-150c-44b2-a293-61de6c066acb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1000x500 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "OCR Evaluation complete! Results saved with improved preprocessing, normalization, and validation checks.\n"
     ]
    }
   ],
   "source": [
    "if similarity_scores:\n",
    "    sorted_indices = sorted(range(len(similarity_scores)), key=lambda i: similarity_scores[i])\n",
    "    sorted_filenames = [filenames[i] for i in sorted_indices]\n",
    "    sorted_scores = [similarity_scores[i] for i in sorted_indices]\n",
    "    \n",
    "    plt.figure(figsize=(10, 5))\n",
    "    plt.barh(sorted_filenames, sorted_scores, color='skyblue')\n",
    "    plt.xlabel(\"Similarity Score\")\n",
    "    plt.ylabel(\"Filename\")\n",
    "    plt.title(\"OCR Accuracy Evaluation\")\n",
    "    plt.xlim(0, 1)\n",
    "    plt.grid(axis='x', linestyle='--', alpha=0.7)\n",
    "    plt.tight_layout()\n",
    "    plt.show()\n",
    "\n",
    "print(\"OCR Evaluation complete! Results saved with improved preprocessing, normalization, and validation checks.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "29f36f35-5b28-4be7-8480-d988704e3a1a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Ground Truth Data: {'thyrocare_0_1001.jpg': 'Thyrocare\\n“Think Thyroid, Think Thyrocar\\n\\n© 022-3090 0000/ 41252525 © 3591866065 ES welinesserryracare-com @ www:thyrocare.com\\n\\nNAME _ASHIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AT =\\n\\nREF. 8Y see (7824957519),KALPANA MEDICOS AND CITY\\nLABBINITOLE ROAD ;HOSAT ASSAM\\n\\nTEST ASKED © AAROGYAM 782835,782435\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\n25-OH VITAMIN D (TOTAL) CLEA 2 ng/mt\\n\\nReference Range\\n\\nDerictency 20 g/m!\\nINSUFFICIENCY : 20-<30 g/m\\nSUFFICIENCY = 30-100 n/m\\nTORICITY = >100.na/m\\n\\n‘Vitamin © Tora test Is analyzed on Siemens ADVIA Centaur, standardized agsinst ID-LC/MS/HS, ax per\\n‘vitamin 0 Stangardtzation Program (VOSP)\\n\\nached FULLY AUTOMATED cit LUM\\n\\nVITAMIN 8-12\\n\\nRaterance Range :\\nNormal 211-981 po/m!\\n\\n35r pat\\n\\nnical signincance\\n\\n‘Vitamin 812 or cyenocobalamin, is complex cormnold edmpound fourd exclusively from animal etary\\nsporees, sich ws meat, eggs and mi Ts criteal ln normal DNA synthesis, which in turn affects erythrocyte\\ntaturation and inthe formation of mycin sheath. Vitarin-BI2 le Used to find ut neuraiogieal abnormalities\\n‘tod impaired DNA syrinesis associated with macrocytic anemuas. Tor éagnastic purpose, results should\\nanys be exsesied in conjunction with the padenta mecical story, clinica! examination aed other Aaaings.\\n\\n‘Specinications: intra assay (%4CV}:4.0%, Inter assay (T8CV):4.4 %:Senetvty:45 palm\\n\\nexternal quality contr program participator\\n‘College of American pathologists: igans assay (general) survey; CAP number- 7193855-01\\n\\nie vaisation references:\\n(Chen 1W Sparing MI, Hemioger IA.Vitarmin 812 In: Pesce Al,Kaipan LA,editors Methods in cin\\n‘StLouls:CV Mosby, 1987.\" 569-7.\\n\\n‘thee 3 KL AUTOMATED REDIBECTIONALLY INTERACED CHEMI WMINESCENT peUNO ASSAY\\nPlease correlate with clinical conditions,', 'thyrocare_0_1174.jpg': 'OCESSED AT: fe =\\nmar acap, Thyrocare®\\n\\n37/1,TTC MIDC,Turbhe, oe ammoupnceee -Thinkc Threats\\nvi Mumbai-400 703 cam hem Oey ta! *\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbat-400703°\\n{© 022-3090 0000 / 41252525 © 8691866066 =A weliness@thyrocare.com @uwnthyrocate com\\n\\nME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\nF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY:\\n\\nse 2 LAB, BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435\\nST ASKED t AAROGYAM A\\n\\nEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nOTAL TRIIODOTHYRONINE (T3) C.L.LA 76 ng/di 60-200\\nOTAL THYROXINE (T4) C.LILA 5 pa/dl | 4.5-12\\nHYROID STIMULATING HORMONE (TSH) C.L.LA 2.14 plu/ml 0,3-5.5\\n\\ncomments = SUGGESTING THYRONORMALCY', 'thyrocare_0_122.jpg': 'ROCESSED AT: =\\narate ecap, Thyrocare\\n\\n37/1, TTC MIDC,Turbhe,\\njavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\n: Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai 400703\\n© 022 - 3090 0000 / 41252525 & 8691856066 = wellness@thyrocare.com\\n\\n2 ASHIM KR SENGUPTA (25/M) SAMPLE COLLECTED AT :\\nes (7824357519), KALPANA MEDICOS AND CITY\\nstaal LAB,BIHUTOLT ROAD ,HOJAT ,ASSAM 782435,782435\\n\\nTOTAL TRHODOTHYRONINE (T3) CALLA 76 g/dl 60-200\\nTOTAL THYROXINE (74) CLA 5 pa/dl  4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 plu/ml 0.3-5.5\\n\\nMethod =\\n\\n73 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n{4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n= SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_123.jpg': 'ICESSED AT :\\n\\necap, Thyrocare\\n\\nrocare\\n7/1,1TC MIDC,Turbhe, heat Think Th\\n| Mumbai-400 703 : Buoys:\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turblhe, Navi Mumbai - 400703\\n© 022 - 3090 0000/4125 2525 @ 8691866066 =a wellness@thyracare.com @www.thyrocare-com\\n\\nME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\n> BY : SELF (7824357519), KALPANA MEDICOS AND CITY\\n\\nZ ; LAB, BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435\\n5T ASKED : AAROGYAM A\\n\\nTECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nST NAME\\n\\nJTAL TRIIODOTHYRONINE (T3) C.LLA 76 ng/di 60-200\\nTAL THYROXINE (T4) CLA 5 ug/dl  4.5-12\\nHYROID STIMULATING HORMONE (TSH) CLA 2.14 plU/ml 0.3-5.5', 'thyrocare_0_1248.jpg': 'DCESSED AT:\\n\\necap, Thyrocare’\\n\\nrocare\\n7/1,TTC MIDC,Turbhe, Pha\\n| Mumbal-400 703 =e Think Thyrond THORS ag\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022-3090 0000 / 41252525 3691866066 = wellness@thyrocare.com @wwwthyrocate.com\\n\\nME 2 ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\n+ SELF (7824357519), KALPANA MEDICOS AND CITY\\ny LAB, BIHUTOLI ROAD ,HOJAI ASSAM 782435,782435\\n\\nST ASKED + AAROGYAM A\\n\\nST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nSTAL TRIIODOTHYRONINE (T3) CLA 76 ng/di 60-200\\n\\nOTAL THYROXINE (T4) C.LLA 5 na/dl  4.5-12\\n\\nHYROID STIMULATING HORMONE (TSH) C.L-LA 2.14 pIu/ml 0.3-5.5', 'thyrocare_0_1374.jpg': 'PROCESSED AT : =\\nShree Towers II, RAA/36, Raghunathpur, Thyro care’\\n\\nVIP Road, Kolkata~700 059 Think Thyroid. Thnk\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000/4125 2525 @ 8691865066 & wellness@thyrocare.com @ wwevethyrocare.com\\n\\nNAME + ASHIM SENGUPTA (S8Y/M)\\n\\nSAMPLE COLLECTED AT :\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\nTEST ASKED = AAROGYAM C LAB, BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435\\n\\nj\\n\\nTEST NAME TECHNOLOGY VALUE __—sOUNITS. ~—_— NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 67 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di <0.%\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 ul <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 u/l <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 u/l <45\\nPROTEIN - TOTAL PHOTOMETRY 7.14 am/di 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 3.93 gm/di 3.2-4.8\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio 0.9-2\\nSERUM GLOBULIN PHOTOMETRY 3.21 am/dt. 2.5-3.4\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_1861.jpg': 'pore yrocare’\\nShree Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata~700 059 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 4125 2525 @ 86918660665 & weliness@thyrocare.com @ wwwwithyrocare.com\\n\\nNAME + ASHIM SENGUPTA (58Y/M) SAMPLE COLLECTED AT :\\nREF. BY ELF (7824357519), KALPANA MEDICOS AND CITY\\nigi — y sanccranc (AB, BIHUTOLT ROAD ,HOJAI ,ASSAM 782435,782435\\n\\n}\\ni\\n\\nTEST NAME q TECHNOLOGY VALUE UNITS NORMAL RANGE\\nALKALINE PHOSPHATASE PHOTOMETRY 7 Of | 45=qo0\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/dl 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 mg/dl < OR\\n\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 u/l <55\\n\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 uA <35\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 u/l <45\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.14 gm/di 5.7-8.2\\n\\nALBUMIN - SERUM PHOTOMETRY 3.93 gm/di 3.2-4.8\\n\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio 09-2\\n\\nSERUM GLOBULIN PHOTOMETRY 3.21 am/di___2.5-3.4 F ;\\nDieses rnrraiata usith clinical conditions. -', 'thyrocare_0_1915.jpg': \"a Thyrocar\\n#5 Il, RAA/36, Raghunathpur, “Think Thyroid Think Thyroea\\n9 D-37/3, TTC MIDC, Turthe, Naw Mumba - 400703,\\n\\nNAME + ASHIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AT. =\\n\\n1 (7828357519) KALPANA MEDICOS AND CITY\\naa ee ‘LAB, BIHUTOL! ROAD ,HOJAI ASSAM\\nTEST ASKED: MROGYANC mnaaas 702433\\nTECHNOLOGY “VALUE UNITS\\ncura 2 g/mi\\n\\nINSUFFIGIENCY » 20-<30 ng/tit\\nSUFFICIENCY = 30-100 n/m)\\nTOXICHTY = >100na/m!\\n\\nVitamin D Total test's analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\nVitamin © Standardization Progrem (VOSF)\\n\\nMethod :_ HALY AUTOMATED CVE: LUMINESCENT IMMUNO ASSAY <a =\\nVITAMIN 8-12 CLEA ccs palm\\n\\nReference Range :\\n\\nNormal: 211-941 palm\\n\\nCinial signiicsrce\\nVicamin B12 or cyanocoblamin, is 8 complex carrinald compound found exclusively from animal dietary\\nsources, such as Meat, eggs and milk. 1's critca in nocmal DNA synthesis, whach in tur affects erytnrocyte\\nmaturation and in the formation of myelin sheath, Vitamin-B12 Is Used to find out newralogical abnormalities\\nand impaired DNA synthesis associated with macrocytic anemian. For agnostic purpose, results should\\nalways be assessed In conjunction withthe patients mecca! history, dinical examination and other finding\\n\\n‘Speerticabions: Intra assay (4CV):4.0%, Inter assay (SWCV):4.4 %4;Sensitivity:45 p9/m\\n\\n{External quality control program participation\\nCollege Of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nit validation references:\\n‘Chen IW Sperling Ml,Heminger IA.Vtamin 812.1n:Pesce I,Kalpan LAedtors Methods in elnca chemistry\\n‘StLouisiCV Most, 1987. 569-73.\\n\\n‘Method i fui’ AUTOMATED BIDIRECTIONALAY INTERES\\nPlease correlate with clinical conditions,\\n\\nOEM LIMINESCENT IMMUNO ASSAY\\n\\n#14 Feb 2020 08:00\\n$12 Feb 2020 18:37 Sar\\n#12 Fab 2020 20:13\\n\\nSERUM\\n\\n#1202038627/0R2500 Dr S Bera MDXPath) Dr-Coesar Sengupta\\n+2Qo419561 e\\nPage: Sof 11\", 'thyrocare_0_2177.jpg': 'YROCESSED AT :\\nhyrocare\\n\\n)-37/1,TTC MIDC,Turbhe,\\nfavi Mumbai-400 703\\n\\ncap, Thyrocare®\\n\\neA samc AO rae Aiee\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703.\\n© 022 - 30900000 / 41252525 © 8691866066 = wellness@thyrocare.com —@wwwthyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT =\\n\\nREF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY\\nTEST ASKED 2 AAROGYAM A\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) C.LLLA 76 ng/di 60-200\\n\\nTOTAL THYROXINE (14) C.LLA 5 ug/dl 4.512\\n\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 plu/mi 0,3-5.5\\n\\n‘Comments: SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod =\\n\\n3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nCOMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n= SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_2300.jpg': 'Shree ‘Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata-700 059\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbat-\\n© 022 - 3090 0000 / 41252525 @ 8691866066 & wellness@thyrocare.com @\\n\\n: ASHIM SENGUPTA (58Y/M) ‘SAMPLE COLLECTED AT\\n(7824357519), KALPANA MEDICOS AND CITY\\nLAB, BIHUTOLT ROAD ,HOJAI ,ASSAM 782435,\\n\\nTEST NAME ee TECHNOLOGY\\nALKALINE PHOSPHATASE PHOTOMETRY\\nBILIRUBIN - TOTAL PHOTOMETRY\\nBILIRUBIN -DIRECT PHOTOMETRY\\nBILIRUBIN (INDIRECT) CALCULATED\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY\\nPROTEIN - TOTAL PHOTOMETRY\\nALBUMIN - SERUM PHOTOMETRY\\nSERUM ALB/GLOBULIN RATIO CALCULATED\\nGLOBULIN PHOTOMETRY\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_2505.jpg': 'ecap, Thyrocare’\\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe, CE SAME PADS,\\n% Think Thyroid. Think Thyrocare.\\n\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022- 30900000 / 4125 2525 @ 8691866066 ka wellness@thyrocare.com @wwwithyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\n\\n* i LAB, BIHUTOLI ROAD ,HOJAL ,ASSAM 782435,782435,\\n\\nTEST ASKED 2 AAROGYAM A\\n\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (13) CLLA 76 ng/dl 60-200\\n\\nTOTAL THYROXINE (T4) CLA 5 va/dh 45-12\\n\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 ulu/ml 0.3-5.5', 'thyrocare_0_2649.jpg': 'AT:\\n\\n‘Shree Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata-700 059\\n\\nCorporate Office : Thyrocare Technologies Limited  0-37/3, TTC MIDC, Turbhe, Navi Mumbal-\\n© 022 - 3090. 0000/4125 2525 @ 8691866066 = wellness@thyrocare.com @wwwt\\n\\n+ ASHIM SENGUPTA (S8Y/M) A\\n\\n: SELF (7824357519), KALPANA MEDICOS AND CITY __\\nfakpcvan € LAB, BIHUTOLT ROAD ,HOJAL ,ASSAM 782435,782435\\n\\nTEST NAME ‘TECHNOLOGY\\n\\nALKALINE PHOSPHATASE PHOTOMETRY 67 U/L\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/dl\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 mo/di\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/di\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 ul\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 us\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 ul\\nPROTEIN - TOTAL PHOTOMETRY 7.14 gm/di\\nALBUMIN - SERUM PHOTOMETRY 3.93 gm/di\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio\\nSERUM GLOBULIN PHOTOMETRY 3.21 gm/dt\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_2691.jpg': '|\\n\\nMumbal-400 703 catia\\n\\n© 022 - 3090 0000/4125. 2525 @ A6S1866066 6 wellness@thyrocare.com @Dwewwthyrocare.com\\n\\nASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT =\\n(7824357519), KALPANA MEDICOS AND CITY\\n\\nBY = SELF\\n\\nASKED = AAROGYAM A\\n\\nNAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nAL TRIIODOTHYRONINE (T3) CLA 76 ng/dt 60-200\\n\\nAL THYROXINE (T4) CLA 5 va/dl  4.5-12\\n\\nROID STIMULATING HORMONE (TSH) GLIA 2.14 wIU/mt_0.3-5.5', 'thyrocare_0_2737.jpg': 'Towers II, RAA/36, Raghunathpur,\\nRoad, Kolkata-700 059\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai\\n© 022- 30900000 / 4125 2525 © 8691866066 4 wellness@thyrocare.com Gwe\\n\\nNAME + ASHIM SENGUPTA (58Y/M) SAMPLE COLLECTED AT :\\nREF. BY + SELF (7824357519) KALPANA MEDICOS AND CITY\\nPew AB, BIHUTOLT ROAD ,HOJAL ,ASSAM 782435\\n\\nTEST NAME TECHNOLOGY\\n\\nALKALINE PHOSPHATASE PHOTOMETRY 67\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18\\nBILIRUBIN (INDIRECT) CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 343\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 34\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nALBUMIN - SERUM PHOTOMETRY 3.93\\nSERUM ALB/GLOBULIN RATIO. CALCULATED 1.22\\n‘SERUM GLOBULIN PHOTOMETRY 3.21\\n\\nDieace correlate with clinical conditions.', 'thyrocare_0_2838.jpg': '(41252575 @\\n\\nTechnologies Limited @ AVA, TTC MIDG, Turehe. Naw Mumba 40X70\\nSPI BEOS6\\n\\nTEST NAME: TECHNOLOGY VALUE UNITS.\\n\\n25-O8 VITAMIN D (TOTAL) cota 2 po/mt\\nReference Range\\n\\nBERCTENGr C20 nai\\n\\nINSUFFICIENCY © 30-30 og/m\\n\\nSURFIGIENCY = 30-300 raymi\\n\\nyoxicy; >190.9a/m\\n\\n\\\\tamin © Total test ls anise on Siemens ADVIA Centaur, standardized against 1O-LC/MS/MS, 96 par\\nSisamin b Standersustion Sroatarn (OS)\\n\\nothe: Hul¥ AUTOMATED ciel \\\\UMINESCEIT IMMUNO ABSA\\n\\n\\\\ETAMIN o-32 cri 35\\nRaretencs Rene?\\n\\nNomar 230811 palms\\n\\nical signmeance\\n‘Vitamin B12 or cyenocohelamin, ts # complex corrinokd compound found exciustvety frat animal dictary\\n\\nSioitnpstred HA syranonis essociaerd with mactocysc anemias: Tor diagrant\\n‘Sineys be asveseed In conjunction with the pawenes medica! istry,\\n\\n“Secmncations: Intra assay (SCV):4.O%, Inter assay (WCY):4.4 Hu: Seneaivty:45 99/m!\\n\\nexterna quality contr proyrarn aertcioation\\n‘Gologe of American pathclogisteligane assay (general) surveys CAP number: 7193855-03\\n\\net vatantion raterences:\\n\\nSasha: FULLY AUTOMATED BIDIRECTONALAY INTERIACED I% QMINESCE JMU SAY\\nPlease correlate with clinical conditions.\\n\\n+212 Feb 2020 18:37 ra\\n\\n£12 Fb 2020 20:13\\n\\nSERUM\\n\\n£1202038827/0R2590 D1 SBora MD(Patn)\\n\\nC.\\n\\nDr. Caesar Sengupta MDM\\nPage 3011', 'thyrocare_0_2841.jpg': 'Shree Towers II, RAA/36, Raghunathpur,\\nVIP Road, Koikata~700 059\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbal\\n© 022 - 3090 0000 / 41252525 @ 8691866066 & weliness@thyrocare.com @\\n\\n+ ASHIM SENGUPTA (SBY/M) SAMPLE COLLECTED AT :\\nREF. BY SELF (7824357519), KALPANA MEDICOS AND CITY\\n> Fa Cara e LAB, BIHUTOLT ROAD ,HOJAI ,ASSAM 782435,782435_\\n\\n3\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\nALKALINE PHOSPHATASE PHOTOMETRY 67 U/L\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/dl\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/di\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 uf\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 us\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 us\\nPROTEIN - TOTAL PHOTOMETRY 7.14 am/di\\nALBUMIN - SERUM PHOTOMETRY 3.93 am/di\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio\\n‘SERUM GLOBULIN _ PHOTOMETRY 3.21 gm/dt_\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_2866.jpg': 'PROCESSED AT :\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022-3090 0000/4125 2525 @ 8691866066 = weliness@thyrocare.com @wwwthyrocare.com\\n\\nNAME ASHIM KR SENGUPTA (25Y/M) ‘SAMPLE COLLECTED AT\\neae aS MeDIGOS AND CITY\\nTEST ASKED + AAROGYAM A\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) 76 ng/dl 60-200\\nTOTAL THYROXINE (14) 5 ya/d)  4,5-12\\nTHYROID STIMULATING HORMONE (TSH) 2.14 plu/ml 0.3-5.5\\n\\nComments: SUGGESTING THYRONORMALCY\\neee net omens', 'thyrocare_0_2885.jpg': 'PROCESSED AT =\\n‘Thyrocare\\nD-37/1,1TC MIDC,Turbhe,\\nNavi Mumbai-400 703.\\n\\nCorporate Office : Thyrocare Technologies Limited Q 0-37/3, TTC MIDC, Turbhe,\\n© 022-3090 0000/4125 2525 @ 8691856066 =A wellness@thyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\nA (7824357519), KALPANA MEDICOS AND CITY\\nREF. BY oes UAB, BIHUTOLT ROAD ,HOJAT ASSAM 782435,782435\\n\\nVALUE UNITS REFERENCE RANGE\\n76 ng/di 60-200\\ns a/dl 4.5-12\\n\\n214 IU/ml 0.3-5.5', 'thyrocare_0_2987.jpg': '(7824357519) KALPANA MEDICOS AND CITY\\n‘ROAD\\n\\nAB, BIHUTOLE ROAD ,HOTAS ASSAM\\n782435,702835\\nTEST NAME TECHNOLOGY VALUE UNITS.\\n25-OH VITAMIN D (TOTAL) CLEA 2 ng /mt\\n“Reference Range:\\n\\nDEFICIENCY | 1<20 roy\\nINSUFFICAENCY :20-<30 n/m\\n‘SUFFICIENCY: 30-100 na/ini\\nToXICTY = >100 afm\\n\\n‘cain © Tota tet is analyzed on Siemens ADVIA Centaur, standardized against ID-LCYMSYMS, a8 per\\n‘Yamin D Starearsuation Program (VOSP)\\n\\n(ator :_ ALY AUTOMATED. QVEME LUMINESCENT NJNO ASSAY —= =\\nVITAMIN 8-12 1 palm\\n‘Reference Range :\\n\\nNorma 211-311 pp/mi\\n\\nnica significance\\n\\\\eamin 812 or cyanocobalamin, is a complex cornoid compound found excisivety from animal dietary\\nsporces, Sich me Meat, e998 and il. Is cca! In normal DNA sytest, which in tu affects erythrocyte\\nmaturation an in the formation of myn sheath, Vitam B12 is ed to find out neurlogia! abnormalives\\n‘and impaired OWA vyriess associated with macracytc anemis, for diagnostic purpese, results syoud\\nSays be asseszed In conjunction with the patients mesial history, cnital examination and other ging\\n\\n“Spectications: Ine assay HEV):M.0%, Inter assay (SHCV):4.4 Wh Senstvty4 p/m\\n\\nsternal queity coro! program participation:\\n‘Gafege of American pathologie: ligand assay (general) survey; CAP number: 719385501\\n\\n1 vain references:\\n“Chen IW sSpering MI:Memnger IA Vitamin 812 In:Pesce Al Kalan LA editors Methods i clinical chemist.\\n‘SkLouisiOV Mosby 1987.7 569-73.\\n\\n9 INTERFACED Ce LUMINES IMMUN ASSAY\\nPease correlate with clinical conditions,\\n\\n#11 Feb 2020 08:00\\n$42.Feb 2020 18:37\\n+12 Feb 2020 20:13,', 'thyrocare_0_3333.jpg': 'SSED AT:\\n\\nSoe m@cGap_ Thyrocar\\nambai-400 703 pes —% Sap in nea Think Thyroid. Think Thyroc\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703 ee\\n© 022 - 30900000 /4125 2525 © 8691866066 = weliness@thyrocare. com —@wwwithyrocare.com\\n\\nASHIM KR SENGUPTA (25¥/M)\\nSELF\\n\\nSAMPLE COLLECTED AT =\\n(7824357519), KALPANA MEDICOS AND CITY\\n\\nFn\\n\\nSKED AAROGYAM A\\n\\nNAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n| TRIIODOTHYRONINE (T3) CLA 76 ng/di 60-200\\n\\nL THYROXINE (14) CLA 5 na/dl -4.5-12\\n\\nOID STIMULATING HORMONE (TSH) CLA 2.14 pIU/ml 0.3-5.5', 'thyrocare_0_3414.jpg': 'NETAMIN 9-12 ess palm\\nKern 53 psim\\n\\n‘ret spncarce =\\n‘Vary Biz cyrecoblean i» caroex corridor oun ec eal etary\\nSEL oy we mene ge art acca in roma BA ses mh nt ae rete\\niRatrtion ae rte formation mein ove. Weare B12 odoin aut nuraigeal tne\\n‘Babiepared oh syrinerstsccats mtn marci semi for agonic prpore teats oa\\nters Se seen ncoponion wt he pare: rates hry, rita xan ana ther Mg.\\n\\n“Specter nr toy (SN), Inter sca (MCV) 48 SY A pm\\n\\nater gunty cect aay pon\\n\\nGatege ot Anca plate: sey (genera) survey CAP number 7193855:\\n“ex vatagion retereces\\n\\n‘Chen tw.souting Macrnge 1A Vtamin B12 n-Peace Wxaban LAr Mets ln chem.\\nSeta cv oy 1987 300-73\\n\\nwith cline condttens.', 'thyrocare_0_3439.jpg': 'AT:\\n\\n‘Thyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n+ ASHIM KR SENGUPTA (25¥/) SAMPLE COLLECTED A’\\naoe (7824357519) KALPANA eDICOS AND CxTY\\nz LAB,BIHUTOLT ROAD ,HOJAL ,ASSAM 782435,782435,\\n‘TEST ASKED + AAROGYAM\\nVALUE UNITS REFERENCE RANGE\\n76 ng/di_ 60-200\\n5 pa/dt 4.5-12\\n\\n2.14 wIu/mt_0.3-5.5', 'thyrocare_0_3558.jpg': 'Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata-700 059\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai -4\\n© 022 - 3090 0000/4125 2525 © 8691865066 4 wellness@thyrocare.com @ thyr\\n\\nNAME + ASHIM SENGUPTA (S8Y/m) SAMPLE COLLECTED AT. +\\nREF. BY + SELF (7824357519),KALPANA MEDICOS AND CITY\\nMEKGKED  : AAROGvANC (AB, BIMUTOLT ROAD ,HOJAL ASSAM\\n\\nTEST NAME TECHNOLOGY\\nALKALINE PHOSPHATASE PHOTOMETRY\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\n\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18\\nBILIRUBIN (INDIRECT) CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.44\\nALBUMIN - SERUM PHOTOMETRY 3.93\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22\\n_ SERUM GLOBULIN PHOTOMETRY 3.21\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_36.jpg': 'Tha Thyrone, FIRE |\\n\\nfice ae ee ene hs\\n52575 @ 3591865066 welinessethyrocarc.com www\\n\\nREPORT\\n1 ASHIM SENGUPTA (58Y/M) SAMPLE COLLECTED AT:\\n\\n2 SELF (7824357519) KALPANA MEDICOS AND CITY\\n\\nUAB,SIHUTOLI ROAD ,HODAT ASSAM\\n\\nSKED = AAROGYAMC 782435,762435\\n\\nAME TECHNOLOGY VALUE UNITS\\n\\n|VETAMIN D (TOTAL) CLA 2 g/mi\\n\\nnee Range :\\n\\nCY 1 <20 ng/ml\\nIGIENCY : 20-<30 ng/mi\\nJENCY = 30-100 ng/mi\\nMy :>100 ng/mi\\n\\n0 Total test Is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\n© Standardization Program (VOSP)\\n{_PULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY. 4\\nIN B-12 CLLA 331 palm\\nnce Range:\\n\\nZAL- 914 palm\\n\\nsignificance\\n812 oF cyanocobalamin, 1s a complex corinold compouind found exclusively from animal dietary\\n\\n. SUch as meat, eggs and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte\\nae) and {nthe formation of myelin sheath. Vitamin-B12 is used fo find out neurological abnormalities\\npaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should\\n\\nbe assessed In conjunction with the patients medical history, clinical examination and other finaings\\n\\nations; Intra assay (S4CV):4.0%, Inter assay (56CV):4.4 %6;Sensntivity:45 pg/m!\\n\\n| Quality contrat program participation:\\n‘Of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\ngation references:\\nN Sperling MI,Heminger 1A.Vitamin B12.tn:Pesce AJ,Kalpan LA,editors. Methods In clinical chemistry.\\ns:CV Mosby, 1987.?.569-73.\\n\\n1 Feb 2020 08:00\\n\\n312 Feb 2020 18:37 ke,\\n\\n#12 Feb 2020 20:13\\n\\nSERUM\\n\\n$1202038627/OR2500 Or S.Bera MD(Path) Dr.Ceesar Sengur\\n\\nPage 3of 11', 'thyrocare_0_3753.jpg': 'AME ‘VALUE unrrs: :\\nVETAMIN D (TOTAL) 2 ng/mi\\nsce Range :\\n\\nNe 20 ngim\\nSIENCY £ 20-<30 ra/\\nENCY = 30-100 na/mi\\nYs >100 nay!\\n\\n© Total test ts analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\nB Standardization Program (VOSP),\\n[PULL AUTOMATED CHEM, LUMINESCENT IMMUNO ASEAY ——— ——\\nEN 8-12 CLEA 3 palma\\nnee Range:\\n\\nBST permit\\n\\nsignificance\\n\"B12 oF cyanacobalamin, ts 2 complex carrinold compound found exciusivety from animal dietary\\nSuch os test, eggs and (ilk. t= critical in normal DNA synthesis, which in turn affects erytnrocyte\\njon and in the formation of myciin aneath. Vitamin-@12 ts used to find out neurological abnormalives\\nsired BNA syrthesis ssucciated with macrocysic anemias, For diagnostic purpose, results shouted\\n\\nBe easested in Conhinction with the patients medical history, elinieal exatmunation and other Andings\\n\\netions: Intra assay (SCV):4.0%, Inter assay (WWCV):4.5 Se;Sensmivity:45 pa/m!\\n\\n| quatty control program participation\\nof American pathologists: ligand aseay (general) survey: CAP number: 7193855-01\\n\\ntion references:\\nV Sperling Mi.Heminger 1A.Vitamin B12 In-Pesce AJ,Kalpan LA,editors. Methods in clinical chemistry.\\nCV Mosby. 1987. 569-72.\\n\\nALLY. INTERFACED CHEMI LUMINESCENT IPIMUND ASSAY.\\ncorrelate with clinical conditions.\\n\\n7H Feb 2020 08:00\\n242 Feb 2020 18:37\\n\\n#12 Fab 2020 20:13 Ji\\n\\n2SERUM\\n\\n+=1202038627/0R2500 Dr S Bera MD(Path) Dr.Caesar Sengu', 'thyrocare_0_3804.jpg': 'i a\\n\\necap, Thyrocare’ ~\\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe, A\\n\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 30900000 / 41252525 © 8691866066 ‘i weliness@thyrocare com: @ veww.thyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\nSeer aed (fisainurout ROAD NODAL ASGAM 702435 782435\\nTEST ASKED + AAROGYAM A ‘\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLLA 76 ng/di 60-200\\nTOTAL THYROXINE (T4) CLA 5 afd) 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLLA 2.14 piu/ml 0.3-5.5\\n\\n‘Comments: SUGGESTING THYRONORMALCY\\n\\nPlease correlate with clinical conditions.\\n\\nMethod =\\n\\n773 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\n= COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\n‘SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY i?', 'thyrocare_0_3813.jpg': 'PROCESSED AT : Th\\nShree Towers II, RAA/36, Raghunathpur, yo care’\\nVIP Road, Kolkata-700 059 Think Thyroid. Think ties\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 4125 2525 © 8691865066 &% wellness@thyrocare.com @wwwathyrocare.com\\n\\nNAME : ASHIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (7824357519),KALPANA MEDICOS AND CITY.\\nTEST ASKED : AAROGYAM C LAB, BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435\\n,\\n,\\nTEST NAME ih TECHNOLOGY VALUE _UNITS NORMAL RANGE |\\nALKALINE PHOSPHATASE PHOTOMETRY ” 68 U/L 45 - 129\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/di 0.3-1.2\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di <0\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/dl 0-0.9\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 ul <55\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 uA <35\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 uf <45\\nPROTEIN - TOTAL PHOTOMETRY 7.14 am/di 5.7-8.2\\nALBUMIN - SERUM PHOTOMETRY 3.93 am/di 3.248\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio 0.9-2\\n\\nm/ dt. 2.5-3.4\\n\\nSERUM GLOBULIN 7 PHOTOMETRY 3.21 gi 4\\nBiesce rarraiate with clinical conditions. F', 'thyrocare_0_4046.jpg': 'eee ual TT\\n¢ThyrocareTedmologies Lined  D37/,T1C MVOC the, Haw Muri 400703\\n)f ALIS 2805 © BUaTB6N0G a weesetnyracare.con wwe tyocare com\\n\\nrane: ASSIA (SH) sans couscreD aT +\\n\\nmeray 58s (osaxszsa) aan nics ao CY\\nSiento soa oa ASSN\\n\\nTEST ASKED — : MAROGYAMC 782435,782435,\\n\\nTEST NAME TecwNoLoGY VALUE UNITS\\n\\n25-011 VITAMIN (TOTAL) cura u n/m\\n\\nRetrence ange:\\n\\nSenet\\n\\nINSUFFINCY 20-<30 gin\\nSUFICIENY : 30-10 p/n\\nyonry < >190 eam)\\n\\nram 0 Teal test aye on Slemons ADM Certar, ards agus 1-LCMSIMG, 8 par\\n\\namin DStrdanaain Program (VOSA,\\netd rut AVTONATEDO8 \\\\nsce¥ nn AS ———\\nVITAMIN 8-12 cua Est palm\\nReference ange:\\n\\nNoma 211-311 pam\\n\\nCina since\\nearn B12 or eynccoolain i crpler cornell compound au excsey rom ania et\\nsures, sucha en, eps ard milk. ce! normal DNA syne, which nt atts arireyte\\nmaura ae the eration of eins. Via sed oi out neurog\\n\\n‘ot impaired A syria eseccied wen matey anemim. Fer Gags ups, res\\n‘Deys be anesed in conhincton wth te pees radial istry, cnc! evanabon and ter frit.\\n\\nSpeciation: Ite any (HEV), re sy (WCV)48 Soy AS pg\\n\\nxem qunty crt program parce\\n‘Gilege ef Aercanpttlois: gan asny (gener) survey CAP ruber 7193835°01\\n\\nat wean rete\\nChen Soeting Meroe IA tari B12 nPesce A apa LAs Meas in cnc remit,\\nSecs Vesa 19877562\\neth _AALCAUTOATED IRECTIONALYINTREACED C2 ESC ONO AS\\nPave correlate wth cna condtions.\\n\\nOF Caesar Sengupta MO Micr————\\nPage Sof 11', 'thyrocare_0_421.jpg': '\"Shree Towers II, RAA/36, Raghunathpur,\\n\\nVIP Road, Kolkata~700 059 Think Thyroid. Think:\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai. ;\\n\\n© 022 - 3090 0000/4125 2525 © 8691865066 & weliness@thyrocare.com @wwwth\\n\\nNAME  ASHIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AT 4\\nREF. BY ‘SELF (7824357519), KALPANA MEDICOS AND CITY\\nWESTASKED _: AAROGYAM C (AB, BIHUTOLT ROAD ,HOJAI ,ASSAM 782435,782435\\n\\nTEST NAME TECHNOLOGY\\nALKALINE PHOSPHATASE PHOTOMETRY\\nBILIRUBIN - TOTAL PHOTOMETRY\\nBILIRUBIN -DIRECT PHOTOMETRY\\nBILIRUBIN (INDIRECT) CALCULATED\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY\\nPROTEIN - TOTAL PHOTOMETRY\\nALBUMIN - SERUM PHOTOMETRY\\nSERUM ALB/GLOBULIN RATIO CALCULATED\\nSERUM GLOBULIN PHOTOMETRY\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_4385.jpg': 'SESSED AT :\\ncare\\nMumbai-400 703\\n\\n@cap., Thyrocare\\n\\nFaster eamemcan mc Tae :\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai- 400703\\n© 022-3090 0000 / 41252525 @ 8691866066 = wellness@thyrocare.com @wwwthyrocare.com\\n\\nASHIM KR SENGUPTA (25Y/M)\\n\\nSAMPLE COLLECTED AT =\\n(7824357519), KALPANA MEDICOS AND CITY:\\nLAB, BIHUTOLT\\n\\naif ROAD ,HOJAI ,ASSAM 782435,782435,\\nASKED = AAROGYAM A\\n\\nT NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nAL TRIIODOTHYRONINE (T3) CLA 76 ng/dl 60-200\\n\\nAL THYROXINE (T4) s na/di  4.5-12\\n\\n(ROID STIMULATING HORMONE (TSH) CLA 2.14 pIU/ml 0.3-5.5', 'thyrocare_0_4468.jpg': '- PROCESSED AT:\\nThyrocare\\n\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbal-400 703\\n\\nScap,, Thyrocare’\\n\\ncis aT\\n\\nCorporate Office: Thyrocare Technologies Limited @ 37/3, TTC MIDC Trbhe, Nav Mumbai 400703\\n© 022-3090.0000/ 4125 2525 8691866066 = welinesst@thyrocare.com @wwwthyracare.com\\n\\nNAME + ASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY\\nLAB, BIHUTOLI ROAD ,HOJAI ASSAM 782435,782435\\nTEST ASKED + AAROGYAM A\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (13) CLA 76 ng/dl 60-200\\nTOTAL THYROXINE (4) CLA 5 ua/dl 4,5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 plu/ml 0,3-5,5\\n\\n‘Comments; SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_447.jpg': '—\\n\\nBe cron & Eee Thyrocare\\nNavi Mumbal-00 703 Wok. nate noid Tink\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022-3090 0000 / 41252525 @ 8691866065 Ei wellness@ethyrocare.com —@wwwithyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\nREF. BY + Ser (7824357519), KALPANA MEDICOS AND CITY\\n: TAB, BIHUTOL! ROAD HOJAE ,ASSAM 782435,782435\\nTEST ASKED AAROGYAM A\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLEA 76 g/dl 60-200\\nTOTAL THYROXINE (T4) CLA 5 wa/dl  4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLLLA 214 ulu/ml 0.3-5.5\\n\\n‘Method\\n73- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n74 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_4498.jpg': 'ICESSED AT:\\n\\nae MDC athe, San. Thyrocare\\n| Mumbai-400 703 Mea, Think Thyroid. Think Thyrocare\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbat -400703\\n© 022- 30900000 /4125 2525 © 8691866066 A wellness@thyrocare.com @wwwithyrocare.com\\n\\nad + ASHIM KR SENGUPTA (25/M) SAMPLE COLLECTED AT =\\n. BY : SELF (7824357519),KALPANA MEDICOS AND CITY\\n\\ni F LAB,BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435,\\nT ASKED : AAROGYAM A\\n\\nTECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nST NAME\\n\\nTAL TRIIODOTHYRONINE (T3) CLLA 76 ng/di 60-200\\nSTAL THYROXINE (T4) C.L.LA 5 wa/dl  4.5-12\\n{YROID STIMULATING HORMONE (TSH) CLA 2.14 piu/ml 0.3-5.5\\n\\n>mments : SUGGESTING THYRONORMALCY\\nease correlate with clinical conditions.\\n\\nethod =\\n3 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_4523.jpg': \"REPORT\\n\\n ASHIM SENGUPTA (58V/M) SAMPLE COLLECTED AT +\\n: one (782435759) KALPANA MEDICOS ANO CITY\\nKED —: AAROGYAM 782435,782435\\nAME ‘TECHNOLOGY VALUE UNITS\\n\\nCLA 2a ng/mt\\n\\n¥  ;>100 na/m!\\n\\nD Total test is anolyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\np Standardization Program (VOSP).\\n\\nFULLY AUTOMATED CHEMI LUMINESCENT imal\\nIN B-12\\n\\nSAY a\\ni Ese pa/mi\\n\\nce Range:\\n241-911 pam\\n\\nsignificance :\\n212 oF cyanocobslamin, 1s a complex corrinold compound found exclusively from animal dietary\\n\\nSuch as meat, eggs and milk. It's critical in normal DNA synthests, which in turn affects erythrocyte\\non and in the formation of myelin sheath. Vitamin-B12 is used to find out neurological abnormalives\\nsired DNA synthesis associated with macrocytic anemins. For diagnostic purpose, results should\\n\\nfe assessed In Conjunction with the patients medical history, clinical examination and other findings\\n\\nsions: Intra assay (%CV):4.0%, Inter assay (96CV):4.4 %;Sensitivity:4S pa/m!\\n\\n‘quality control program participation:\\nof American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nation references:\\n,Sperting Ml,Heminger 1A Vitamin B12-tn:Pesce AI,Kalpan LA,editors. Methods in clinical chemistry.\\n‘EV Mosby, 1987.P.569-73.\\n\\n|_ FULLY AUTOMATED BIDIRECTIONALLY INTERFACED Ci€MI \\\\UMINESCENT IMPEUND ASSAY\\n\\ncorrelate with clinical conditions.\\n\\n‘t11 Feb 2020\\n$12 Feb 2020 18:37 h,\\n\\n212 Feb 2020 20:13\\n\\nSERUM\\n\\n$1202038627/0R2500 Dr S.Bera MD(Path)\", 'thyrocare_0_4557.jpg': '{= ASHIME SENGUPTA (SNM)\\n\\n2 MAROGYAN C\\n\\n\\\\iamin © Tonal tst is anatyted on Steers ADVIA Cantar, suansorcied against IO-LCIMS/MS, a par\\n\\n‘eamin © Standarceavn Program (WoSr)\\n\\netn = TUALYANTOMRTED ove Sumter mmo assay\\nLTA sr Par\\n\\n‘emir 812.0 eyanocobalami, m 9 campiex cord compound found excusvely torn animal sierary\\n‘Eoetes sch oe mest, egge and min: Sn rte! n normal DNA syne, whch orn aes wry\\nnaturation ara in te frmaton = myein swath vam B12 ined to Hind out reursogleabnarmaives\\nSes impaired ONA eyrnentsansocates with Macrocy= aren For Gagnon purpose, resuts shout\\n‘Maays ox sserend inconjunction wth the patience medias story, cite! examination and eter fein\\n\\nSoecncaions: Inte nesty (NEV:A.O%, Irae seay (REVI:A A Me Senwrvty 45 P/M\\n\\nSe\\n\\na\\n\\nKat valiawion seterences:\\n\\noe ee\\nSoe\\n\\n= SaaS Stems\\n\\nSe\\n\\nol\\n\\n#1 Feb 2020 08:00\\n#12 Feb 2020 16:37\\n#42 Feb 2020 20:13', 'thyrocare_0_4618.jpg': 'Thyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\ncap, Thyrocare’\\n\\ncee Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n‘© 022- 3090 0000 / 4125 2525 © 8691866066 EA wellness@thyrocare.com G wwnnthyrocare: cor\\n\\nNAME + ASHIM KR SENGUPTA (25V/M) SAMPLE COLLECTED AT :\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\nLAB, BIHUTOLT ROAD ,HOJAT ASSAM 782435,\\n\\nTEST ASKED + AAROGYAM A aes\\nTEST NAME VALUE _ UNITS REFERENCE RANGE\\nJOTAL TRIIODOTHYRONINE (T3) 76 ng/di 60-200\\n\\nTOTAL THYROXINE (14) 5 vad 4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) 214 pIU/ml 0.3-5.5\\n\\nComments: SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\n773 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_4670.jpg': 'J\\n\\nPROCESSED AT :\\n\\necap,, Thyrocare®\\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022-3090 0000 / 41252525 @ 2691866066 © Weliness@thyrocare.com (www thyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\nREF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY\\nLAB, BIHUTOLT ROAD ,HOJAT ,ASSAM 782435,782435\\nTEST ASKED 2 AAROGYAM A\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLLA 76 ng/di 60-200\\nTOTAL THYROXINE (T4) C.LLLA 5 ug/dl  4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CALLA 2.14 ylu/ml 0.3-5.5\\n\\nComments: SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\n73 - COMPETITIVE (CHEMI LUMINESCENT IMMUNO ASSAY\\n\\n-\\n\\n= COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY ad', 'thyrocare_0_4683.jpg': 'D-37/1,TTC MIDC,Turbhe, pede ee\\nNavi Mumbal-a00 703 i\\n\\n‘ aT:\\n“Thyrocare & = CAP.\\nACCREDITED\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Ture,\\n© 022 - 30900000 / 4125 2575 @ 8691866066 EA weliness@thyrocare.com\\n\\n+ ASHIM KR SENGUPTA (25¥/M)\\nREF. BY + SELF TAB, BIHUTOLT ROAD ,HOJAL ,ASSAM 782435, 782435,\\nTEST ASKED + AAROGYAM A\\n\\nVALUE UNITS REFERENCE RANGE\\n76 ng/di 60-200\\n5 ug/dl  4.5-12\\n2.14 pIU/ml_0.3-5.5', 'thyrocare_0_4748.jpg': '-ThyrocareTechoologies Limited @ 0°37/3, TTC AIDC, Trt Mav Mamba 400703\\n41252525 © 8691865066 EB wetinessfPrnyrocare.com @wwwithyrocarecem\\n\\naM |: ASHIM SENGUFTA (58074) SAMPLE COLLECTED AT:\\n+ (7824357519) KALPAWA MEDICOS AND CITY\\n\\n= Weis TAB SIBLITOCL ROAD /HOIAT ASSAM,\\n\\nTESTASKED — AAROGYANC Waa 702435\\n\\n‘TEST NAME TechNoLoGY VALUE UNITS\\n\\n-25-0H VITAMIN D (TOTAL) CLA pay g/m\\n\\nReference Range :\\n\\nBerierency 20 oan\\n\\nINSUFFICIENCY : 20°30 n/n\\nSUFFICIENCY = 30-100 ng\\nFoxy: 100 aa/m!\\n\\n\\\\vcarnin D Tora test is snalyed on Siemens ADVIA Centaur standarcaed against ID-LC/MS/MS, #8 per\\n‘veamin O Standardization Program (VS?)\\n\\net [UMLY AUTOMATED EM: nacht em ASAT\\n\\nVITAMIN 8-12 GLIA Est palm\\nReference Range :\\n\\nermal 211-811 palm\\n\\n‘nical ssninconce\\n{Vtarin B12 or cyanocabslanin, 3 compiex cornold compound found excisiety from animal dietary\\nSource, sch as ea, egg and mls Ie cre! In normal ONA syrhels, which tur affects erythrocyte\\n‘maturation anc Une formation f myelin sheath. Viera B12 used to fin out neurological abnormal\\nfed impaired OWA srtneds asocated wth macracytie anemia. For Gagaosc purpose, results should\\ninate assesed In conjunction with the patents mesa! Nistor, circa! examination and other fing.\\n\\n“Specicatons: Intra assay (%CV):4.0%, Int assay (SCV): 4-4 94;Senatvny45 pam\\n\\n{Exteral quality contre progam paicipston:\\n‘Gllege of Arercan pathologie: and assay (general) survey: CAP rumber: 7193855-08\\n\\nee validation references:\\n{Chen TW,Spering ML, Heminger IA tain 812.1: Pesce A,Kalpan LA.eltors Methods In inca chemistry\\nSELDUSCV Mosby 1987 7569-73.\\n\\neth uty Avene RDIRECTTONAAY LUMINESCENT NM ASSAY\\nPreate correlate with clinical conditions.\\n\\n#11 Feb 2020 08:\\n\\n1212 Feb 2020 18:37 h\\n\\n#12 Feb 2020 20:13\\n\\nSERUM\\n\\n+11202038627/0R2500 Dr $ Bera MD(Path) ‘Dr. Caesar Sengupta MOXMier=', 'thyrocare_0_4790.jpg': '=\\n\\nD-37/1,1TC MIDG,Turbhe, ae RAP Thyrocare’\\n\\nNavi Mumbai-400 703 oats\\n\\nwna Sine Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090.0000 / 4125 2525 © 8691856066. EF weliness@thyrocare.com @wowwihyrocare com\\n\\nNAME + ASHIM KR SENGUPTA (25V/¢) SAMPLE COLLECTED AT =\\nEs (7824357519), KALPANA MEDICOS AND CITY,\\nUAB, BINUTOLI ROAD ,HOJAT ASSAM 782435,782435\\nTEST ASKED\\nTEST NAME \"TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nFOTAL TRHODOTHYRONINE (T3) ELIA 76 g/dl 60-200\\nTOTAL THYROXINE (T4) CLA 5 pa/dl 45-12\\nTHYROID STIMULATING HORMONE (TSH) C.LLLA 214 plu/mt_ 0.3-5.5\\n\\nComments: SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\n‘Method :\\n\\n73 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTa - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n‘SH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_4979.jpg': '‘Towers II, RAA/36, Raghunathpur,\\nRoad, Kolkata~700 059\\nCorporate Office : Thyrocare Technologies Limited @ -37/3, TIC MIDC, Turbhe, Navit\\n© 022-3090 0000/4125 2525 8691866065 && wellnesséBthyrocae.com ©\\n\\nNAME + ASHIM SENGUPTA (S8Y/M)\\n\\n‘REF, BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\nTEST ASKED + AAROGYAM C LAB, BIHUTOLI ROAD ,HOJAL ASSAM 782435,7\\n\\nTEST NAME\\n\\nTECHNOLOGY VALUE _ UNITS\\n\\nALKALINE PHOSPHATASE PHOTOMETRY 67\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di\\nBILIRUBIN (INDIRECT) CALCULATED 0,39 ma/di\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nel ALBUMIN - SERUM. PHOTOMETRY 3.93\\n— ‘SERUM ALB/GLOBULIN RATIO CALCULATED 1.22\\n\\nfj ‘SERUM GLOBULIN PHOTOMETRY 3.21', 'thyrocare_0_5074.jpg': 'x aT:\\n‘Thyrocare\\nD-37/1,1TC MIDC,Turbhe,\\nNavi Mumbai-400 703 a _\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TIC MIDC, Turbhe, |\\n© 022 -3090.0000 / 4125 2525 © 8691866066 Es wellness@thyrocare.com\\n\\nNAME ‘ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT,\\n(7aaeae rato aan AND CITY\\n\\n‘REF. BY + SELF [BIHUTOLT ROAD ,HOJAT ,ASSAM 782435,782435\\n\\n‘TEST ASKED + AAROGYAM A\\n\\nVALUE UNITS REFERENCE RANGE\\n7 ng/di 60-200\\n5 pa/dl  4.5-12\\n\\n244 piu/mt 0.3-5.5', 'thyrocare_0_511.jpg': '——\\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\necap, Thyrocare’\\n\\ncame hak Tyee Tae ‘\\n\\nCorporate Office : Thyrocare Technologies Limited © 0-37/3, TTC MIC, Turbhe, Navi Mumbai - 400703\\n© 022-3090 0000/4125 2525 8691866065 A wellness@thyrocare com @ywwthyracare-com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT +\\n\\nFe (7824357519), KALPANA MEDICOS AND CITY\\nLas hod LAB BIHUTOLT ROAD ,HOJAI ASSAM 782439,782435\\nTEST ASKED + AAROGYAM A\\nTEST NAME te UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) ng/dl 60-200\\nTOTAL THYROXINE (T4) CLA 5 ya/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLIA 2.14 plu/ml 0,3-5.5\\n\\n‘Comments ; SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\nMethod :', 'thyrocare_0_517.jpg': 'PROCESSED AT\\n\\n‘Thyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, |\\n© 022 - 30900000 / 41252525 @ 8691866066 © wellness@thyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25¥/M)\\n\\nSAMPLE COLLECTED AT =\\n(7824357519), KALPANA MEDICOS AND CITY\\n\\nor LAB,BIHUTOLT ROAD ,HOJAT ,ASSAM 782435,782435\\n+ AAROGYAM A\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nFJOTAL TRIIODOTHYRONINE (13) CLA 76 ng/dt_ 60-200\\n‘TOTAL THYROXINE (14), CLLA 5 wash 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 plu/ml 0,-5.5', 'thyrocare_0_532.jpg': \"Thyrocare®\\n\\nCorporate Office :Thyrocare Technologies Limited | 9 D-A7/3, TTC MIDC, Ture, Mavi Mumbat 400703\\n‘Ganz 307 00/4195 2525 © HUNIBETDEL EAwWetnemenmacate cry @ wyerhyrocarecem\\n\\nname + ASHIM SENGUPTA (S8Y/™) SAMPLE COLLECTED AT.\\n: (7825357519) KALPANA MEDICOS AND CITY\\n\\neacail SG TABBINJTOLE ROAD ,MOIAL ASSAM\\n\\nTeSTASKED — ; MAROGVAME TIA, 7B2AIS\\n\\nTEST NAME TECHNOLOGY UNITS\\n\\n25-OH VITAMIN D (TOTAL) CLEA 2 n/m\\n\\nReterence\\n\\nange:\\nDenicteNcy 120 n9/r)\\nINSUPFIGIENCY : 20-20 rift\\nSUFFICIENCY = 30-100 ra/m)\\nTOXICTTY = +100 ea/m\\n\\nican © Total tet Is anlyred on Siemens ADVIA Centaur, stadansieed against 1O-LC/MS/MS, as por\\nYVeamin © Standarduation Program (VOSP)\\n\\nMethod: EUALY AUTOMATED CHE ALM IMMUNO ASSAY = one\\nVITAMIN 8-12 GLIA sr Pale\\neterence\\n\\nNewmar 211-3914 pa/m\\n\\n‘ina soniearce\\n\\n‘itary 82 or cyorocobalamin, te complex cornold compound found exclsivaly from animal dietary\\n‘arcs, eh a meat, A0Q% an! rie Tes eal In normal DNA synthest, which n turn affects erytrrocyte\\nmaturation and in the formation of mys sheath, Viesmin-B12 fs used ta find aut neurologeal abnotmalives\\n[Bat Impaired OWA syrinens asvociated with macrocysic anemis. For diagnostic purpose, results should\\nsiways be asseseed in Coniunction withthe patents media! history, ena examination and other ndings.\\n\\n‘Speciteatons: Intra aseay (%4CV):4.0%, Inter astay (®HCW):4 4 Seruvy:4s pay\\n\\nExternal quality contrel prograin potciaton\\nCGallege ot American pathologists: igang ascay (general) survey; CAP number: 7193855-01,\\n\\n‘te validation references:\\n\\n{Chen IW Sperling MI Heminger IA\\\\Vtarin B12.1n'Pesce/A,Kalpan LA eltors Methods in clinical chemistry\\n‘Method ALY AUTOMATED BIDIRECTIONALLY.\\n‘Please correlate with clinical conditions.\\n\\nERFACED Gigb LINES MIND ASSAY\\n\\n#11 Feb 2020 08:00\\n+12 Feb 2020 18:37 he\\n#42.Feb 2020 20:13\\n\\nSERUM\\n\\nee oe rronaie OS oer Hoh) Ds Caesar Sengurta MOM\\nae Page s0t11\", 'thyrocare_0_5338.jpg': 'AT:\\n\\n‘Thyrocare = ECAP\\n-37/1,TTC MIDC,Turbhe, AccREDMEDW/\\nNavi Mumbal-400 703 ont!\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe,\\n‘© 022 - 3090 0000 /4125 2525 © 8691866066 EA wellness@thyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT.\\nREF. BY + SELF Cee UTOL ROAD OUAL\\nTEST ASKED + AAROGYAM A\\n\\nVALUE UNITS REFERENCE RANGE\\n76 g/dl 60-200\\n5 wa/dl  4,5-12\\n214 plu/ml 0.3-5.5', 'thyrocare_0_5357.jpg': 'Thyroca\\n\\ns Limited 9 D-37/3, TTC MIDC, Turbhe. Naw Mumba - 400703\\nyreriing Een Ciolalbe sects Cid\\n\\n© 1 ASMIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AT =\\nBY see (7824957919) KALPANA MEDICOS AND CITY\\n15, BIMUTOL! ROAD ,HO3AT ,ASSAM\\nTASKED: AAROGYAMC. 702435,702435\\nT NAME: = UNITS\\nOH VITAMIN D (TOTAL) cLLA 2 ng/mt\\nerence Range»\\nIGIENEY 1 20 ng fent\\n\\nUFFIGIENCY | 20-<30 mg/m\\nFICIENCY = 30-100 no/mi\\nCETY = >100 pa/m!\\n\\nerin © Total test ls anaiyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\nrnin © Standardization Program (VOSP),\\n\\ned: _FUUY AUTOMATED CHEM LUD\\nAMIN B-12\\n\\nerence Range :\\n\\nmia): 211-814 pov\\n\\nmnyno assav =\\nLA sr pari\\n\\nyeal igrvfeanice\\nnin B12 oF cyanocobularnin, I a complex corrinold compound found exclusively from animal dietary\\nfees, sich as meat, eggs and milk, It\\'s critica in normal DMA synthesis, which in turn affects erythrocyte\\nuration and in the formation of myelin sheath, Vitamnin-B12 = Used to find out neurological abnormalities\\njimpaired ONA synthesis asecciated with macracytic anemins. For aiagnastic purpose, results show\\'s\\n\\nays be assessed In conjunction with the patients medical history, clinical exarhination and other fings.\\n\\ncifcations: Intra assay (MCV}:4.0%, Inter assay (SECV)-44 Ne; Sentivity:#5 pa/m|\\n\\nernal quality control program perticipation:\\njoge of American pathologists: ligand assay (general) survey; CAP number: 7193855-01\\n\\nvalidation references:\\nIW, Sperting MI,Heminger 1A vitamin 812.In:Pesce A},Kalpan LAeditors. Methods in clinical chemistry.\\nLouls:CV Mosby, 1987.\" 69-73.\\n\\nAY IVTERPACED CHENH LuMNESceNT IMMUNO Assay\\nae correlate with clinical conditions.\\n\\n£12 Fab 2020 20:13\\nSERUM\\n£1202038627/0R2500 Or S Bera MD(Path) ‘Gibiacs Sone\\n\\nPage: 3.0f 11', 'thyrocare_0_5503.jpg': 'NAME 4 ASHIM SENGUPTA (58Y/™) SAMPLE COLLECTED AT.\\n\\n4 (7824357519) KALPANA HEDICOS AND CITY.\\nae ji {ABSINUTOL ROAD ;MOJAL ASSAM\\nTEST ASKED =: AAROGYAMC 702435, 782435\\nTEST NAME TECHNOLOGY VALUE. OUNITS,\\n25-OH VITAMIN D (TOTAL) CLEA 2 ng/mt\\nReference Range\\n\\nDERICTENCY1\"<20 ogi\\nINSUFFICIENCY £ 20-<30 n/m\\nSUFFICIENCY = 30-100 na/mi\\nToxic; >100 ng/ml\\n\\n\\\\vaamin D Yotal test analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/ES, a8 per\\n\\\\viamin D Standardization Program (VOSP)\\n\\notheed :_FOUY AUTOMATED QHMt |omNs-SCENT DMMUNO ASSAY =\\n\\nVITAMIN 8-12 CLEA eo palm\\n\\nNonmal ait\\n\\n‘Cimicalsgniiconce\\n\\n‘Vitamin B12 or cyanocobolamin, 1s 2 complex carrnoid compouns Tound exciusivey trom animal dietary\\n‘Spuroes, stich ne Meat, epg and ilk. Ils eral in normal DNA syrthess, which in turn affects erytwrocyte\\nmaturation and in tne formation of msi sheath, Viamiy-BL2 fe led ta find cut neurologica) abnormalities\\n‘tnd impaired DNA synthesis associated with macrocytic anemins. For diagnostic purpose, resus should\\n‘Shays be assessed io conjonction with the patienes medical history, ciniea! examination and other findings\\n\\n‘Specincations: Intra assay (S4CV}:4.0%6, Inter assay (S6CV):4:4 %;Sensmivty:45 p9/m!\\n\\nExternal quatity control progratn participation\\nCollege of American pathologists: ang aseay (general) survey: CAP number: 7193885:01\\n\\n0 vaisiacon references:\\n\\n‘Chen IW Sporting MI,Heminger 1A.vtemin 812-In:Pesce AJ,Kalpan LA,esitors Methods in einical chemistry.\\n‘SELouIs:CV Mosby.1987 ?.569-72,\\n\\nthd :_PUlky AVTOMATED BIDIRECTIONA\\\\AY INTERPACED CIM \\\\UMESCRNT IMMUNE ASSAY\\n\\nPlease correlate with clinical conditions,\\n\\n#41 Feb 2020 08:00\\n312 Feb 2020 18:37 bey\\n#12 Feb 2020 20:13\\nSERUM\\n+#1202038627/0R2500 Dr S.Bora MD\\\\Path) ‘Dr-Coesar Sengupta MOI\\n\\nSaal Page:3.0f 11', 'thyrocare_0_5608.jpg': 'aa 9 Saino MIS vise oA\\n{43252575 OD SETISEAOEG ES welinesseetinrocare.com\\n\\n1 ASHIM SENGUPTA (SiN¥/H) SAMPLE COLLECTED AT. =\\n. (ciasas7s19),nALPawn MEOICOS AND CITY\\nSKED Yaeaanvozeas\\n\\nAme TecnnoLocy wane =\\n| VETAMIN D (TOTAL) una 2\\n\\nRange:\\nBey 20 rose!\\nNGIENCY | 20-30 mg/m\\nTENCY - 30-100 novrnl\\nfr = >300 ng/ml\\n\\n2 Total test analysed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS. a5 per\\n: B Seandardieation Program (VOS!\\n\\n| FRAY AUTOMATED COVEN LUMINESCENT JManUC ASSAY a\\nsn 8-32 rota 9 Eo pave\\n\\neT TST parm\\n\\ngnincance\\ntien and in the formation of myelin sheath. Vitarnin- B12 tm med fo find out neurological abnormalibes\\npaired ONA syritncrs ssecciated with ractocyric anemuns. For diagnostic purpose, results shouia\\n\\nSoe savested In conhinction with te patients medica! history, chiles! examination and other Rng\\n\\ncations: Intre assay (HEN):M.0%, Inter aacay (MCVI4.4 We:Seneniity:45 pa/m!\\n\\na! quatity control program participation\\nof Amorican patnalogiat: lgnns ascay (generat) survey: CAP number 7193835-01\\n\\nanton references\\nWy Sparing MIMerNnger IA.Vitaimin B12 In:Pesce AI,Keipan LAeditors Methods In cline\\nSCV Mosby 1987 P.309-73.\\n\\n—\\n\\nDr. Caesar Sengup\\nPage 30f tt', 'thyrocare_0_5640.jpg': \"2 Towers II, RAA/36, Raghunathpur,\\nRoad, Kolkata-700 059\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai -40\\n© 022 - 3090 0000 / 41252525 @ 8691866065 4 weliness@thyrocare.com @\\n\\nNAME + ASHIM SENGUPTA (58¥/M) SAMPLE COLLECTED AT :\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\nWelrmeen = Aanocvan'c (AB, BIHUTOLT ROAD ,HOJAT ASSAM 782435,\\n\\nTEST NAME TECHNOLOGY\\n\\nALKALINE PHOSPHATASE PHOTOMETRY\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/di\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/di\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 us\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 uA\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 ul\\nPROTEIN - TOTAL PHOTOMETRY 714 am/dl\\nALBUMIN - SERUM PHOTOMETRY 3.93 arn/dl\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio\\nSERUM GLOBULIN PHOTOMETRY 3.21 am/dt.\\n\\nPlease correlate with clinical conditions.\", 'thyrocare_0_5816.jpg': 'bedi\\n\\n1 I, RAA/36, Raghunathpur,\\nRoad, Kolkata-700 059\\n\\n4 Corporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai -\\n© 022-3090 0000/4125 2525 @ s691866066 m&% wellness@thyrocare.com @:\\n\\nThink Thyroid,\\n\\nNAME : ASHIM SENGUPTA (58Y/M) SAMPLE COLLE pet \"\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY _\\nTESTASKED —: AAROGYAM C LAB,BIHUTOLT ROAD ,HOJAL ,ASSAM 782435,78\\nTEST NAME TECHNOLOGY\\n\\nALKALINE PHOSPHATASE PHOTOMETRY\\n\\nBILIRUBIN - TOTAL PHOTOMETRY\\n\\nBILIRUBIN -DIRECT PHOTOMETRY\\n\\nBILIRUBIN (INDIRECT) CALCULATED\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY\\n\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY\\n\\nPROTEIN - TOTAL PHOTOMETRY\\n\\nALBUMIN - SERUM PHOTOMETRY\\n\\nSERUM ALB/GLOBULIN RATIO CALCULATED\\n\\nSERUM GLOBULIN PHOTOMETRY', 'thyrocare_0_5858.jpg': 'PROCESSED AT :\\nThyrocare\\n\\nShree Towers II, RAA/36, Raghunathpur, oO\\n\\nVIP Road, Kolkata~700 059 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000/4125 2525 @ 8691866066 4 weliness@thyrocare.com @www:thyrocare.com\\n\\nNAME : ASHIM SENGUPTA (58Y/M) SAMPLE COLLECTED AT :\\n\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\n\\nTEST ASKED = AAROGYAM C LAB,BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435 ‘\\n} L\\n\\nTEST NAME TECHNOLOGY VALUE UNITS _ NORMAL RANGE\\n\\nALKALINE PHOSPHATASE PHOTOMETRY 67 Ui. -45=cs aa\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 mg/dl 0.3-1.2\\n\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di <0.%\\n\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/dl 0-0.9\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 uA <55\\n\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4 u/l <35\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 ul <45\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.14 gm/di 5.7-8.2\\n\\nALBUMIN - SERUM PHOTOMETRY 3.93 gm/di 3.2-4.8\\n\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio 09-2\\n\\ngm/dt 2.5-3.4\\n\\nSERUM GLOBULIN PHOTOMETRY 3.21', 'thyrocare_0_5879.jpg': '. a\\n\\nae & ecap,, Thyrocare®\\n\\nD-37/1,1TC MIDC,Turbhe,\\nNavi Mumbai-400 703 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited (TC MIDC, Turbhe, Navi Mumbai - 400703,\\n© 022 - 30900000 / 4125 2525 Se eae? re eee @veww.thyrocare.com\\n\\n+ ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\n: SELF (7824357519), KALPANA MEDICOS AND CITY\\nLAB, BIHUTOLT ROAD ,HOJAI ,ASSAM 782435,782435,\\n= AAROGYAM A\\n‘TEST NAME __TECHNOLOGY _ VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 76 ng/dl 60-200\\nTOTAL THYROXINE (74) CLA 5 vg/dl  4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 plu/ml 0.3-5.5\\n\\nComments: SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\nMethod =\\n\\n73 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n4 ~ COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n|= SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_5896.jpg': \"75125 3525 gepREKORS Ka welnesienrocare com _@worw:tny?Oeare cam\\n\\ntain 1 Total tet ts analyzed on Siemens ADVIA Centaur, stancarsized against ID-LC/MS/MS. a8 per\\nramin @ Standardization Program (Vos).\\n\\nend FULLY AUTOMATED rea LUMINESCENT IMMUNO ASSAY.\\n\\nITAMIN 8-12 cLIA 3s Palm\\n\\nnforence Range :\\n\\nSmal 21 = 314 poy\\n\\nical significance\\ntorn Baz oF cyanocobsalemin, te» complex corrineid compound found exclusively froma arial dietary\\nmires, sich ms Meat egge and mit. Hee ental in normal OMA synths, which sn turn aMects eryorrocyte\\nmturation an In the formation st myelin sheath, vitamin B12 fe ined te find out neurological aonormalives\\ncd impaired DNA syrinctie sszociated with macrocytic anemins. for agnostic purpase, results shou\\nwafa be Eascssed in Conhinction with the patients medica! history, dinica exermination and other figs\\n\\npecincations: Intra assay (*6CV):4.0%, Inter ascay (HCV)'A.4 Se:Senaitvity:45 po/m!\\n\\nsternal quality control program partcioation:\\nllege of American pathologists igana assay (general) uurvey: CAP number: 7193855-01\\n\\nt velaton references:\\nnon IW, Sperling MI,feminger 1A. Vitamin B12 In:Resce Al,Kalpan LAseditors Methods i cinical chemistry\\nrails: EV Mosby, 1987 0.569-73.\\n\\nethed : MMAY AUTOMATED BIDIRECTIONAL INTEMFACED Cs LUMINESCENT:\\njenee correlate with clinical congitions.\\n\\nHit Feb 2020 08:00\\n$12 Feb 2020 18:37 hy,\\n\\n£42 Feb 2020 20:13\\n\\nDr.-Caesar Sengupta M\\nPage Sottt\", 'thyrocare_0_5928.jpg': 'Thyroocare’\\n\\ncare Tec tinted 9 0377, TTC MID, Trdhe Nw Muro 00703\\nAIDS 2573 © SEFIBBOES Eh welhessetnyrocarecom @wawthyrocareceey\\n\\naM 1 AIIM SENGUPTA (8H) SAMPLE COLLECTED AT:\\n+ (782957519) KALPANA HEDICOS AND CT\\n\\nbated ee {AR BIHUTOR! ROAD OAS ASSAM\\n\\nTesTasKeD + AAROGHINC 75 70838\\n\\n‘TEST NAME TECHNOLOGY VALUE UNITS\\n\\n25-08 VITAMIN D (TOTAL) Crery a g/m\\n\\nReference Range:\\n\\nDerrENCY 20 ir\\n\\nINSUFFICIENCY 20-<30 g/t\\nSUFFICIENCY. = 30-00 na/mi\\nTOXCTY —;>100 oy\\n\\namin Teta tes i aptyed on Semen ADVIACartaur, standard apart IDLGMSIMS, a8 per\\ntamin 0 Stanariation Progam (VO5P)\\n\\nPetia :_Tuu AVTONATID CHM mrescc. NN ASSAL\\n\\nVITAMIN 8-12 GLIA Bs alm\\nReference Range :\\n\\nNeem; 211-811 ppm\\n\\nCincal sgntiance\\n‘amin B12 or eyanecobulamn, a camples corr compound found excuse fem aml delay\\nSources, Sith 9 tea, eg lk It cal in namal ONA ste, wich turn aFecsertroeyte\\n‘aration andi th formation of ein seat, Vans 2 ine to i ext neurciogeaabrarmalies\\nod ipaired DNA sybet esscated wan macys anemia, For agnostic purpose, ess sho\\n\\n‘Mays be steed In conction wt he patents die nstoy, cnc evatinaon and ater frig.\\n\\nSoectcations:rra nny (SCVI6.0%, titer assay (CV) :44 8 Senaty:AS pn)\\n\\n{tera quaity corre program parison\\nCale f Amen patios: oan assay (gener) survey; CAP number: 719985501,\\n\\nee vlitation references:\\nChen W Soaring ML Heringer Tain B12 Pesce A,Kapan Leder Meth in cal chery\\nSe Las: CV Moy 1987 569-73\\nuA INERCED EME MEMES IND ASS —\\nPlease correlate wit clinea conditions.\\n\\n1 Feb 2020 08:00\\n\\na2 Feb 2000 18:37 h,\\n\\n142 Fb 2000 20:13\\n\\n‘SERUM\\n\\n+1202038627/0R2500. Or S.Bera MOYPath) Contr Senguta MOO\\nPage: 30f11', 'thyrocare_0_6185.jpg': 'REPORT\\n\\nNAME, + ASHIM SENGUPTA (S/H) ‘SAMPLE COLLECTED AT :\\n\\nmersy 2 SELF (7824357539) KALPANA MEDICOS AN CITY\\nLhe atHUTOU ROAD ,MOMAL ASSAM\\n\\nTEST ASKED: AAROGYANC overs\\n\\nTEST NAME TECHNOLOGY VALUE UNITS\\n\\n25-OH VITAMIN D (TOTAL) CLEA u g/m\\n\\nReference Range:\\n\\nDertetencr 20 git\\n\\nINSUFFICIENCY : 20-<30 og/mt\\nSUFFICIENCY = 30-100 nay\\nTOXICITY: >100 na/mni\\n\\nVitamin © Total test i analyzed on Siemens ADVIA Certaur, standardized against ID-LC/MS/MS, a8 per\\n‘tamin 0 Standardization Program (vOSP)\\n\\nMethod: TUALY AUTOMATED OM LUMINESCENT NO ASSAY\\n\\nVITAMIN 8-12 CLIA oar pal\\n\\n‘Reference Range:\\nNormal 211-911 pam\\n\\nlineal sgriicance\\n\\n‘Vitamin B12 or cyanccobalamn, is 2 complex cornnaié compound found exccsvey tr animal itary\\n‘Sources, sich as meat, e998 and rth ts cite in normal DNA syitess, which n tur affects erythrocyte\\n‘maturation anc othe formation myn sheath, Varin B12 ie tsed to ind out neurological atnormalties\\n{thd Impaired DNA syteslsassecated with macrocyc anemias, for agnortic purpose, resuits oud\\n‘atways be assessed In conjunction wih the patents mesic: rstry, clinica examination and o:ner fining\\n\\n‘Specieatons: Inte asiay (HCV) 4.0%, Inter assay (WCW). 8 W%;Sensivty:45 pq/m!\\n\\nExternal quaity control program partcioation:\\n(College of American pathologie: Igand assay (general) survey; CAP number: 7193855-01\\n\\ni valiaationeeferences\\n‘Chen IW Sparing Mi, Heminger IA.vitain B12.tn-Pasce Al Kalpan LA,esitors Methods In cna chemistry.\\nSS LoUlssCV Mosby, 1907 9. 589-73.\\nIWTERPACED CHEN LMINESCENT SHON ASSAY\\nPlease correlate with clinical conditions,\\n\\nJa\\n\\nPage: 3.0811', 'thyrocare_0_6214.jpg': '1/4125.2525 © sentRESN6S ee ee\\n\\nREPORT\\n\\n+ ASHIM SENGUPTA (587M) SAMPLE COLLECTED AT:\\n\\nay 1 See (7828357519) KALPANA MEDICOS AND CITY\\nLAB,BIHUTOLI ROAD ,MOJAT ASSAM\\n\\nASKED: AAROGYAM C 792435,702435,\\n\\nr NAME _ TECHNOLOGY VALUE. UNITS\\n\\nOH VITAMIN D (TOTAL) CLEA 2 ng/mt\\n\\nrence Range =\\n\\nCIENCY 1 <20 n/m)\\n\\nFFIGIENCY : 20-<30 ng/mt\\nICIENCY. = 30-100 na/imi\\nEY; >100 mg/m\\n\\nnin b Total testis analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\nnin Standardization Program (VOSP),\\n\\ned |_TULLY AUTOMATED CHEMI LUMINESCENT IMMUNO ASSAY ———\\nAMIN B-12 GLIA 352 parm\\n\\nrence Range:\\n\\nna: 211-911 pg/ml\\n\\nca significance\\npin B12 oF cyanocobslamin, is a complex carrinold compound found exclusively from animal dietary\\nces, sich as meat, eggs and milk, It is critical in normal DNA synthesis, which In turn affects erythrocyte\\nwratin and in the formation of myelin sheath, Vitamin-B12 is used to find out neurological abnormalities\\nimpaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should\\n\\nys be assessed in conjunction with the patients medica! nstory, clinical examination and\\n\\ncations: Intra assay (S4CV):4.0%, Inter assay (SCV):4.4 %,;Sensitvity:45 pa/m\\n\\nmal quality control program participation:\\n39€ of American pathologists: ligand ascay (general) survey; CAP number: 7193855-01\\n\\nlhdation references:\\n1 1W,Sperting MI,Herninger 1A.Vitamin B12.tn* Pesce AJ,Kalpan LA,edltors. Methods In clinical chemistry.\\nQuis:CV Mosby, 1987.P.569-73.\\n\\n(LY INTERFACED CHEM LUMINESCENT INMUND ASSAY.\\ns5e correlate with clinical conditions.\\n\\n£12 Feb 2020 20:13\\nSERUM,\\n+:1202038627/0R2500 Or S.Bera MD(Path) Dr. Caesar Sengupta\\n\\nPage :3.0f 11', 'thyrocare_0_6222.jpg': 'Thyrocare”\\nThink Thyroid, Think Thyrocane.\\n(9 37/3. TTC MIDE, Turd. Nae Mimiba- 400703\\n\\nname «ASHIM SENGUFTA (SOM) SsaMPe couEcTED AT +\\nmeray tLe (7e2tis730) KALPANA MEDICS 40 CITY\\nTEST ASKED: AAROGYAMC sree seas ON ASS\\nTEST NAME\\n\\n25-08 VITAMIN 0 (TOTAL)\\n\\nfeterence Ranoe\\n\\nDemeter 29 im\\n\\nINSUFFICIENCY © 20-<30 nmi\\n‘SUFFICIENCY ~ 30-300 na/mt\\nYORICHTY —- >100 pa/m!\\n\\n\\\\eamin D Tora tests analysed on Siemens ADVIA Centaur\\n\\\\eamin D Stancarazation Program (¥OSP).\\n\\neto’ j_FUALYAUTOMATED Cb \\\\Umunsce¥T mono ASA\\nVITAMIN 8-12 CLIA 35 palm\\nMeterence Range :\\n\\nNowam 23t- S11 pa/m)\\n\\nLandardied against ID-LCIMSIMS, a5 per\\n\\ninal signincance\\n\\n‘Vicari B12 or cyenecobslamia, is complex conoid compound found excel from animal dietary\\n‘Surces, sich as meat, eggs and fh. 1 eral In normal DNA syithests, which in turn afects erythrocyte\\n‘raturalon ana inthe formation of mycin sheath. Vitam B12 ls used tof ut neurologist sonrmalives\\n‘Bad impaired OMA syritesls associated with mactacyic anemia, for Bageortic purpore, results Powe\\n‘Shean Ue assessed In conhnction wih the patents mec history, ints! examination aa oxher Amaia\\n\\nSpectcatons: tnre assay (WEY) :4.0%, Inter assay (WCV):44 4; Sen8m\\n\\n45 pa/ml\\n\\n{External quaity contre! program paricipanon\\n‘Galege of Arserican patalogists:Iigand assay (Qeneral) survey) CAP number: 7193855-01\\n\\nse vaiamion reterences:\\n\\n{Chen fw Speting MI,Merninger 1A. Vitaran 812.In-Pesce A.Kalpan LAeators Methods in eliical chemistry\\n“St LousiCV Mosby, 1987.9.569.79\\n\\n‘Method ;_ RU AUTOMATED BIDIRECTIONALLY ILAYACED Core\\n‘Please correlate with clinical congitions,\\n\\n711 Feb 2020 08:\\n£12 Feb 2020\\n\\n#12 Fob 2020 20:13 tie\\n\\nSERUM\\n\\n+£1202038627/0R2500 Dr Bera MD(Path) r Caesar Sengupta MD (Mic\\n\\nPage: 3.0f 11', 'thyrocare_0_640.jpg': 'ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\n(7824357519),KALPANA MEDICOS AND CITY\\n(AB, BIHUTOLT\\n\\nASKED + AAROGYAM A\\n\\nT NAME VALUE UNITS REFERENCE RANGE\\nFAL TRIIODOTHYRONINE (T3) 76 ng/dl 60-200\\n\\nTAL THYROXINE (T4) 5 va/dl  4.5-12\\n\\nYROID STIMULATING HORMONE (TSH) CLA 2.14 plU/ml 0.3-5.5\\n\\nmments : SUGGESTING THYRONORMALCY\\n\\nase correlate with clinical conditions.\\n\\nthod =\\n\\n- (CHEMI LUMINESCENT IMMUNO ASSAY\\nCOMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nerate CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_657.jpg': 'Towers II, RAA/36, Raghunathpur,\\nRoad, Kolkata-700 059\\nCorporate Office : Thyrocare Technologies Limited @ 0:37/3, TTC MIDC, Turbhe, Navi Mumba\\n© 022-3090 0000/4125 2525 © 8691865066 «4 wellness@thyrocare.com @wweu.thyrocar\\n\\nNAME + ASHIM SENGUPTA (58Y/M)\\n\\n‘REF. BY + SELF (7824357519),KALPANA MEDICOS AND CITY. I.\\nTESTASKED —: AAROGYAMC (AB, BIHUTOLT ROAD ,HOJAL ASSAM 782435,782435\\n\\nTEST NAME TECHNOLOGY\\n\\n‘ALKALINE PHOSPHATASE PHOTOMETRY\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18\\nBILIRUBIN (INDIRECT) CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.4\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nALBUMIN - SERUM PHOTOMETRY 3.93\\nSERUM ALB/GLOBULIN RATIO. CALCULATED 1.22\\nSERUM GLOBULIN PHOTOMETRY 3.21\\n\\nee. Please correlate with clinical conditions.', 'thyrocare_0_6698.jpg': \"|¢ ASHIM SENGUPTA (58¥/M) SAMPLE COLLECTED AT\\n¥ ser (7824357519),KALPANA MEDICOS AND CITY\\nLag. sinuTOU\\n\\nROAD /HOJAT ASSAM\\nSKED = AAROGYAMC\\n\\nNAME TECHNOLOGY VALUE UNITS:\\n# VITAMIN D (TOTAL) CLITA 2 nose\\nence Range\\n\\nENCY 1 <20 ng/mt\\n\\nFICIENCY : 20-<30 ng/mt\\nSIENCY : 30-100 na/mi\\nTy: >100 na/mi\\n\\nn Total test Is analyzed on Siemens ADVIA Centaur, standardized against ID-LC/MS/MS, as per\\nn © Standardization Program (VOSF).\\nd¢ FULLY AUTOMATED CHEMI LUMNESCHNT IMMUNO ASSAY _\\nMIN 8-12 CLA\\nence Range:\\n\\nToit 931 pom!\\n\\n“palmt\\n\\n{significance\\n7 B12 oF cyanacabalamin, 's 8 complex corrinold compound found exclusively from arvinal dietary\\n\\n=, such as meat, eggs and milk. 3s critical in normal DNA synthests, which in turn affects erythrocyte\\nation and in the formation of myelin sheuth, Vitamin-B12 is Used to find out neurological abnormalities\\npaired DNA synthesis associated with macrocytic anemias, For diagnostic purpase, results should\\n\\nIie axsessed In conjunction with the patients medica! story, clinical examination and other findings\\n\\nJeations: Intra assay (%CV):4.0%, Inter assay (96CV):4.4 Ye; Sensivity:45 pa/m!\\n\\nal quality control program particlomtion'\\n€ of American pathologists: ligand assay (general) survey: CAP number: 7193855-01\\n\\nlation references:\\nW. Sperling MI,Heminger IA. Vitarmin B12.tn: Pesce AJ,Kalpan LA,editors. Methods In clnical chemistry.\\nIs:CV Mosby, 1987.0 569-73.\\n\\nMLVINTERFACED CHEM LUMINESCENT IDUMUND ASSAY\\n\\ne correlate with clinical conditions.\\n\\n#11 Feb 2020 08:00\\n\\nDr. Caesar Sengup\\nPage 3 0f 11\", 'thyrocare_0_6716.jpg': '+ ASHIM KR SENGUPTA (25¥/M)\\nSELF\\nARROGYAM A\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe,\\n© 022 - 30900000 /41252525 © 8691866066 4 weliness@thyrocare.com\\n\\nSAMPLE COLLECTED\\n(7e24357 510) KALPAN\\n| BIHUTOLT ROAD.\\n\\nAND CITY\\n\"ROAD ,HOJAI ,ASSAM 782435,782435,\\n\\nTECHNOLOGY VALUE\\n\\n2.14\\n\\nng/di 60-200\\nva/dl 4.5-12\\npIU/mt_ 0.3-5.5', 'thyrocare_0_6723.jpg': 'Thyrocare® 7\\n\\nThyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai 400703\\n© 022 - 30900000 /4125 2525 © 8691866066 m4 wellness@thyrocare.com @www.thyrocate.com\\n\\nNAME 3 ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT +\\n. (7824357519), KALPANA MEDICOS AND CITY.\\nTEST ASKED + AAROGYAM A\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CALLA 76 ng/di 60-200\\nTOTAL THYROXINE (74) CLLA 5 pad  4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLLA 2.14 plu/ml 0,3-5.5', 'thyrocare_0_6743.jpg': 'es\\n\\nThyrocare\\nD-37/1,1TC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nacap,, Thyrocare®\\n\\nci sani re ne,\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbat- 400703\\n© 022-3090.0000 /4125 2525 © 8691866066 4 wellness@thyrocare.com www thyrocare-com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\nee ay Lag (7824357519) KALPANA MEDICOS AND CITY\\n\\n: LAB, BIHUTOLI ROAD ,HOJAL ASSAM 782435,782435\\nTEST ASKED + AAROGYAM A\\n\\nTEST NAME TECHNOLOGY VALUE _UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CALLA 76 ng/dl 60-200\\nTOTAL THYROXINE (14) CLA 5 pa/dl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 plu/m! 0,3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\nMethod =\\n\\n73 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTé ~ COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_6884.jpg': 'sean ar:\\n\\nThyrocare\\nD-37/1,1TC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M)\\n\\necap, Thyrocare’\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-7/3, TTC MDC, Turbhe, Navi Mumbat- 400708\\n© 022- 30800000/ 4125 2525 © 8691866066 Es weliness@thyrocare.com @www:thyrocate-com\\n\\nThink Thyroid. Think Thyrocare,\\n\\nSAMPLE COLLECTED AT :\\n: (7824357519), KALPANA MEDICOS AND CITY\\n\\npar BY Boer LAB, BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435\\nTEST ASKED : AAROGYAM A\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) C.LLA 76 ng/dl 60-200\\n\\nTOTAL THYROXINE (T4) CLA 5 pa/dl 4,512\\n\\nTHYROID STIMULATING HORMONE (TSH) C.LLA 2.14 ylu/ml 0.3-5.5\\n\\n‘Comments : SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\nMethod :\\n\\n773- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n% COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_7075.jpg': '|\\n\\nBe imcnn & cae Thyrocare\\n\\nNavi Mumbai-400 703\\n\\naa Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 30900000 /4125 2525 © 8691866066. Si wellness@thyrocare.com @wwwthyrocare-com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) ‘SAMPLE COLLECTED AT\\nREF. BY : SELF (7824357519) KALPANA MEDICOS AND CITY\\nLAB BIHUTOLT ROAD ,HOJAL ASSAM 782435,782435\\n‘TEST ASKED + AAROGYAM A\\n‘TEST NAME = TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLEA 76 g/dl 60-200\\nTOTAL THYROXINE (T4) CLIA 5 va/dl 45-12\\nTHYROID STIMULATING HORMONE (TSH) CLILA 2.14 plu/mi 0.3-5.5\\n\\n‘Comments : SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\nMethod =\\n\\n773 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n\\nT4 - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n‘TSH - SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_7082.jpg': '', 'thyrocare_0_7083.jpg': \"REPORT\\n\\npane + ASHIM SENGUPTA (581) ‘SAMPLE COLLECTED AT +\\n\\ner : (7825357519) KACPAWA MEDICOS AND CITY\\nlel veh LAB,BIHUTOLT ROAD ,HOJAI ASSAM:\\n\\nTESTASKED © AAROGYANC means 720\\n\\n‘TEST NAME TECHNOLOGY VALUE UNITS\\n\\n25-08 VITAMIN D (TOTAL) cura Fa g/m\\n\\nReference Range:\\n\\nDERICTENGY 1 C20 ni\\n\\nINSUFFIGIENCY | 20-<30 rg/mt\\nSUFFICIENCY: 30-100 0g/m!\\nYoucHY —:>100 parm\\n\\n\\\\Vieamin 0 Total est bs analyzed on Siemens ADVIA Centaur, standardized against ID-LCIMSIMS, as per\\n\\naa\\n\\n‘Cimea signincance\\n\\nView B12 or cyanocobalamin, is 8 complex corinckt compound found exciosvety from animal dietary\\n“Sporees, such ag meat, eggs and mii. IE's ctieas in normal DNA sythese, which in turn affects eryenrocyte\\n‘matatiog ad inthe formation of myelin sheath. Vkamir-B12 fe tue to fed out neurological abnormalies\\n‘and impaired ONA syrinens sssclated with macrocys aremias, for ciagnostc purpose, resuits shows\\n‘rays be assessed In conjunction withthe patenes medica histor, clea! exarnnation and other ngings\\n\\n‘Specincations: Inte assay (%4CV):4.0%, Iter assay (S8OV):4.4 9; Sensivy:4S pain\\n\\n‘External quality contrat program partcipston:\\n‘Galege of American pathologists: gang ascay (general) survey; CAP number: 7193855-01,\\n\\nee vallanon references:\\n\\n‘Chen IW Sparing Ml Heninger IA Vitamin B12 In:Pasce AJ Kaipan LA,eitors Metnods In cnical chemistry.\\nStLouisCV Mosby.1987_P'60-73.\\n\\nMethod |FULL AUTOMATED BIDIRECTIONAL INTEBPACED CHM LUMINESCENT DMD ASSAY\\n\\nPlaase correlate with clinical conditions.\\n\\n#11 Feb 2020,\\n$12 Feb 2020 18:37 he\\n#12 Feb 2020 20:13,\\n\\nPage 3 0f 11\\n\\n#1202038627/0R2500 Dr S.Bera MD\\\\Path) Or Coeser Sengupta MOMicr\", 'thyrocare_0_7109.jpg': 'PROCESSED AT: E\\nFhyrocare Thyroeall\\nShree Towers II, RAA/36, Raghunathpur,\\n\\nVIP Road, Kolkata~700 059 Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 @ 8691865066 & wellness@thyrocare.com @www.thyrocare.com\\n\\nNAME ASHIM SENGUPTA (58Y/M) eAuplecouee nn ee\\nREF. BY SELF (7824357519), KALPANA MEDICOS AND CITY\\nTEST ASKED AAROGYAM C LAB,BIHUTOLI ROAD ,HOJAI ,ASSAM 782435,782435\\nH\\nTESTNAME TECHNOLOGY VALUE\\nALKALINE PHOSPHATASE PHOTOMETRY \"Oe\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18\\nBILIRUBIN (INDIRECT) CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nALBUMIN - SERUM PHOTOMETRY 3.93\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22\\nPHOTOMETRY 3.21\\n\\nSERUM GLOBULIN ae |\\nPlease correlate with clinical conditions. ;', 'thyrocare_0_7219.jpg': 'Z\\n\\nPROCESSED AT: \"\\nD-37/1,TTC MIDC,Turbhe, CARY Thyro care’\\nNavi Mumbai-400 703 ‘aii reer daaemcan m.oeS\\n\\nmara Sm Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai -400703\\n© 022-3090 0000/4125 2525 © 8691866066 EA weliness@thyrocare.com wwwith ol\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\n\\nnee, oes (7824357519), KALPANA MEDICOS AND CITY\\nTEST ASKED + AAROGYAM A\\n\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) - LA 76 ng/dl 60-200\\n\\nTOTAL THYROXINE (T4) C.LLA 5 va/dl  4,5-12\\n\\n‘THYROID STIMULATING HORMONE (TSH) CLA 2.14 ulu/ml 0.3-5.5\\n\\nComments = SUGGESTING THYRONORMALCY', 'thyrocare_0_757.jpg': 'D-37/1,TTC MIDC,Turbhe, & EAP Thyrocare’\\n\\nNavi Mumbai-400 703 nhc, menses Think Thyroid. Think Thyrocae.\\n\\nCorporate Office :Thyrocae Technologies Limited  0-37/3, TIC MIDE, Tarbhe, Nav Mumbai 400703\\n© 022 -3090.0000 / 4125 2525 © 8691866066 EA weliness@thyrocare.com @ wwwhyrocare-com,\\n\\nNAME + ASHIM KR SENGUPTA (25Y/N) SAMPLE COLLECTED AT :\\n\\n(7824357519) KALPANA MEDICOS AND CITY\\nner BY Beat LAB, BIHUTOLI ROAD ,HOIAL ASSAM 782435,782435\\nTEST ASKED AAROGYAM A\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 76 g/dl 60-200\\nTOTAL THYROXINE (T4), CLIA 5 pail 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLI.A 2.14 ulu/ml 0.3-5.5', 'thyrocare_0_7571.jpg': 'ecap, Thyrocare™\\n\\nsusescmonisnecs\\\\ Think Thyfod. Tink Thyrocare.\\n\\n‘Thyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703.\\n\\nCorporate Office: Throcae Technolgies Limited @ 0-7/3, TTC MDG, Turbhe Na Mumbai 40703 |\\n© 022-3090 0000 / 4125 2525 © 8691866066 EA wellness@thyrocare com @wwwithyracare-comy\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\n\\n: (7824357519), KALPANA MEDICOS AND CITY\\nGalil ‘aie LAB, BIMUTOLT ROAD ,HOJAL ASSAM 782435,782435\\nTEST ASKED 1 AAROGYAM A\\nTEST NAME TECHNOLOGY VALUE —_ UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 76 ng/él 60-200\\nTOTAL THYROXINE (T4) CLA 5 va/dl 45-12\\n\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 ulu/ml 0,3-5.5', 'thyrocare_0_7601.jpg': 'ROCESSED AT:\\nhyrocare\\n\\n-37/1,1TC MIDC,Turbhe,\\navi Mumbal-400 703\\n\\n=cARP, Thyrocare\\n\\nei Think Thyroid. Think Thyrocare-\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703,\\n© 022 - 3090 0000 / 41252525 © 8691866066 &4 weliness@thyrocare.com  @www.thyrocare com}\\n\\nLAME 2 ASHIM KR SENGUPTA (25¥/™) SAMPLE COLLECTED AT :\\naie (7824357519), KALPANA MEDICOS AND CITY\\n\\nier. BY. LAB, BIMUTOLT ROAD ,HOJAI ASSAM 782435,782435\\n\\nEST ASKED AAROGYAM A,\\n\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nng/di 60-200\\nug/dt 45-12\\n14 pIU/ml 0.3-5.5', 'thyrocare_0_7635.jpg': 's Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata~700 059\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbal\\n© 022 - 3090 0000/4125 2525 @ 3691865066 & weliness@thyrocare.com @\\n\\n+ ASHIM SENGUPTA (58Y/M) ‘SAMPLE COLLECTED AT\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\n\\nTEST ASKED + AAROGYAM C\\n\\n___ TECHNOLOGY\\n\\n“ALKALINE PHOSPHATASE PHOTOMETRY\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18\\nBILIRUBIN (INDIRECT) CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nALBUMIN - SERUM PHOTOMETRY 3.93\\n‘SERUM ALB/GLOBULIN RATIO CALCULATED 1.22\\n‘SERUM GLOBULIN PHOTOMETRY 3.21\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_7758.jpg': '— @ 2c Thyrocare\\n\\nNavi Mumbai-400 703 eee, ammnnonsess Think Thyroid. Think Thyrocare,\\n\\n Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 3090 0000 / 41252525 © 8691866066 4 wellness@thyrocare.com (www:hyrocare tom\\n\\nNAME + ASHIM KR SENGUPTA (25Y/™)\\n\\nSAMPLE COLLECTED AT :\\n\\n+ SELF (7824357519), KALPANA MEDICOS AND CITY\\n\\n‘ LAB, BIHUTOLI ROAD ,HOIAL ASSAM 782435,782435\\n+ AAROGYAM A\\n\\nTEST NAME VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) 76 g/dl 60-200\\n‘JOTAL THYROXINE (T4) 5 pa/dl  4.5-12\\nTHYROID STIMULATING HORMONE (TSH) 2.14 plu/mi 0.3-5.5', 'thyrocare_0_7791.jpg': 'aT\\n\\nTowers II, RAA/36, Raghunathpur, :\\nAP Road, Kolkata—700 059 Think Thyroid. Th\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai -\\n© 022 - 3090 0000 / 41252525 © 8691866066 © wellness@thyrocare.com @www.th)\\n\\n‘AME = ASHIM SENGUPTA (S8Y/M) SAMPLE CO! ‘\\n\\nEF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY.\\n\\nEST ASKED = AAROGYAM C LAB, BIHUTOLI ROAD ,HOJAL ,ASSAM 782435, 7824\\n3\\n\\nrEST NAME x TECHNOLOGY ___ WALUE\\n\\n\\\\LKALINE PHOSPHATASE PHOTOMETRY 67\\n\\nSILIRUBIN - TOTAL PHOTOMETRY 0.57\\n\\nSILIRUBIN -DIRECT PHOTOMETRY 0.18\\n\\nILIRUBIN (INDIRECT) CALCULATED 0.39\\n\\nSAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\n\\nSPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\n\\nLANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\n\\nROTEIN - TOTAL PHOTOMETRY 7.14\\n\\nLBUMIN - SERUM PHOTOMETRY 3.93\\n\\nERUM ALB/GLOBULIN RATIO CALCULATED 1.22\\n\\nERUM GLOBULIN __ PHOTOMETRY 3.21\\n\\nlease correlate with clinical conditions.', 'thyrocare_0_7805.jpg': '~\\n\\nThyrocare\\nBe cen, ecae, Thyrocare’\\nNavi Mumbal-400 703 meen Tink Thytoid. Think Thyrocare,\\n\\nCorporate Ofice:Thyrocare Technologies Limited @ 37/3, TTC MIDC, Turbhe, Navi Mumbai 400703\\n© 022-3090 0000/4125 2525 © 8691866066 4 welinesst@thyrocare.com www thyrocare com:\\n\\nNAME + ASHIM KR SENGUPTA (25/M) SAMPLE COLLECTED AT:\\nREF. BY + SELF (7824357519) KALPANA MEDICOS AND CITY\\n\\ni i LAB, BIHUTOLI ROAD ,HOJAL ASSAM 782435,782435\\n‘TEST ASKED + AAROGYAM A\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nCee _____ —————\\nTOTAL TRIIODOTHYRONINE (13) CLLA 76 g/dl 60-200\\nTOTAL THYROXINE (T4) GLIA 5 va/dl 45-12\\nTHYROID STIMULATING HORMONE (TSH) GLIA 2.14 plu/ml 0.3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n\\n‘Method :\\n\\n7B- COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\nTé - COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY\\n‘TSH = SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_8214.jpg': 'PROCESSED aT:\\n‘Thyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbal-400 703,\\n\\nSAMPLE COLLECTED AT : :\\n\\nREF. BY eet naire MEDICOS AND CITY :\\nTEST ASKED Ke ON SS a t\\nTEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRHODOTHYRONINE (T3) CLA 76 na/di 60-200\\n\\nTOTAL THYROXINE (14) CLEA 5 vast 4.5-12\\n\\n“THYROID STIMULATING HORMONE (TSH) CLEA 2.14 plU/mt 0.3-5.5,\\n\\nComments: SUGGESTING THYRONORMALCY', 'thyrocare_0_8231.jpg': 'aie ee aceamalaiaatalie Think: Think Th\\n\\n-Thyocare Technologies Limited 9 0-37/3, TTC MID, Turbhe, Naw Mumba 00703.\\n00/ 41252525 © Be71866066 SH weliessehiyracarecom www thyrocare-com\\n\\nREPORT\\n\\nNAME: | -ASHIM SENGUPTA (SBY/M) SAMPLE COLLECTED AT +\\n\\n+ (7824357519), KALPANA MEDICOS AND CITY.\\neen: sil ‘LAB, BIHUTOLL ROAD ,HOJAT ASSAM\\nTESTASKED —¢ AAROGYAN 792435,782435\\n‘TEST NAME TECHNOLOGY “UNITS\\n25-OH VITAMIN D (TOTAL) CLA pay ng/mi\\nReference Range\\nDEFICIENCY! <20 rai\\n\\nINSUFFICIENCY :20-<30 ng/mt\\nSUFFICIENCY = 30-100 n/m\\nTOXICITY >190 na/mi\\n\\namin Tora tests arayzed on Siemens ADVIA Centaur, standardized against ID-LCIMS/MS, a per\\nVitamin D Standardization Program (VOSP),\\n\\nMet i 1U¥ AUTOMATED Cho mec LAO ASSAY Ee —\\nVITAMIN 8-12 CLA ‘$51 asm\\n\\nReference Range :\\n\\nNormals 281-311 pgmt\\n\\nlineal signicance\\n\\n‘Vitamin 812 or cyanocobalamin, is 8 complex carnnold compound found exclusively orn animal dietary\\nsources, ih as meat, eggs and milk. 1 ritalin normal DNA synthests, which in turn affects erythrocyte\\n‘maturation ané inthe formation ef myelin sheath, Vtamir-B12 fs used to find out neurological abnormalities\\n‘and impsired DNA synthesis associated with macrocytic anemins. For diagnostic purpose, resus should\\nalyays be assessed in conjunction with the patents medical history, clinical examinaton and other fining\\n\\n“Specincatons: Int assay (%CV):4.0%, Inter assay (SHCV)4.4 H;Sensnvitys#5 pq/m!\\n\\n‘External quay control prograrm participation\\nCCillege of American pathologit: Igand assay (general) survey; CAP number: 7193855-01,\\n\\nie vaittion references:\\n‘Chen 1 Sperting ML, Heminger 1A Vitamin B12,n:Pesce Al Kalpan LA,eitors Methods in cncal chemistry.\\nSELISICV Mosby, 197. 569-79.\\n\\\\LINTERFACED cmt LUHENESCENT MIN ASSAY\\nPlease correlate with clinical conditions,\\n\\n+31 Feb 2020 08:00\\n\\n+312 Feb 2020 18:37\\n\\n12 Feb 2020 20:13\\n\\nSERUM\\n\\n+1202038627/0R2500 Or S Bera MD\\\\Path) Dr Caesar Sengupta DIM\\n+1Qoi9561\\n\\nPage 3 of 11', 'thyrocare_0_8251.jpg': 'Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata~700 059\\n\\n© 022 - 3090 0000 / 4125 2525\\n\\n+ ASHIM SENGUPTA (58Y/M)\\n\\nREF. BY : SELF\\nTEST ASKED  AAROGYAM C\\nTEST NAME\\n\\nALKALINE PHOSPHATASE\\nBILIRUBIN - TOTAL\\n\\nBILIRUBIN -DIRECT PHOTOMETRY\\n\\nBILIRUBIN (INDIRECT) (CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nALBUMIN - SERUM PHOTOMETRY 3.93\\n‘SERUM ALB/GLOBULIN RATIO ‘CALCULATED 1.22\\nSERUM GLOBULIN PHOTOMETRY 3.21\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbal\\n© 8691866066 © wellness@thyrocare.com @:\\n\\n(7824357519) KALPANA MEDICOS AND CITY\\n\\\\AB, BIHUTOLT ROAD ,HOJAL ,ASSAM 782435,782435\\n\\nPHOTOMETRY\\nPHOTOMETRY\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_8265.jpg': '(824357539) XALRANA MEDICOS AND CITY\\n\\nROAD HOIAT\\n1 MAROGYAN E TITS 7BATS a\\n: —-* :\\n‘TEST NAME TECHNOLOGY VALUE UNITS\\n25-OH VITAMIN D (TOTAL) CLEA 2 n9/mt\\nReference Range:\\nDERGIENCY 20 g/t\\nINSUFFICIENCY: 20-<30 g/t\\n\\nSUFFICIENCY. 30-100 rg/nt\\nTONEY; >100-9/n\\n\\n‘Varin Teal tes strayed on Siemens ADVIA Certaur, standard against ID-UCIMS/MS, ms per\\n‘Varin D Standarlzatin Program (VDSP),\\nMethod: IULLY AUTOMATED. CHEMELDMUNESCENT nto agsky —-\\n\\nVITAMIN 8-12 cLIA Est pam\\n‘Reference Range :\\nNormal» 211-811 pol\\n\\nCirca sorfcance *\\nVitamin B12 or cyanccobsiamin, 1: a complex corinidcampoun found excise rm animal etary\\nspurces, sh af meat, e998 and milk IE ral normal DNA yess, which n tun affects enthrooyee\\nmaturation and nthe formation sf mein sheath, Vitamin B12 is used to in out newrciogies abnormalities\\n‘and impaired DNA syrtess associate with macrocyicanemins For agnosic purpose, rests shoul\\n‘tvs be assessed In colunction with the patents mecca hstry, inca examination ad ote ndings.\\n\\n‘Speciation: Ietre stay (CV) 4.0%, Iter say (WCV):4:4 H;Senetiviy:45 pg\\n\\n{Exteral quay control program partipanon\\n‘College of Anerican pathologists: igand assy (gener) survey; CAP number: 7193855-01\\n\\n‘it valaion references:\\n‘Chen IW.Speing ML, Heranger IAiamin B12 Jn:Psce A) xalpan LAetors Methods cial chemistry.\\nSeau:cV Mosby, 1987 7560-73.\\n\\n‘ 1 INTERUACED LUMENS MONO AY\\n\\nPlease correlate with clinical conditions.\\n\\n111 Feb 2020)\\n\\n$42 Feb 2020 kh,\\n$12 Feb 2020 20:13 g\\n\\n++ SERUM\\nanor rS.BeaMOPat)', 'thyrocare_0_8302.jpg': '\"Shree Towers II, RAA/36, Raghunathpur,\\nVIP Road, Kolkata~700 059\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai -\\n© 022 - 3090 0000/4125 2525 © 8691866066 © weliness@thyrocare.com @wwwthyro\\n\\nNAME + ASHIM SENGUPTA (58Y/M) SAMPLE COLLECTED AT :\\nREF. BY +: SELF (7824357519), KALPANA MEDICOS AND CITY\\near AGKED —: AAROGYANC LAB, BIHUTOLT ROAD ,HOJAL ASSAM 782435,782435\\n\\nTEST NAME TECHNOLOGY VALUE\\nALKALINE PHOSPHATASE PHOTOMETRY\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18\\nBILIRUBIN (INDIRECT) CALCULATED 0.39\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9\\nPROTEIN - TOTAL PHOTOMETRY 7.14\\nALBUMIN - SERUM PHOTOMETRY 3.93\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22\\n\\nSERUM GLOBULIN ___PHOTOMETRY 3.21', 'thyrocare_0_8310.jpg': 'TEST NAHE\\n\\nacon ran ora) = mm\\n=\\noon\\nsia\\nee sarc\\n= st\\n\\n‘yearn 0 otal tess matyzed on Semen ADVIA Ceraur tanned opus ID-LCIMSING, a8 par\\n‘rami 8 Seancarizaton Proram (VOSP)\\n\\n‘ete MALE Ama MONT NO ASSAY\\nSETAMIN 8-12 Lua Ey a\\nNormat at 911 parm\\n\\nea sgriicance x\\n\\nSEL sci een, egg ard mit: Te cise Ie rermat BNA pean, wri tr ats eryorocea\\niacrien an nine fereaion of myn coast Wen -B e ted o find ou nereage!aanormabes\\n{Bat impaired BWA eyten assasatea wah maroc: meme For apropos, resute shove\\nBaers se cscs nconnicion wa the paneres media! nafry, ical examinain a ater nas\\n\\n“Spectcatons: Sora ousny (NEV): 0%, Iter say (SCV:4 Senay 45 09/m)\\n\\nserait conto orograr oariconton\\n‘Conan enous: han sey (genera) survey CAP runt 7393855-01,\\n“ex valgvon references:\\n‘Ghat Souting Mierenger YAViamin B12 tn Pace Alain LAedtors Methods in elncal cherry.\\nice ote SIIRECTIONAAITERIACED CPO LMENESCERT ID ASSAY\\ncorrelate with clinica conditions. =e\\n\\n+41 Feb 2020 08:00\\n132 Feb 2020 18:37\\n+12 Feb 2020 20:13,\\n\\n7ronzso0 Dr Bera MOXPat)', 'thyrocare_0_838.jpg': 'REPORT\\n\\nname £ASHIM SENGUTA (SB1/M) SAMPLE COLLECTED AT +\\n\\nmerey —: StF (7824397919) KALPANA MEDICOS AND CTY\\n{A IUTOU ROAD MODAL ASSAM\\n\\nTEST ASKED: AAROSYANC aoe\\n\\nTEST NAME zs _ TECHNOLOGY “VALUE UNITS\\n\\n25-OH VITAMIN D (TOTAL) CLEA Pa a/mi\\n\\nReference Range:\\n\\nDeriereneY 20 gn!\\n\\nINSUFFICIENCY : 20-<30 ng/i\\nSUFFICIENCY = 30-100 na/m)\\nTOXICITY; >100 mg/m\\n\\nVitamin Total test Is wralyzed on Slemens ADVIA Centaur, standardized against IO-LC/MSIMS, as per\\n\\nccs palm\\n\\nClinical significance\\n‘Veamin 812 or cyanacobslamin, is» complex cornold compound found exclusively from animal dietary\\n\\nsources, ch as meat, eggs and mk. ts crtieal in normal DNA synthesis, which in tum affects erythr\\n‘aturation ana jn the formation of myetin sheath. Vitamin-B12 Is used ta find cut neurological abnormalities\\nfad impaired DNA syrthesss associated wth macrocytic anemis, For Waghostlc purpose, resuts should\\n‘ays be assessed In conjunction with the pavents medica history, drial exatination and other findings\\n\\n‘Spectncations; Intra assay (SCV): 4.0%, Inter assay (%9CV):4-4 %;Senstvty:45 pg/ml\\n\\nExternal quality control program participation:\\n‘allege of American pathologist: ligand assay (general) survey; CAP number: 7193855°01\\n\\nKit validation references:\\n‘Chen IW, Sperting Mi,Heminger IA\\\\Vtamin 812 In:Pesce A,Kaipan LA,editors Methods in cinical chemistry,\\n‘StLouis:CV Mosby 1967 # 569-73.\\n\\na\\n\\nathod :_fUSLY AUTOMATED BIDIRECTIONA\\\\LYINTERFACED CHEM LUMINESCENT IMMUNO ASSAY _\\nPlease correlate with clinical consitions.\\n\\nFeb 2020 08:00\\n\\n212 Feb 2020 18:37 he,\\n\\n#12 Feb 2020 20:13 a\\n\\nSERUM\\n\\n#1202038627/0R2500 Dr S Bera MD(Path) Di-Caesar Sengupta MDM\\n\\n+7Q0419561', 'thyrocare_0_8394.jpg': 'D-37/1,1TC MIDC,Turbhe,\\n~ Think Thyroid. Think Thyrocare.\\n\\nNavi Mumbai-400 703\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai = 400703\\n© 022 - 30900000 / 4125 2525 © 8691866066 © wellness@thyrocare.com @ www:thyrocare. com\\n\\nNAME + ASHIM KR SENGUPTA (25¥/M) SAMPLE aT:\\nREF. BY + SELF (7824357519), KALPANA MEDICOS AND CITY\\nLAB, BIHUTOLT ROAD ,HOJAI ASSAM 782435,782435,\\n\\nTEST ASKED + AAROGYAM A\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) CALLA 76 ng/dl 60-200\\n\\nTOTAL THYROXINE (T4) C.LLA 5 pa/dl 4.512\\n\\nTHYROID STIMULATING HORMONE (TSH) CLA 214 plu/m! 0.3-5.5\\n\\n|\\n\\nComments : SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\n3 CHEMI LUMINESCENT IMMUNO ASSAY\\n\\n‘SANDWICH CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_8491.jpg': 'name | ASHIM SENGUPTA (5817) SAMPLE COLLECTED AT\\n\\nner. By 3 Ser (7824357519) KALPANA MEDICOS AMD CITY\\nUieinutout ROAD. MODAL ASSAM\\n\\nTESTASKED — : AAROGYAMC Taner\\n\\n‘TEST NAME TECHNOLOGY VALUE UNITS\\n\\n25-OH VETAMIN D (TOTAL) CLEA 2 na/mt\\n\\nReference Range :\\n\\nBertcieNey  <20 maim\\n\\nINSUFFICIENCY :20-<30 n/m\\nSUFFICIENCY = 30-100 nq/mi\\nFOXIGTY +100 n/m\\n\\n\\\\eaminD Total text aoayeed on Siemens ADVIA Centaur, standosied agent JOMUCMSIMS, 48 per\\n\\\\ramin D Sancarczavon Program (VOS#).\\n\\netd TUL AUTOMATE HEM, mace meno AGA\\nVITAMIN 2-12 cLIA Ee palm\\neterence Range :\\n\\n‘Noma 211314 aim)\\n\\nClinical sonieance\\n‘Vien 812 or cyacobalamin, 2 complex cornoid compound found exclusively fom arial dietary\\nSources, such mo Mest ange and mila Its crtcal nnormal DMA syteas, which num aPectserytnrceyte\\nfraturtion ana inthe fermation of mye sheath, iar 812 e use to find out reurloges) abnarmaities\\ntd impaired ONA synttensossccates wat macracyic anemias For agnostic purpose, rests should\\niSmsfs be eatessd in omjintion withthe patents meses Mistry, neal exahanaton gt other fending.\\n\\n“Specncations: Intra assay (SCV),\\n\\nanny (HCV) AA Senay AS 09/1\\n\\n‘Eee qusity control program saticeaon\\n‘Clloge of american pathologist igand assay (General survey; CAP number: 7193855°01\\n\\nox vosnbon references:\\n‘Chen IW Sporting HL Hering IAVtamin 812 10:Pesce A} Kalpan UAeators Method neni chemistry.\\n‘Seu: Host 1987 F673.\\n\\n5 TERACED C1 MNES IM AS\\n\\n“Wet :_Fulby AUTOMATED BIDIRECTIONA\\n‘Pease correlate with clinical conditions,\\n\\n112 Feb 2020 10:37 hi\\n\\n#12 Feb 2020 20:13 g\\n\\n+ SERUM\\n\\n“11292038627/0R2500 Dr S Bera MDYPath)', 'thyrocare_0_8748.jpg': 'PROCESSED AT: =\\n‘Thyrocare\\n\\nD-37/1,1TC MIDC,Turbhe, ECAP Th Vie) care’ 5\\nNavi Mumbai-400 703 N\\n\\nThink Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbat=400703)\\n\\n© 022-3090 0000 / 4125 2525 @ 8691866066 =z wellness@thyrocare com @wwwithyrocare com\\n\\nNAME = ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\n. (7824357519), KALPANA MEDICOS AND CITY\\nTEST ASKED 2 AAROGYAM A\\n\\nTECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 76 ng/di 60-200\\n\\nTOTAL THYROXINE (T4) CLLA 5 pa/dl  4.5-12\\n\\n‘THYROID STIMULATING HORMONE (TSH) CLLA 2.14\\n\\nplu/ml 0.3-5.5\\n\\nComments: SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\nod =', 'thyrocare_0_8749.jpg': '‘Thyrocare\\nD-37/1,TTC MIDC,Turbhe,\\nNavi Mumbai-400 703\\n\\n=cap,, Thyrocare®\\n\\nsicsuemiaaaeed es a :\\n\\nCorporate Office: Thyrocare Technologies Limited  0-37/3, TTC MIDC, Turbhe, Navi Mumbai -400703)\\n© 022-3090 0000 / 4125 2525 @ 8691856066 A wellness@thyrocare com Gwenn Ahyracare comm\\n\\n ASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT =\\n\\nESA (7824357519), KALPANA MEDICOS AND CITY\\n\\n- AB, BIHUTOLI ROAD ,HOJAL ASSAM 782435,782435,\\n+ AAROGYAM A\\n\\nTEST NAME TECHNOLOGY VALUE _UNTTS REFERENCE RANGE.\\nTOTAL TRIIODOTHYRONINE (T3) CLA 76 g/dl 60-200\\nTOTAL THYROXINE (T4) CLA 5 vafdl 4.5-12\\nTHYROID STIMULATING HORMONE (TSH) CLA 2.14 ulu/ml_0.3-5.5', 'thyrocare_0_9047.jpg': 'PROCESSED AT:\\n\\n— Thyro\\nShree Towers II, RAA/36, Raghunathpur,\\n\\nVIP Road, Kolkata~700 059 ‘Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited 9 D-37/3, TTC MIDC, Turbhe, Navi Mumbai- 400703.\\n© 022 - 3090 0000 / 41252525 © 8691865066 & wellness@thyrocare.com @www.thyrocare.com\\n\\nNAME : ASHIM SENGUPTA (S8Y/M) ‘SAMPLE COLLECTED AT =\\n\\nREF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY\\n\\nTEST ASKED = AAROGYAM C (AB, BIHUTOLI ROAD ,HOJAL ASSAM 782435,782435\\n\\n3\\n\\nTEST NAME = TECHNOLOGY VALUE UNITS\\n\\nALKALINE PHOSPHATASE PHOTOMETRY 67, U/L\\n\\nBILIRUBIN - TOTAL PHOTOMETRY 0.57 ma/dt\\n\\nBILIRUBIN -DIRECT PHOTOMETRY 0.18 ma/di\\n\\nBILIRUBIN (INDIRECT) CALCULATED 0.39 ma/di\\n\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 34.3 us\\n\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.1 uf\\n\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 us\\n\\nPROTEIN - TOTAL PHOTOMETRY 7.14 am/dl\\nPHOTOMETRY 393 gam/di\\n\\nALBUMIN - SERUM\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio\\n‘SERUM GLOBULIN PHOTOMETRY 3.21 gm/dt\\n\\nPlease correlate with clinical conditions.', 'thyrocare_0_9076.jpg': 'ROCESSED AT =\\n\\n-37/1,TTC MIDC,Turbhe, : Re cxeanlow Thyro care’\\navi Mumbai-400 703 sansa ‘Think Thyroid. Think Thyrocare._\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703,\\n{© 022 - 30900000 /4125 2525 © 8691866066 = wellness@thyrocare com @www.thyrocare-com\\n\\nAME + ASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT =\\nSar (7824357519), KALPANA MEDICOS AND CITY\\n\\nEST ASKED AAROGYAM A\\n\\nrEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) CLEA 76 ng/dl 60-200\\n\\nTOTAL THYROXINE (T4) CLLA 5 adh 4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) CLLA 2.14 plu/ml 0.3-5.5', 'thyrocare_0_9108.jpg': 'Corporate Office : Thyrocare Technologies Limited  0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703\\n© 022 - 30900000 /4125 2525 @ 8691866066 = wellness@thyrocare.com @www.thyrocate.com\\n\\n= ASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT =\\n\\noa : SELF (7824357519), KALPANA MEDICOS AND CITY\\nASKED = AAROGYAM A\\n\\nNAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n(L TRIIODOTHYRONINE (13) CLLA 76 ng/dl 60-200\\n\\nML THYROXINE (74) CLA s pa/dl  4.5-12\\n\\n2OID STIMULATING HORMONE (TSH) CLA 2.14 wIU/ml 0.3-5.5', 'thyrocare_0_912.jpg': 'PROCESSED AT: 2, .\\nore e@cap, Thyrocare\\n\\nD-37/1,TTC MIDC,Turbhe, ie mre\\nNavi Mumbai-400 703 ie Think Thyroid. Think Thyrocare,\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumibat - 400703,\\n© 022-3030 0000 / 41252525 @ 8691866066 = wellness@thyrocare com —@www.thyrocare,com\\n\\nASHIM KR SENGUPTA (25¥/M) SAMPLE COLLECTED AT =\\nae (7824357519), KALPANA MEDICOS AND CITY\\n\\nLAB, BIHUTOLT ROAD ,HOJAI ,ASSAM 782435,782435\\n AAROGYAM A\\n\\nVALUE UNITS REFERENCE RANGE\\n76 ng/dl 60-200\\n5 wa/d)  4.5-12\\n\\n2.14 IU/ml 0.3-5.5', 'thyrocare_0_9207.jpg': '‘AE\\n\\nI, RAA/36, Raghunathpur,\\nF Rood, K Kolkata-700 059\\n\\nCorporate Office : Thyrocare Technologies Limited @ D-37/3, TTC MIDC, Turbhe, Navi\\n© 022 - 3090 0000/4125 2525 @ 8691866066 & wellness@thyrocare.com @\\n\\nASHIM SENGUPTA (S8Y/M) SAMPLE AT:\\nCOLLECTED\\n\\nREF. BY ? SELF (7824357519), KALPANA MEDICOS AND ary\\n‘TEST ASKED ? AAROGYAM C LAB, BIHUTOLI ROAD ,HOJAI ,ASSAM\\nTEST NAME TECHNOLOGY\\nALKALINE PHOSPHATASE PHOTOMETRY\\nBILIRUBIN - TOTAL PHOTOMETRY\\nBILIRUBIN -DIRECT PHOTOMETRY\\nBILIRUBIN (INDIRECT) CALCULATED\\nGAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY\\nASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY\\nPROTEIN - TOTAL PHOTOMETRY\\nALBUMIN - SERUM PHOTOMETRY\\nCALCULATED\\n\\nSERUM ALB/GLOBULIN RATIO\\n\\nSERUM GLOBULIN PHOTOMETRY\\nPlease\\n\\n‘correlate with clinical conditions.', 'thyrocare_0_9445.jpg': \"United @ 0-27/3, TTCAMIDC, Trt, Naa Mumba 400709\\nSEBLBEGOGG SB welrestnyrocate.com  @wwuznyrocate. com\\n\\nname 1 ASHOM SENGUPTA 5817) ‘SAMPLE couLECTED AT +\\n\\nwurcny SELF (74357918) KALPANA MEDICOS AND CHTY\\n‘essed nono Nova ASSAM\\n\\nTESTASKED = MMROGIANC maaans.709 we\\n\\n“TEST NAME TECHNOLOGY VALUE UNITS\\n\\n25-0H VITAMIN (TOTAL) cura Pa g/t\\n\\neterence Range:\\nDeniciencr 1220 na/mt\\nINSURFIGIENCY : 20-30 ogni\\nSUFFICIENCY = 30-100 ray\\nTOMCIY >190-Aa/m\\n\\namin otal test ls enahyzed en Siemens ADVIA Certaur sandarsued against ID-LC/MS/MS, a8 er\\n‘karin © Searsarization Progra (VOSP)\\n\\nVetted 1 ALY AUTOMATED tthe LUmInscENT immo asx =a =\\nVITAMIN 8-12 CLIA Ecst pall\\neterence Range\\n\\n‘Normal 211813 pp/m\\n\\n‘incl sigrinconce\\n\\n‘ieami) B42 oF cyanceabalamin, a compiex comnaidcompourd found excusvely Moin ania etary\\nSeercess such reat egge an ri. em rca in normal OWA syninesi, wesc i tan ects eryrrocyte\\ntmauration and i te formation & mei sheath, Vitmin-B12 fs ose to find eat nearoloieal abpormaliies\\nthd impaired DNA spree azcouted wan macocyoc anemas. for Gagnosic purpose, resuts shoud\\nSera be esecened In conjuction withthe patents mesial history, cine! examination ara cher findings\\n\\npecineaions tr sesay (HENI'A.O%, Inter assay (CV):A-4 Me Seraivty 48 pa/m\\n\\nExtemal quaity contre! program sarccanon\\nCCohege of Aretca pathologists igang assay (genera! survey; CAP number: 7193855-01,\\nex valanon references\\n\\nGoon tw spering Milemnge+ Ata 112 Sn'PesceAl,Kalpan LAedtors Methods in cial chemistry.\\n‘SeLaulsicv Monty 1967 » 509-73.\\n\\n#41 Feb 2020 08:00\\n312 Feb 2020 18:37 he\\n#12 Feb 2020 20:13\\n\\nSERUM\\n\\n#1202038627/082500 Dr $ Bera MO(Path) (Or Caesar Sengupta MOM\\n\\nPage Soft\", 'thyrocare_0_9447.jpg': 'a & 2, Thyrocare\\nNavi Mumbai-400 703 eet, NP nk Thi. Tk yore\\n\\nCorporat Office: Thyocare Technologies tinited @ 0-37/3, TTC MDC Ture, Navi Mum -400703\\n© w22-3090.0000/ 41252525 © 8691866066 A welness@thyocare com @uwwthyrcate my\\n\\n(NAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT :\\n\\n+ SELF (7824357519), KALPANA MEDICOS AND CITY\\nRerey i LAB BIHUTOLI ROAD ,HOJAI ASSAM 782435,782435\\nTESTASKED ——: AAROGYAMA\\nTEST NAME TECHNOLOGY VALUE _UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLA 76 g/dl 60-200\\n\\n5 pa/dl 45-12\\n214 plu/ml 0,3-5.5', 'thyrocare_0_9575.jpg': '\"PROCESSED AT:\\n\\nD-37/1,TTC MIDC,Turbhe, Ei Thyroc\\n‘Navi Mumbai-400 703 Sr aad Think Thyroid. Think Thyr\\n\\nCorporate Office: Tc ace inn 0078 ib a a\\n‘© 022-3090 0000/4125 2525 © 8691866056 =i wellness@thyrocare.com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE\\n: (7824357519), KALPANA pee AND CITY\\n\\nCai ‘aad AB, BIHUTOLT ROAD ,HOJAL ASSAM 782435,782435\\n\\n‘TEST ASKED + AAROGYAM A\\n\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\n\\nTOTAL TRIIODOTHYRONINE (T3) CLEA 76 ng/dl 60-200\\n\\n“TOTAL THYROXINE (T4) CLA 5 pa/dl  4.5-12\\n\\nTHYROID STIMULATING HORMONE (TSH) C.L-LA 214 plu/ml 0,3-5.5', 'thyrocare_0_9691.jpg': ', PROCESSED AT : 5\\nD-37/1,TTC MIDC,Turbhe, PAP Thyro care’\\n\\nNavi Mumbal-400 703 oe oe Think Thyroid. Think Thyrocare.\\n\\nCorporate Office : Thyrocare Technologies Limited @ 0-37/3, TTC MIDC, Turbhe, Navi Mumbai - 400703,\\n© 022-3090 0000/4125 2525 © 8691866066 4 wellness@thyrocare.com  wwwithyrocate:com\\n\\nNAME + ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\nREF. BY : SELF (7824357519), KALPANA MEDICOS AND CITY\\ng * LaB, BIHUTOLT ROAD ,HOJAT ASSAM 782435,782435\\nTEST ASKED 2 AAROGYAM A\\n‘TEST NAME TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nTOTAL TRIIODOTHYRONINE (T3) CLLA 76 ng/dl 60-200\\nTOTAL THYROXINE (14) CLA 5 va/dl 45-12\\nTHYROID STIMULATING HORMONE (TSH) C.L.LA 2.14 plu/ml 0,3-5.5\\n\\nComments : SUGGESTING THYRONORMALCY\\nPlease correlate with clinical conditions.\\nMethod :\\n\\n‘73 - COMPETITIVE (CHEMI LUMINESCENT IMMUNO ASSAY\\nta. COMPETITIVE CHEMI LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_9833.jpg': '@CAP Thyrocare\\n\\n/11TC MIDC,Turbhe, Coen seaman\\nThink Thyroid. Think Thyrocare\\n\\nMumbai-400 703\\n\\n= = ASHIM KR SENGUPTA (25Y/M) SAMPLE COLLECTED AT =\\nny. ae (7824357519), KALPANA MEDICOS AND CITY\\n\\nASKED : AAROGYAM A\\n\\nT NAME VALUE UNITS REFERENCE RANGE\\n\\nTAL TRIIODOTHYRONINE (T3) 76 ng/dl 60-200\\n\\nTAL THYROXINE (14) s pa/dl  4.5-12\\n\\nYROID STIMULATING HORMONE (TSH) CLA 2.14 BIU/ml 0.3-5.5'}\n",
      "Extracted Data: {'region_0.jpg': 'ROCESSED A', 'region_1.jpg': 'Sa', 'region_10.jpg': 'A 1)', 'region_100.jpg': '', 'region_101.jpg': 'Ait ¥', 'region_102.jpg': 'Aan CTYTY', 'region_103.jpg': '+', 'region_104.jpg': '', 'region_105.jpg': '', 'region_106.jpg': 'a Ad', 'region_107.jpg': 'AME', 'region_108.jpg': 'ZAED', 'region_109.jpg': '26 y sm)', 'region_11.jpg': '', 'region_110.jpg': '[LAST AM 4', 'region_111.jpg': 'wis ¥', 'region_112.jpg': 'Lae v', 'region_113.jpg': 'wus ¥', 'region_114.jpg': 'VNGE', 'region_115.jpg': '', 'region_116.jpg': 'Ctsry)', 'region_117.jpg': '', 'region_118.jpg': '~~\" ron 2 “TF” A”', 'region_119.jpg': 'AERO', 'region_12.jpg': 'ay', 'region_120.jpg': 'Trace', 'region_121.jpg': 'Luivrocare.', 'region_122.jpg': '~ss\\\\_8.%', 'region_123.jpg': '‘CFE K AS!', 'region_124.jpg': 'Veit', 'region_125.jpg': 'ALINE PHOS', 'region_126.jpg': '', 'region_127.jpg': 's9DTA (COV /as\\\\', 'region_128.jpg': 'i§tmTTANRyYi —', 'region_129.jpg': '', 'region_13.jpg': 're', 'region_130.jpg': '-Ac’ cE', 'region_131.jpg': 'sei 2', 'region_132.jpg': 'fx', 'region_133.jpg': 'sted edd A', 'region_134.jpg': 'WVeed Slope Wa <*iYET* LY', 'region_135.jpg': 'ses trea if', 'region_136.jpg': 'MCHC AAN CT', 'region_137.jpg': 'eed', 'region_138.jpg': 'Le |', 'region_139.jpg': 'i=', 'region_14.jpg': 'AT?', 'region_140.jpg': 'ARS', 'region_141.jpg': 'ARfar\"w Aha £', 'region_142.jpg': 'APA', 'region_143.jpg': '', 'region_144.jpg': 'TASE', 'region_145.jpg': '', 'region_146.jpg': 'VYat\"al’ “eae &!', 'region_147.jpg': '', 'region_149.jpg': 'Quilt TA', 'region_15.jpg': '\"AT)', 'region_150.jpg': \"ap one nd'd@., tha) ee\", 'region_151.jpg': 'AST', 'region_152.jpg': 'ES ie)', 'region_153.jpg': 'sen rcmrmlma gn', 'region_154.jpg': 'Ui oe', 'region_155.jpg': '‘1. \\\\ af am ch *', 'region_156.jpg': 'AmATLIWwOrAiiAie fT 4', 'region_158.jpg': 'ANINE', 'region_159.jpg': 'hentia temedied', 'region_16.jpg': 'A MEDIC!\\nHOJAS AE', 'region_160.jpg': 'CTTMi mm ATING, I', 'region_162.jpg': 'Y <i .* be', 'region_163.jpg': 'c > }', 'region_164.jpg': '', 'region_165.jpg': 'TAL 3', 'region_166.jpg': 'wT Eo', 'region_167.jpg': '3)', 'region_168.jpg': 'am mit’ gee', 'region_169.jpg': '', 'region_17.jpg': 'Bee %', 'region_170.jpg': 'AM A', 'region_171.jpg': 'NGSIU. TO', 'region_172.jpg': 'dlelalk ¥', 'region_173.jpg': 'PAS (f.f.1.', 'region_174.jpg': ',R/C-1 OR!', 'region_175.jpg': 'IFA TASC', 'region_176.jpg': 'ORMALCY', 'region_177.jpg': '', 'region_178.jpg': 'Bat =.', 'region_179.jpg': 'man LY', 'region_18.jpg': 'A Sy,', 'region_180.jpg': 'RPALLT', 'region_181.jpg': 'whe bo', 'region_182.jpg': 'neneen', 'region_183.jpg': 'nonin *', 'region_184.jpg': 'fAITAIC |', 'region_186.jpg': 'Cao Seen FFT srr ews', 'region_187.jpg': 'Tiet.t}', 'region_188.jpg': 'EST', 'region_189.jpg': 'Zeca COrrTelaTe wWwit!', 'region_19.jpg': 'AK', 'region_190.jpg': 'I0Ons.', 'region_191.jpg': 'gf Nat', 'region_192.jpg': 'vi. =', 'region_193.jpg': 'Wes Peatuyy!', 'region_195.jpg': 'Aat 7', 'region_196.jpg': 'Ast Tv |', 'region_197.jpg': 'im mat, %', 'region_199.jpg': 'VLA LE', 'region_2.jpg': '— mi-~<«it.w t on', 'region_20.jpg': 'VICJUd', 'region_200.jpg': 'Duden T', 'region_201.jpg': 'AULA IC!', 'region_203.jpg': 'mei’ is wteai', 'region_204.jpg': '', 'region_205.jpg': '', 'region_206.jpg': 'MiNNc (1', 'region_207.jpg': \"seagi'\", 'region_21.jpg': 'JLaAIL CU', 'region_210.jpg': '7', 'region_211.jpg': 'oe wlan', 'region_212.jpg': 'QKMET)', 'region_213.jpg': 'cy', 'region_215.jpg': '‘VI ATr AMIN', 'region_216.jpg': 'WULIWE (9S)', 'region_217.jpg': 'ern\\neee ee eee Pt', 'region_218.jpg': 'UPTLIN - 2', 'region_22.jpg': 'HC Yuet', 'region_220.jpg': 'IOULIN KAI!', 'region_221.jpg': 'FSI FF', 'region_224.jpg': 'ef', 'region_225.jpg': 'et Sow', 'region_226.jpg': '', 'region_227.jpg': 'om COTT Se', 'region_229.jpg': 'AING | RAT', 'region_23.jpg': '7a', 'region_232.jpg': '-JLA ICU', 'region_233.jpg': 'Cae? eee”', 'region_234.jpg': '\\\\AITAI£C T', 'region_237.jpg': 'sve “\\\\', 'region_238.jpg': 'dt ed', 'region_239.jpg': 'al', 'region_24.jpg': '11cC', 'region_245.jpg': '', 'region_247.jpg': 'TUPIE T|', 'region_248.jpg': 'ONURMALLT', 'region_25.jpg': 'yee - ThyToG', 'region_252.jpg': '', 'region_253.jpg': 'pur', 'region_255.jpg': '~-2 |', 'region_257.jpg': 'Vv\\nPur.\\nJUIN', 'region_258.jpg': 'ait', 'region_259.jpg': 'PIEsee Fe', 'region_26.jpg': 'ay', 'region_260.jpg': '_ vole', 'region_261.jpg': 'JM ALD/OLVUBDL', 'region_262.jpg': 'POUMmMIN', 'region_263.jpg': 'PrmVvorr', 'region_264.jpg': 'AA Al R/f.1 CRIT OTE', 'region_267.jpg': 'TCLH ALE', 'region_268.jpg': 'MATA', 'region_269.jpg': '-ULAITEL', 'region_27.jpg': 'reer', 'region_272.jpg': 'SCKUrT', 'region_273.jpg': 'Bites: Bate)', 'region_277.jpg': '{VULVDOVULITN NA!', 'region_279.jpg': 'Paaun ity mga yt it)', 'region_28.jpg': 'ECOL 5', 'region_280.jpg': 'LLULAICY', 'region_288.jpg': '- 5 &', 'region_29.jpg': 'A CT 6 F', 'region_293.jpg': 'ee\\nPS', 'region_3.jpg': 'Sse AT\\nare', 'region_30.jpg': 'JUALILY', 'region_31.jpg': 'fers Ii k', 'region_318.jpg': 'XKiAiCc', 'region_32.jpg': 'TO', 'region_321.jpg': 'TaTVU TRANG', 'region_33.jpg': 'Tt Ore 5 on', 'region_330.jpg': 'PAD o. |', 'region_34.jpg': 'Ualiv', 'region_35.jpg': 'Care', 'region_351.jpg': 'PU at’', 'region_359.jpg': 'TesisLi sree 2eN', 'region_36.jpg': '1435', 'region_366.jpg': 'IN RA TIL', 'region_37.jpg': 'Mi/ 50.', 'region_373.jpg': 've Siemmwennieceys Manned wemenmen Seen Ste sWarh\\nEE', 'region_38.jpg': ',CAA Ww', 'region_39.jpg': 'JUAILL', 'region_4.jpg': 'XY [>', 'region_40.jpg': 'Talelarzi¢alelll am', 'region_41.jpg': '', 'region_42.jpg': 'ow ee', 'region_43.jpg': 'pov re,', 'region_44.jpg': '', 'region_45.jpg': '', 'region_46.jpg': 'oe ee ee a, See', 'region_47.jpg': 'ileata', 'region_48.jpg': '225 2S.', 'region_49.jpg': 'vy ano.', 'region_5.jpg': 'i win mee FAL.', 'region_50.jpg': 'RS 1 RECOGL', 'region_51.jpg': '~X, Turorne,', 'region_52.jpg': 'mt mA emeeesres fT 2)', 'region_53.jpg': '—VsPE)', 'region_54.jpg': '', 'region_55.jpg': \"Me tilae' at.)\", 'region_56.jpg': 'FRAPS § Vid 4.', 'region_57.jpg': 'tTYTOCafé.', 'region_58.jpg': '', 'region_59.jpg': '', 'region_6.jpg': '', 'region_60.jpg': 'pgoes = Sores', 'region_61.jpg': 'WE. § ear om', 'region_62.jpg': 'VT a', 'region_63.jpg': 'PAST VAR (ZOTs ht)', 'region_64.jpg': '47s, TTC WW', 'region_65.jpg': 'Higa a’', 'region_66.jpg': 'imited ¥', 'region_67.jpg': '37/3. TTC MIDC ©', 'region_68.jpg': 'PT VU t SA)', 'region_69.jpg': '37/3, Vil AA, tur', 'region_7.jpg': 'Ly”', 'region_70.jpg': 'fT 23', 'region_71.jpg': 'agen UE', 'region_72.jpg': 'mmar ~esfrtat', 'region_73.jpg': '» 2249', 'region_74.jpg': 'Aree WIRE. 1h', 'region_75.jpg': '', 'region_76.jpg': 'OF L5OCK700', 'region_77.jpg': '', 'region_78.jpg': 'Laven T', 'region_79.jpg': 'co1easctnes', 'region_8.jpg': '', 'region_80.jpg': 'woe\\nPee', 'region_81.jpg': 'jecnno', 'region_82.jpg': '', 'region_83.jpg': '—_—', 'region_84.jpg': '', 'region_85.jpg': '37/3, TTC MIDC, Turon', 'region_86.jpg': '«tm 463', 'region_87.jpg': '7 es', 'region_88.jpg': 'Ld) J)', 'region_89.jpg': 'tnt 6 6s', 'region_9.jpg': 'CT \\\\)SCATrTRA', 'region_90.jpg': 'ioTaA (Rawvsne', 'region_91.jpg': 'ss S\\n——', 'region_92.jpg': 'i Mth A', 'region_93.jpg': 'ae =a d', 'region_94.jpg': '', 'region_95.jpg': 'ada', 'region_96.jpg': 'WW. IU Say', 'region_97.jpg': 'YROID StF', 'region_98.jpg': '— a a? Ve', 'region_99.jpg': 'S419 AST', 'thyrocare_0_1001.jpg': 'ae ne\\noe\\n+ ee aE ee TES COLTER AT:\\n~ 1’ monn ee AS\\n————_ rome\\n‘swan EEO (tere) ne » nafet\\n=,\\nSE care\\neee\\nns\\n—\\nis i a aes an assess scicier\\npron pete bhepnbchems\\nhaf\\n—er\\na\\ncue apres\\nTTT oe re ee\\npe emer eee peneaiapeer aye eaertaey\\nSee ee ee\\nSS\\nSee a\\npene ee ee (A nee mee OE A Re\\nRES WEG eit Epi ie\\nSo i es tees\\nnaan cae\\ni a ge ie Si ts nae ey\\naot\\niia aos _\\n———\\nAS pS SS\\nsme mee\\nis fois i', 'thyrocare_0_1174.jpg': 'wecare we  =CaP, Th\\n37/1, TTC MIDC,Turbhe, ty ACCREDITED ytO care’\\nvi Mumbai-400 703 sacs veneeeeee Think Thyroid. Thine Thyra.\\n\\nConperate Office: Toyrocore Vechmalogies United © 0-7/3, TTC MIDC, Txt, Pe Mima - A000\\n\\n72-2090 7/4125 525 OMNES Bectnenethrocre com Gwumtywcralea:\\na] 1 ASHDS KR SENGUPTA (257/11) SAMPLE COULBCTED AT:\\nrev : SEF ( 7024357519}, RALPANA MEDICOS AND CITY\\n\\nLAB, BIMUTOLT ROAD .WOJAL ASSAM 762435, 702635\\nST RS 1 AAROGYAM A\\na Le eee a —\\n\\nsree TetmOORY VA ETS re\\nOTAL TRISODOTHYROMINE (T3) CLA % rgd = 60-200\\nCOTAL THYROXINE (T4) CALLA 5 vy 45-12\\nVYROND STROULATING HORMONE (TSH) C.LLA 214 wluyed 0.3-5.5\\nYIRRORD STIBQULATING HORMONE (TSH) CATA fe\\nNpmmente : SUGGESTING THYROWORMALCY\\nwena correlate with clinical conditions.\\neetieed :\\n5S < CONWPETITIVE CHEN LUMINESCENT IMMUNO ASSAY', 'thyrocare_0_122.jpg': 'POCO AT: CAP ’\\nTET a 2\\nSenn mec, Wy LAR. Thyrocare\\njew Puerne-@00 703 Peete oe ~ Think Thyratd. Think Thyra.\\n‘Caporate Olptes : Veyracese Wtneabagien Unniind @ 0-37/2, TTC MDC. Treen, Maal Adee\\n© O22 . IOOON00 / 4175 2575 @ 0681 SENES EP wetnrEPeyrocore cm\\ncad 1 ASHI KR SENGUPTA (25470) SA;PLE COLLECTED AT 3\\n—— 2 ser (7824357510), KALPAMA MEDIODE AND CITY\\nLAR. BEAUTOU RQAD .HOIAL ASEAN PERO, FUD4IS\\n\\nrae 2c + ARRIGT AS A\\nTenT sane _ Tecnmovosy «VALUE UnITs RePeRENCe RARER\\nForas, TREOOOTCTRONINE (13) Cua 1s reid 60-200 _\\n‘Total Tervmnouver (74) cue 5 vaya 4.512\\nTHYRDED STHARLATING HORMONE (TSH) CLA 216 a\\n@Quameia: tMabeeded THYRONORMALCY\\nSenass aurratats wht aintonl conditions.\\nSomes\\nFO COOPETETIVE CURE LUDUNESCERT DNSUNO ASSAY\\n\\nCOPETITIVE CHEDE LUNWMESCENT PHUUED ASSAY\\na', 'thyrocare_0_123.jpg': 'ICESSED AT:\\nSe ecu @ LQe, Thyrocare\\n# Mumnbet-400 703 sacs Oe: eee Think Thyoid. Thank Thyoenre.\\nCorporate Office : Teyrecere Yochnategios United @0-37/3, TTC MDC, Rrthe, un Mend -<a0ten—- agi\\n© 022 - 30900000 / 4125 7525 © N6NEGS ME wetneP Onecare com Guemtiynecerneent. |\\nREPORT\\naed + ASHIM KA SENGUPTA (257/41) SAMPLE COLLECTED AT >\\nBY : SEF (7024357519), KALPAMA MEDICOS AND CITY\\nLAB, BIHUTOL ROAD ,HOJAl ASSAM 782635, 782035\\n1 1 AAROGYAM A\\noe — = eS\\normae TECHNOLOGY VALUE UNITS REPERENCE GANGS\\nSIAL TRIIODOTHYRONINE (T3) Cua 7% ng 60-200\\nJTAL THYROXINE (14) CLA s vad 45-12\\nHYROID STIMULATING HORMONE (TSH) CALLA 2.14 pluymd 0.3-$.5\\nOLA 28 ee\\nSERRE 1 SUGGESTING THYRONORMALCY\\npenne corretate with clinical conditions.\\nbaahed ¢\\n» COMPETITIVE CHEML LUPENESCENT IMMUNO ASSAY', 'thyrocare_0_1248.jpg': 'CREBED AT :\\nen Ley Thyrocare\\nA Murnber-400 703 ee ow omremenes Think Thyroid. Think Thyrnoare.\\nCospevete (Office : Voyracare Tachasiogies Undtad @ 0-371, TTC MDC, Teste, lind Mambel - C0008 ae\\n© 022-3090 0000/4175 2525 @ SAIRENEE MvetrewPtoyrocare com Qwentywecwaned \\\\ g\\nREPORT\\nat 2 ASHI IR SENGUPTA (257/44) SAMPLE COLLECTED AT +\\noY : SEU (7824357519), KALPANA MEDICOS AND CITY\\nLAB, SIHUTOL ROAD .HOJAL ASSAM 7824635,782438\\na asiecaice 1 AMROGYAM A\\nce ee — ee\\nsprue TRINOLORY _VALUE UNITS RRPERENCE RANGE\\n57a, TRIIODOTHYRONINE 7m CALLA 76 ng/dl = 60-200\\nOTA THYROXINE (14) Cl LA 5 vad =4.$-12\\nYYROED STIMULATING HORMONE (TSH) CALLA 2.14 luvs 0.3-5.5\\nYVRCND STIUAATING HORMONE (TSH) CATA 800\\nCEIOAD t SUGGESTING THYRONORMALCY\\ndunce enrrefate with clinical conditions.\\nbathed:\\n> = COMPETITIVE (CHES LUMINESCENT DMIUNO ASSAY', 'thyrocare_0_1374.jpg': 'ats a]\\nLa\\n12, RAA/36, Raghunathpur, za\\nfeed, Kolkate-700 os9 ‘Think Tiguan,\\n‘Cunperate Office : Teqrecare Tachnotogies Unnited @ 0-37/3, TTC MOC, tarthe, fiat\\n© 022 3090. 0000 / 4125 2525 @ 8691866066 a wetnen@tnyocure.com ~*\\nfi sas\\nREPORT\\nLd 1 ASHIM SENGUPTA (SBY/M) ‘SAMPLE COLLECTED AT 1 j\\non. ov 1 SELF (7824357319), KALPANA MEDIOOS AND OF A\\nVER ABED 1 AAROGYAM C LAB, BIMUTOL ROAD ,HOJAL ASEAN 38] F\\nf a .\\n: +\\n. ‘TRST NANG TECHMOLOGY VALUE ‘UMTS -\\nALKALINE PHOSPHATASE PHOTOMETRY 67 wh ‘6 - tae\\nGOLIRUBIN - TOTAL PHOTOMETRY OS? na esta.\\nSARUBIN -DIRECT PHOTOMETRY 0.18 mold <0,\\nGALIRUBRN (INDIRECT) CALCULATED 0.39 ma /\\n‘ QATAA GLUTAPYL TRANSFERASE (GGI) PHOTOMETRY 3 ry) <\\n’ ASPARTATE AMINOTRANSFERASE (SGOT } PHOTOMETRY 33.1 mw <i\\nMANENE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 wi rr. i\\nPROTERE - TOTAL PHOTOMETRY 7.14 one nf\\nALBUMEN - SERUM PHOTOMETRY 3.93 owe aa\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Rate pa\\nPHOTOMETRY 3.21 FR\\n, Set acsu _ sETRY _ -\\nin Manse correlate with clinical conditions.', 'thyrocare_0_1861.jpg': '4\\na Thyr\\n, Kolkate~700 059 ‘Tein Thea,\\n(Comparate Office : Tuqrocare Technologies United © D-37/3, TTC MIDC. Terbhe, land\\n© 022 - 10900000 / 4125 2525 © 0691066066 @ wetnes@unwocinecom ae\\nous\\nREPORT .\\name 1 ASMIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AY 1\\netka 1 SELF (7024357519), KALPANA meDeCos sup coy\\nFAST AKER: AAROGYANC LAS,GIMUTOL ROAD .HOUAS ASEAN\\n|\\n‘TEST MADE TECHNOLOGY _ va wars a\\nALKALINE PHOSPHATASE PHOTOMETRY 7 we 7 Ee\\nGRIRUBIN - TOTAL PHOTOMETRY 0.57 mod ptrry\\n, - GRAM -DIRECT PHOTOMETRY 0.18 a <ey\\nQRLINUBIN (INDIRECT) CALCULATED 0.39 moe eg\\nGRPBU GUTAMML. TRANSFERASE (GG1) PHOTOMETRY “3 w «< !\\nAGPARTATE AMINOTRANSFERASE (SGOT } PHOTOMETRY 33.4 wi «\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 wi -_—\\n-* DROTEME - TOTAL PHOTOMETRY nw ove a\\nALBUMEN - SERUM PHOTOMETRY 3.93 owe 3\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 fatto os\\n+ BRU GLOBULIN ___ PHOTOMETRY 3.21 m\\nBienes sausaiahs mutts rinicel conditions.', 'thyrocare_0_1915.jpg': '3 : ;\\n6 es Gas ae ES SLSENRG BTs\\n-_ Plepreatnly rm ggeinny—~ ahaa\\ntem 1 wsemenc Se eee\\n——— ee\\nEros CCC cy a\\nmoeu eameute © (vere) cane Fy aves\\nestes Gaga:\\nCOY «aye\\nCRY 3 seg\\nEY ye\\nrons saan\\n(train © Yoel tem eresyand on Maners SOV Cartan. kartertined sgn 1D (LMWOTD, i pt\\nVass D tanterpeteen Sages (ON)\\nCs _ DALE eer Ore ELT PO abies\\nwera 6-12 ery By oom\\nfaterenas enage |\\nmomen ors fee\\nmrad eRe\\nWepne OL! or Ceorecataomen. 0 6 sarpen Carved compa feud tos hateey Ro enone etary\\ncenvean, ach wb oe, cag ond mena Cnet oat DOA aenentan neh rt Aas ence\\naeUen 00 © De Rome of tren anh tare BIL sete oo hd nk Mero smrermabins\\nal enperes OA eyrtame aammciened ah matrarys aren to Ragraat’ pies \"oO Ned\\nSates be cote Scone: we papers ody MY Sein cea od I Ne\\nAenea HOO conte TRY) 4 bee mee LY) O48 Meme oe\\nOnmnS Ey eed pepe pee\\nCage of houeraen pang. SgUPd cases (QURarEE vey CAP momar INHETS 01\\nfm petra ecru:\\neas ee\\nCian Lee # Sib. +3.\\nRRR UPC NRO Mena .\\na\\nCTs. 1\\nLY Sademdecad hg,\\nsan ne 2)\\neden ney =~\\n\\'', 'thyrocare_0_2177.jpg': 'i\\n\\na\\n\\n.\\nROCESSED AT:\\naie eess %y LgAk, Thyrocare\\nfevi Puenber-600 703 he at a Thank Thyroid, Think Tryooase,\\nCarpesate Office : Teyrecare Techasiagins Linndtind @ 0-37/3, STC MIDC, Tortie, find Miwutel- <M >\\n© 022 - SHNDONND /4175 2 2691866 MB wetenetyare om Owain :\\nAR 1 ASMEPE KR SENGUPTA (259/90) SAMPLE COLLECTED AT :\\nrar. ov 1 seu (7024357519), LALPAMA MEDICDS AND CITY\\nLAB, BIHUTOL ROAD .WOJAL ASSAM 783495, 702638\\n\\nFOOT ASD 1 MAROGYA A\\nTT _ YeCHNOLOSY VALUE _ UNITS nevEREnece Ramen\\nTOTAL TRIIODOTHYRONINE (T3) Cua 7 ead 60-200\\nTOTAL THYROXINE (74) Cua 5 wad 4.512\\nTHIRORD STRRAATING HORMONE (TSH) CLA 214 wiuymd 0.3-5.5\\nQQ esse = - eee\\nGCemmants : SUGGESTING THYRONORMALCY\\ntense corvatate with clinical conanions.\\n(Geared 5\\nFS - COMPETITIVE CHEST LUMINESCENT INMUNO ASSAY\\n[JO ~ COMPETITIVE CHEDH LUDENIESCENTT EAUND ASSAY\\nGUI SAUEECH CHENG LUBENESCENT BAPTUNO ASSAY d', 'thyrocare_0_2300.jpg': '/ = Thyn\\n‘\\n1, RAA/36, Raghunathowr, .\\np Rotkate-700 059 ‘Think’ *\\nCasparate Cifice : Torocase Yachowtogies United © 0-32/3, TTC MNDC, 7 .\\nWrthe, fee\\nA © 022. 1090 0000 / 4275 2575 © 5691066066 Mo weinen@erwecencom ee\\n. REPORT\\nmow 1 ASHIM SENGUPTA (58¥/4) saneue CONNECTED AT + i\\nmaw 3 SHU (7824357519) UAL PAA MEDICS ASID CI\\n: VOR AOMED —: AAROGYAM (AB,STHUTOU ROAD HOA ASEAN i\\n!\\n‘Test NAME TECHNOLOGY VATS >\\nPAKALINE PHOSPHATASE PHOTOMETRY 67 we\\nGRIRUBIN - TOTAL PHOTOMETRY 0.87 maa esae:\\nGRIUON -DIRECT PHOTOMETRY 0.18 mae i\\nORIUEIN (INDIRECT) CALCULATED 0.39 mae :\\n(QRODTA GLUTADIL TRANSFERASE (GGT) PHOTOMETRY 43 w py\\nABPAITATE AMINOTRANSFERASE (SGOT } PHOTOMETRY CURT w ,v\\nMAASENE TRANSAMINASE (SGPT) PHOTOMETRY 36.9 w ot\\n\\\\ PROTERE - TOTAL PHOTOMETRY 714 owe is\\nADU - Seu PHOTOMETRY 3.93 wwe as\\n‘ SERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio :\\nVG. TT) _ PHOTOMETRY 3.21 —\\nLe aase enevelate with clinical conditions.', 'thyrocare_0_2505.jpg': '= .\\negroawre CAP Th\\n<n ® Eee Thyrocare\\nfrevi Meemninet-400 703 a etares Toor Thyrced. Think Tyree,\\nCaspevane Office ; Thyrecave Tochnstagies United @ 0-37/3, TTC MDC, Tartine, tt hipaa - GAN0AR -\\n© 022 - WIOGND 4175 7525 OREM SES Eh erinenethpccee cam Qwendpecweee\\nae 1 AGHIM KR SENGUPTA (251/) SAMPLE COLLACTED AT =\\n-w.or : See (7824357519), KALPAMA MEDECOS AND CTY\\n~ - LAB, SEHUTOU ROAD HODAL ASSAM PEDA3S, 7EIA3S\\n‘Test 2am 1 AAROGYAM &\\n‘Test mane TecmoLocy VALUE TY AEPERENCE RARET\\nee ee ee ——__—\\nTOTAL TAIOOOTHYROMIME (T3) CLA % reid 60-200\\nTOTAL THYROXINE (74) fame 5 wud 45-12\\nTAVRORD STAAATING HORMONE (TSH) CIA 26 wud 0.35.5\\neee cg\\nCasmmanta : SUGGESTING THYRONORMALCY\\nQeenee carveiate with clinical conditions.\\n‘emmed t F\\nTB + CORWETITIVE CHEPSL LUMENESCENT InMUNO ASSAY\\n90 - CORPETITIVE CHEDN LISUNESCENT BEHIND ASSAY\\nae eames Pam 1 er FT IELINO ASSAY', 'thyrocare_0_2649.jpg': \", a Thyn\\n4 1, BAN/36, Reghunathpur,\\nKoRate-700-059 Tw:\\nCorporate Offer : Trocare Yochastagies Uniaed 9 0 37/3, TTC MADC, Teste, lant\\n1 @ G22 3090 0000 / 4125 2525 © 0691066006 welnem@wnrecensom ~\\nry REPORT\\nenees 1 ASHIM SENGUPTA (S8¥/H) sas cOUSCTES AT 3\\no_o 1 Seu (7824157519) KALPANA MEDIOOS AND Cl :\\n‘vat semee 1 MAROGYAM LAB,REMUTOLT ROAD OIA AGEAM a\\n'\\n\\na Technowosy VALU\\nMAKALINE PHOSPHATASE PHOTOMETRY a7 WA 5\\n@RIRUBEN - TOTAL PHOTOMETRY 0.87 age esag!\\nBRLIRUBIN -DIRECT PHOTOMETRY. 0.18 maa oie\\nGRIRUSR (INDIRECT) CALCULATED. O39 roa &\\n\\n' ‘GROWU GLUTAMTVL TRANSFERASE (GG1) PHOTOMETRY MI wm «\\n\\n_ ABPORTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY Ba wm\\nALANEME TRANSAMINASE (SGPT) PHOTOMETRY 339 wi i\\nPROTEM - TOTAL PHOTOMETRY ra we e\\n\\na 7S\\nABU - SERUM PHOTOMETRY 3.93 owe a\\n‘SERUM AB/GLOGULIM RATIO CALCULATED: 1.22 fe cee\\n\\n‘a ae mroromerty __3.21 pve.\\n\\nb>  Rinaas cxeraiats leh clinical conditions.\\na] ]\", 'thyrocare_0_2691.jpg': 'qi\\nBOSEP AT:\\nare aC\\nes wy e042. Thyrocare\\neumibat-200 703 perce ia ib Tiss ‘Thanh Thryroed. Think Theyreame\\nCorpecete Cae . Tyran tonestage led & © 37/3, TTC MNDC, stem, Cte Seana =\\n© 022 - 90900000 / 4125 2525 @ BETIREEOKE EE wetinem@pyrocare comm ee\\n] 2 AINE RE UUETA (25/9) SArerce COLLSCTED AT +\\nw 2 ser (pata 357510) RALPARA MEDNCOR AMD CITY\\nUSTaba Tons ROAD DOA A@OAN 762438, 7UB28\\ncoe 1 ARV A A\\nnn Tecnmowoey vate warts serenanceaanea\\nfa, TARIOOOTHYRONING (TS) CLA % rele 60-200\\nAa THYROKINE (74) cna > vara 45-12\\nROS STORULATIOG HORMONE (1514) Che 214 Mind 0.3-5.3\\nvan va — Isha\\narmas ¢ | EAMETS THYRONORMALCY\\nnen curvulate with clintest condone.\\narene +\\nCOMPETETIVE CHEE LUMINESCENT IMMUNO ASSAY\\n-GOOETECVER CHEN LIMTIESCE DTT WetUINS ASSAY\\nas', 'thyrocare_0_2737.jpg': '__f > vail Thyd\\nRowers H, ANY, Raghunsthour, -\\nHaliesta-700 059 Tan tae\\nCanparate Cian : Toyrecare Yechoatagies Unie’ © 0-7/1, THC MOC, est\\nI © 622-0 0000/6125 2525 @ 04510660 nee a:\\n: REPORT\\n, 1 ASHI SENGLITA (S81) SAMPLE COUECTED AT 1\\naw Ser (7R23S7S19) ZAIN ROS A\\nfeorneme sang LARLMUTOR ROAD JOR ARRON\\n!\\nAARALINE PHOSPHATASE PHOTOMETRY 7 w\\nCRIUBNN- TOTAL PHOTOMETRY 057 oe N\\nGapanen -DeECT PHOTOMETRY 018 wed ‘\\nORRURE (HORECT) CALCULATED x) mae\\nGIBOW GUUTHOETL TRANSFERASE (GG) PHOTOMETRY wa w «@q\\nAGPRETATE NMONOTRANSFERASE (SGOT) PHOTOMETRY m4 w ?\\nMANE TRNGAMINASE (SGPT) PHOTOMETRY m9 wi eu\\nenoTeM - TOTAL. PHOTOMETRY 714 owe iS\\nA - S PHOTOMETRY 393 ova ee\\nSERN MA/GLOOUUN RATIO CALCULATED 12 Calle :\\n\\\\@g. UT) PHOTOMETRY 321 —\\ntee eens matty siiatrel conditions.', 'thyrocare_0_2838.jpg': '\" 1. (ere .\\ns -\\nGd LT nemtiameentamiemtasied OGRE CARLA\\nose tear nanos\\nwes wenemne Semana\\n—— ead wae are =\\ntoes weemsee © Crosse) cre x —\\nel\\nTa mare\\nSoe see\\npos\\nLat po\\nree 9 roe tao erevend ao emer AONE Cerne ener epee AI nO\\nbore feserrnteleertemraettresy\\nHates es aries Ca ere te! oes sae\\nSerena oer oat av ~~\\nny\\ner es es\\nDn an TT se Se\\nSe\\nBae ee\\nSSeS a ST\\nemeent eed mm (ME 4S te omy EN ene ON\\ncee ate eens mover bomen\\nma vette eteerese.\\nSaEpoae asaomarae taka) be Pimms Ai AMR LA.virs Memeo tts sty\\nPere orin\\nSTAR eB: em Sanne\\n| ———\\nhh Pe RE TO\\nsxavemanee ann\\n‘ane A f\\na\\nin REG', 'thyrocare_0_2841.jpg': '4\\n, I, RAA/26, Raghunsthpur, -\\nNoltate-700 059 ‘Treas Pigeae\\'\\nConparate Offien : Thyrecare Yachostogies Limed © 0-37/%. TTC MOC, Rann, tant tell\\niy © 022 - 3090 0000 / 4125 2525 © 9691066066 Mh weatnenegpunsecan :\\nREPORT\\nam 1 ASHIM SENGUPTA (S8v/\") SANPLE COLLECTED AT +\\nesate 1 ser (7824357519) KALPANA MECROOS AMD CS\\nWERT ASEED | AAROGYANC LABEIUTOL ROAD COAL AMBAIN\\n‘ 1\\n‘TEST MAME . TECHWOLOSY vate ware @\\nPARALIME PHOSPHATASE PHOTOMETRY 6? we\\n; SRRUBN - TOTAL PHOTOMETRY 0.87 mye 4\\nOREM -OMECT PHOTOMETRY O18 mye\\n4 SELIRUEIE (INDIRECT) CALCULATED 0.39 wee ng\\na GROBU GLUTAITNL TRANSFERASE (GG1) PROTOME TRY “ed w *\\nABPORTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY Bt wa -\\n1 SLADE TRANSAMINASE (SGPT) PHOTOMETRY m9 w  -\\n‘ PROTEIN - TOTAL PROTOMETRY ne owe me\\nSADE - SER PHOTOMETRY 3.93 ova Ee\\n, SAR ALB/QLOBA.IN RATIO CALCULATED 1.22 te\\neacunm PHOTOMETRY 324 a', 'thyrocare_0_2866.jpg': \"ly\\n@recuseen at: , ;\\n‘Wyreure SCA\\nfavs otemminat200, 709 ee a een ‘Thar Teypuid. Then Thyveear\\n‘\\n(Casporute Cian : Vepenare tedhnciagien Uintind @ 0-37/2, FIC AIDC, Teastihe, Mant\\nOon- sees 5 Comes BS wtenee jaa\\n‘\\nna 2. ARES KR SLOT A (ZS) ‘SADPLE COLLBCTED AT +\\n-Z. or .sey (70243957599) KALPANA EBDRCOS AND CITT\\nUns SDOUTOU ROAD HOI) ABRAM TED FEMS\\nva soma 1 RANOTTNIN A\\nLs reoeotomy vaue wants aarananecs mann\\nFERAL TRAODOTHRONENE (73) CALA ” wwe 00-200\\n‘Tou, Terncnceer (74) amr 5 waa 4.$-12 '\\nDOREED STBAAATING HORMONE (TEN) C11A 2.14 etUd 0.3-5.5\\nDOVROED STIOMAATING NORPIONE CTH) Ct\\nCommnente : SUBBRSTING THYRONORMALCY\\n(SRunns eavretans with efadcel eontibens.\\n- - neds ‘\\n. CIR LUNERESCENT BENUND ASSAY\\nCHET URENESCENT BURNED ASSAY\\nCODE UREENICENT FONE ASSAY\", 'thyrocare_0_2885.jpg': \") a *\\n‘Wyremre\\nSec netan @ shh Thyro\\n‘Senet Peymbes-400 703 hoe ae - ‘Tatris Thyoond, Trash Thysseain'\\nCeperate Can : Vrgrommre toteantagpen Untind @ 0-47/3, TK: MDC, Nati :\\n© 0G). OEE NAA ON Bait\\nee A MEP KR SENCAUPTA (250/00) ALE COLT AT 1\\npag | or Uaapar sae Ran DG SD TY ‘\\na sa 1 AAEAEC RS :\\nFoer, TENNDOTIrROTE (TI) cute ~~ w/a «(40-200\\nvows, Tervmominee (14) Cabal 3 wee 45-12\\n‘WRREED STRRAATING MORSONE (TH) CLA as waved OIAS\\nRRRAED STORRATING HONE ee\\nGuamente: SussESTING NirRONCRMLCY bd\\neeemateie ih oltmient exeaiintuor.\\n1s\\n(CRERPT LDEREERCENWT eEeUNO ABEAY\\nCHIN LNEMERCEST WORNO ADLAY\\nEOE LADEERECHNT EUNED ABSA\", 'thyrocare_0_2987.jpg': 'i .\\n:\\n¢ Rare GA a A\\ni= (messes mar\\n+ aR SOT\\n shenwrsmne gems) cana x ves\\n=.\\nSwe\\n=e see\\nSawn\\naly\\neee 0 se oer es one AO Cee, erect ert DIM\\nSa eres apes nen\\nbe: PELL eee, ei per tee\\nby ar e wee\\nony\\nSz.\\ncooper\\nSo ene acces sate sesso east\\npa a a er peer ares\\n—\\nGensmannunoentnsicoes Soar aco aes coe\\nSS\\neens Pee mm FEN HN ls TE te og\\ncars gat wean epee cee\\nSS a ewe are cor nee rion\\nmeson store\\nai i oso em a ly\\n4}\\nCR AUR Po _\\nmina\\npy _SEA PD 2000 etd,\\n. Penman .\\n5', 'thyrocare_0_3333.jpg': 'RA ST\\nore , CAI\\nATIC MEDC, Turbhe, Fea ESAR Thyrocar\\nsmibat—-400 703 pea er aaa Think Thyroid. Thank Thyos\\nCorporate Offer : Tieyrecave Tochasiagien Unnitad @ 0- 37/2, TTC MOC, Tortie, avi tihenieel -\\n© 022 - 89900000 / 4175 2525 METIREEEE BB wertnemepeyrocare com :\\n\\n3 ASAD CR SE SOUT A (25/4) SALE COLASCTED AT +\\n\\n, + seur (7024257519), KALPARA REDIODG AND CITY\\nLAB. OTHUTOLT ROAD .HOJAL AMEAG 702438, 702025\\n\\nSal 1 AAROGYAM A\\nee Tecneo.cey value _ UNITS REFERENCE RANGE\\nL TRIBODOTIYROMINE (T3) CLA 6 ned 60-200\\nL. THYROXINE (74) CAA > va 45-12\\nDED STIWULATING HORMONE (TSH) CLA 214 alu 0.3-5.5\\nee a . ae SS\\neran: SUGGESTING THYRONORMALCY\\noe earratete with sintan conditions.\\ncandied\\nOOGMEVETEVE CHEPGE LUMINESCENT [DUNO ASSAY\\nDROGPETETIVE CHHESS LARMIESCENT WesutEO ASSAY\\nOREN CHUDE LLMEDCENT IIMUND ASSAY\\n| :', 'thyrocare_0_3414.jpg': '|\\n” 1 ee ere cree «\\na =—=\\na |\\n—_ moenew ane =\\nes cus ee\\n=~\\nes\\n—\\nte set nar aati on\\nee\\nee\\nSS Ri ewe\\n=o\\nSSS ae\\nSSeS ee\\nSee\\npacnlapacnlin ah ame aa\\npanepeepeiela\\nSee\\npoaigeaiag\\nSEES - ene\\n——_-—-~\\n=\\nA Pale EE a\\nsamor\\nv. a a\\nsand\\ntt Benoa', 'thyrocare_0_3439.jpg': '.\\nSant Parnat-200 703 —ate ‘Rare Tagua, Toa To\\n.— Catpanate Ogfae : Payrneere Yoshantnfan tintin © 0-17/9, T9C MAC, Nation al\\nOe-mNEN/ NAT CeNmN Buiagi~ERAN 7\\nRey + AER ER SETA (ISY AO) A0PLE COLLECTOR AF 3\\nan we vee Le sberhin} Gc omar aus Pen ODO\\nve0r comme 1 RATERS\\noe ee ee\\nTat nent ___ _ ecnquoey vant UTS Aare MS\\n‘Fous, MROOOTHYRCHNNE (79) ers ” we ome\\n‘yous, REMONDEE (74) eee , wee\\nWORE STRRAATING HOROIE TE) CLA 216 ware oos\\nannem\\nQQemmeste: « SuBEESTING NTMONORIHLCY\\nwin linked eontmiers.\\n2\\n{CNN LLSUNESCENT DERUNO ADEA\\nCHEE LIDUENECENT DEHEOO ADEAT\\nAERO CIT OUND ABTA', 'thyrocare_0_3558.jpg': 'ep Thyn\\nie\\n2, RAA/36, Raghunathour,\\nKXafnte-700 059 ‘Tek Perens\\nComperete Office : Thyrecare Tachnatogirs Unmet © D-37/3, TTC MOC. etave. Nant Bhan\\n1 © O22 090.0000 / 4175 2525 O 5491 BONS ees iecee ai\\nREPORT\\nomen 1 ASHI SENGUPTA (S8v/%) sano avs\\n— esa (7024987319) ,KALPamA Wepecoe Aa\\nveovammm =: AAnOGTAN C (AR, BERTOL ROAD OIA AMAT\\n1\\n‘Tas? nae TECHNOLOGY vas wats i\\nMKALINE PHOSPHATASE PHOTOMETRY 67 we °\\nGRmAEE - TOTAL PHOTOMETRY 0.57 wwe Peery\\neneM DIRECT PHOTOMETRY O18 mae\\nSORES (INDIRECT) CALCULATED: on we ve\\nGAOUNA GLUTAMIYL, TRANSFERASE (GG1) PHOTOMETRY ma w «ti\\nABPORTATE AMUHOTRANSFERASE (SGOT } PHOTOMETRY 334 wi <-%\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 9 w a\\nA, pRoTem - TOTAL PHOTOMETRY 7.14 ond :\\nAA EARTE - STR PHOTOMETRY 3.93 wwe a\\n‘SERUM ALB/OLOBUL IN RATIO CALCULATED 1.22 Rette an\\ni. Guan PHOTOMETRY 3.21 eng :\\nRens cometnts wih clinical conditions.', 'thyrocare_0_36.jpg': '(ner cee  hclushnsapadeellld\\n= Pra\\nwD 1 AARNE bovegtterhy\\n| EERE © (VOTE) cota B na/en\\nae Seg |\\nCY 1 «2 name\\nIQPECY : 38-<30 ngs\\neka nal\\nry. Fst agra\\n1D Tat east sretyeed ah tetera ADVIA Cares, uandertived operat ID LCE, on per\\n0 Rareentusven Pregrem (OS?)\\n\\n1_ PALL MPSBATO OOP UPI UN POND Ase” -\\nwm 22 cla so are\\n_ 1\\npee ea)\\negrtcwres\\nBED oF cyarmcainahenmen, 8 compune Correeas Com~murd found Ca habenty Om awa carulry\\nan OO, AON ORE ONE CCR Marl DRA parties, WK on Buen SPATS YEON\\nee Terkel a mak itesdlatodeatncn Aeccdeuaal\\npred OMA SyreMm sameciatad wD macrecyix aren lor DagrOm< pLrpeNe, raME Move\\na auUUEE CUNARD wt re panenes eC NAAT, ONLH exeinetion ered oe oR\\neen: Wie aati (LN 4 ON. Vir oaney FREY) 48 Nerney 49 BY\\nf Quai Cortes pragrame permctesm=on\\net Rmaraan qabbamngin Meare eaney (quand) mavey CAP monte PIS RFS 01\\ndatton soferpoans:\\nparry VE Ranting Wheres 17 in Coace ALRaibin LASimere Manet i Caracal Cherwstry\\nOe Deeutiy, S08? #.800-75.\\n0S OE COIN) MIE NCAD ETS WEEN PONIND AaRAT\\naaraciee wie ates! confistares,\\n—\\ni Pe SBS OES\\njy _ sched 2008 8:37\\n208 fe 2mm 20:33\\npeanee OrG.Sen lenges) ‘\\n1\\n0 ty 7', 'thyrocare_0_3753.jpg': 'A ae - of\\n0 Ge Gam GERD enews emserED ar +\\n, sm {yeaaerere mapean maseons nam eae\\npa | aa —-\\nRENNER & CPT OL) cote rTy we\\nShes\\nFae mere\\nSone\\newe nates\\ny eaee ges\\nfo Panel Wet bs entrees an ferimens ADEA Cartan, entered mete (0 (Csr pe\\n© tertereeeeen Degen trom\\nparte nsowe: alr arertvoand Se ere\\nry ers vy own\\nTate Set perme\\ned\\nTed er ceovaceneinman, % 0 Campus sarrent rniteman Smad S1:eeare tern erat tetas\\nSaian os mocks ween ek woe mn Coe mn DMR Sots OTT i ae ore vere Ae\\nson ane wwe Ren @ erro naan ame wt) tna Pre ak mrrmnat a weno\\nSad Gaus pyrapous caressa weer nrelre wrememn ta oregreen< prponn rents Doone\\nSs aeeereed ms ereweees a a hanes een ee aoe emer ek oY\\names Se 20N0y EEN) 4 OT Ln omg LV) OA eres 8 rem\\njem eave erage nereccwee\\nSemana aD MeL Sesey SORA mewae CAP muerte PISTON OF\\nsito co\\nRaepang SNe 2A.Wenen BL? bo Petes AI.Aatman LALeeare Mattei cirecet chameatry\\n<1 evs.\\na aR TOA I0 OPS RECT meme Panny\\nce AS —— i\\nALE Pate Ene Geet\\n70h ED wea7 775\\nce A\\nGresam MRrany :', 'thyrocare_0_3804.jpg': '5\\nf.. .\\nPascEness ar:\\nTeyreare A Pp\\nSia mec neem @ £6ee, Thyrocare\\nfenvi Phumivel-400 703 teen = Trt Thyseed. Thank: Thywenms,\\n‘Conperete Offian : Peyrocare Techastagies Unsed © 0-37/3, TTC 00C, Darth, Met hasnt =\\n© 2. WHAT 4175 25 © RONEN BE weieeR Eye CMD les\\noxoen 1 ASIAN A SENGARTA (2577) SAMPLE COLLECTED AT:\\nCd 2 Sey TENSES LARA REDS 00 Te\\nvest samae 1 RAROGTAR A\\n= - pe a —\\nveer mand Tecnmovoey VALUE ee\\nveer mae : _ oe\\nTOT. TRIIODOTHYRONINE (T3) cua ES ng’ 60-200\\nTOTAL THEPROXINE (74) rama 5 wa 4512\\n‘WIROND STBARATING HORMONE (TSH) CLA 2 werd 0.35.5\\nWHRRED STRRAATING HORMONE TP vt\\nCammments : SUQGESTING THYRONORMALCY\\n(Glens carreiate with cinical conditions.\\n‘ease 0 5\\nWe-Cowenne (COHEIEL LIMMENESCENT RIUND ASSAY\\nCHENN LIBUESCENT ERUND ASSAY D\\nSANRICH CDE UPERESCENT POTUNO ASSAY', 'thyrocare_0_3813.jpg': 'AT: Th \\\\\\n, RAA/26, Raghunethpur, a\\nined, Kolkate-700 059 ‘Think Tague\\n(Comparate Office : Tryrocare Yechnologies Unihed 9 0-37/3, TTC MIOC, herbie, i\\nLo\\n© 022 - 3090 0000 / 4125 2535 © 5691855056 ab wetinewse@purecere.com zy\\nfi REPORT\\nnasty 1 RERU SEMGUETA (SEI) SAMPLE COLLECTED AT + .\\n= ean (7824357319) KALPANA MEDICOS AMD CHPY\\nTORT AGKED =—: AAROGYAMC LAB, BTHUTOU ROAD .HOIAL AGGAN TEMES\\n}\\nq\\n, Testnae TECHNOLOGY == VALUE wars y\\nALKALINE PHOSPHATASE PHOTOMETRY 67 we - an\\n, GRLIRUBIN - TOTAL PHOTOMETRY 0.57 mae 03-42\\nSRIRUBIN -DIRECT PHOTOMETRY 0.18 mod <0}\\nGRIRUBIN (INDIRECT) CALCULATED 0.39 mae i\\nGIOTHA GUUTAMYL TRANSFERASE (GG!) PHOTOMETRY m3 wi <%,)\\n4 ABPARTATE AMINOTRANSFERASE (SGOT } PHOTOMETRY 4 w <m\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 w <a\\nPROTEIN - TOTAL PHOTOMETRY 7.14 owed :\\nAABUMEN - SERUM PHOTOMETRY 3.93 onedl ae\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio S\\n, ‘SqRU GLOBULIN _ PHOTOMETRY 3.21 ma\\nNo ae eh ctinicnd comuitione..', 'thyrocare_0_4046.jpg': 'fa 5\\n6 A an RR\\n- ARES OND SRY AA\\nsemana =\\n| ashen mae ca Fy we\\nan\\nPO way\\na\\nae\\nmans ets renee tees So rms ered me Bm\\net rere er\\na, fee CI rer re ee\\n‘Sanaa et cus ety —\\nomen en:\\nPar i\\ntena eget\\nGor Nocera 2 ene tenet named ed tn et man nny\\nSm moan paves Cecee see ba wire ann orn orte\\nposonboyetiperiaciatenenapen een nepeneni eaaeaainl\\nSeep ean woes eta oo veers ronan \"soaps pre es Pe\\nnan amatp opener seme enn may Sao eran nad eee\\nrene 08 A IA. oe mS Nom ae\\nOe ey at oe ee\\n(SE tagen pewege yrs en Qe ren Ut mee TE ET\\nmanana\\nfae tr» ae Se Aan Pe = ne my\\nrch)\\nend\\nil Oa a\\nEY lead ie\\n) ames\\nrecente\\n| - ,', 'thyrocare_0_421.jpg': '/ .\\n atate-700 059 Tam\\n(Conparate Offer : Teyrecare Technotagios Limined © 0-97/3, TTC MOC, Ratha, ad\\nAan\\ng @© 022 - 2090 0000 / 4125 2525 © 8651066066 wetnenPryraceecem\\n, REPORT :\\nonsen 1 ASMIM SENGUPTA (58v/) euwrs couscres\\nat\\nmov 1 ser (7024957519) KALPOOA ABDECOS Ala CHR]\\nTROT AGKED | AAROGYANC (AS, BENAITOU\\'ROAD 200A ABBAS\\n’\\nTa TECHNOLOGY vue wate 2a\\n‘ ALKALINE PHOSPHATASE PHOTOMETRY or ww\\né GRIRUBE - TOTAL PHOTOMETRY 0.57 wale\\n‘, BULINUGI -DIRECT PHOTOMETRY 0.18 ne \\'\\ni GRRWSM (INDIRECT) CALCULATED: 0.39 wwe -\\nZ ‘@IOWAA GUSTAML. TRANSFERASE (GG!) PHOTOMETRY “3 w er\\nRBPARTRTE AMINOTRANSFERASE (SGOT ) PHOTOMETRY Ba wa a\\n‘ SEANINE TRANSAMINASE (SGPT) PHOTOMETRY 309 rr) aan\\n\" PROTEMS - TOTAL PHOTOMETRY 714 owe 3\\n-f ALDUNEN - SERUE PHOTOMETRY 3.93 owe 2\\nSERUM ALB/OLOBULIN RATIO CALCULATED 1.22 fate\\n. wmmmacum PHOTOMETRY 3.22 ae\\nSL. Clause cavvetate with clinical conditions.', 'thyrocare_0_4385.jpg': 'L.\\n\\nBOOED AT: ; . ‘3\\n= , gga, Th\\nTTC MDC, Turbhe, E3] ACCREOTEDW yrocare\\nMurniat-400 703 cues eres ‘Thank Thyroid. Think Thyreean\\n\\nCorpersts Offer ; Treprocom thatesingin Uestied © 0-37/1, TTC ADC, Tastee, Stand Meni - OD — 7\\n\\n© 022 - 30900000 / 4125 2525 @ 8691866056 Eh wefinwe@thyrocare com 4\\n1 ASHIM ER SENGUPTA (259/61) SAMPLE COLLECTED AT 3\\nor 1 Seu {7824357519}, KALPANA MRDECOS AND CITY\\n\\nLAB, EIMUTOU ROAD .HOJAL ASSAM 7RD626, 700038\\n\\naD 1 AAROGYAM A\\nee TecHmOLogy VALUE UNITS QEVERENCE RANGE\\nAa. TREIODGTHYROMINE (T3) Cina 76 rgd 60-200\\nAa, THYROXINE (14) CLA s vad 45-12\\n{ROED STIPRALATING HORMONE (TSH) CALLA 214 wruyed 0.3-5.5\\nOED STORLATING HORNE OS.  - -\\nmeant: SUGGESTING THYRONORMALCY\\neen eorratene with ciinicul conditions.\\npues 5\\n= COMPETITIVE CHEM LUMINESCENT IPtOUNO ASSAY\\n» COMPETITIVE CHEP LUMINESCENT BHSUNO ASSAY\\nfe RSURUNECY! COEF LUDEINEDCENT EURO ASSAY\\n1s rn', 'thyrocare_0_4468.jpg': 'Jf OROCESSED AT : CAI\\nDa ® 2h Thyrocare\\n‘feavi Peembei-400 703 ye ‘Thank Tyre. Thi Thysmene,\\nCopenne Offer: VprconTehastagjes United © 057, TCA, Rake, Ma theta\\n© 2 39900000/4175 7525 © NONE, Mectrsgtyncrcn Guuntpemreley:\\neee 1: ASHIDA KR SENGUPTA (25178) SAMPLE COLLECTED AT =\\nmw > Sa (7UO357519 JAPA MEDICS AMD COTY\\na UAB KIHUTOU GAD HOM ASSAM 7EDA3S, ODS\\nTeor sense =: MAOGTINA\\n-. _ . _ ___\\nTw TeQMOLOGY VALU UTS AEPRSINCE RANE\\nJowe TRROOOTMRONDE (79) CIA % mya 0-200\\n‘TORa, THYROZIME (T4) c1ta 5 wid 4512\\nROND STIOAATING HORMONE (TSH) CLLA 2a paves 0553 _\\nARID STIGAATING HORMONE (TSH) TEEN\\nCpuementn : SUCGESTING THYRONORMALCY\\ntense corvetete with clinical conditions,\\need:\\nTa <CORWETITIVE CEE LRUNESCENT BETUNO ASSAY ;', 'thyrocare_0_447.jpg': '. SCAP Th\\npes\\nen te oe yee ee\\n= Cospgnntr ioe : Ramana Pashantagies tind © O-7a, THC bat, ™ :\\nOe. mens 4125 425 Cena Butenteeen Gale ~\\nAEPORT\\noe | AEN OR BEATA {SY} ALS CNL acectsn Asm CRY\\nane vd (ARRAN ROAD JOURS AGRON FERED PEDO\\nvar eae 3 AARON 8\\n8 _ ee\\nay eee Teamovoey veiue wna eEvORECE ee\\nre cua ” ws om\\nvuena, Remnnecmer (4) cle 2 we tess\\n‘WORD STRRAATING HORMONE (TH CLA Pry ened O53\\ncaprataie cits Gombaet coméicbes,\\n(CONE LAIKEREADCEAT ERPELO ArmA\\nCUTE EEECENT PURI ADEAY\\nCT WADED AEA\\n, ‘', 'thyrocare_0_4498.jpg': 'CESSED AT:\\nrecare ey EcaP, Thyr\\n711, TTC MDC, Turbhe, ty ACCREOTEDW ocare\\n| Mrumibal-400 703 ace ee =“ Thank Twyroid. Think Thywonare.\\nCorporate Office : Toyrocare Tocienslagies United @ 0-37/2, TTC MID, Tarte, Was emda - 40000 = aa\\n@ 22 - 30900000 / 4175 525 9 BASES Bi welneugtyourecom ry\\nREPORT\\n= 7 ASHI KR SENGUPTA (257/M) SAMPLE COLLECTED AT ;\\nov : SEE { 7824357519), KALPAMA MEDECOS AMD CITY\\nLAB, BIHUTOL ROAD HOIAL ASSAM 763435, 782435\\nT Aan 1 MAROGYAM A\\nITAL TRIBOOOTHYRONINE m3) CLA 76 rgd = 60-200\\nITAL, THYROXINE (74) CLA $ vad = 4.5-12\\nIYROED STIMULATING HORMONE (TSH) CLA 214 plum 0.3-5.5\\nRON STIRAATING HORMONE (TSH) CLA 218 __ ae\\nPEROTEEES 1 SUQGESTING THYRONORMALCY\\nease ewraiate wih clinical conditions.\\nwed :\\nBe COMPETITIVE (CHEMIE LUMINESCENT [aneUNO ASSAY', 'thyrocare_0_4523.jpg': '0 TTA AS GRA GOLLETOGD OF +\\na (eowent ence onion anes\\na + NC A\\nARES 0 Cea.) paw yy xn i\\nnnn\\n\\nTae agit\\nPCY : 38-<38 nares\\nniditiediasdindatd\\nyee gems\\nD Yate tal W enetyend en Semen ADMIA Carter, endertsed eperet ID LC/OS/Omh, a per\\nD Rear weeen Preges (YOK)\\nUAE ALD COPE PILL PD Abit -—\\nme O-12 Cora ES ener\\nme mange |\\nnite tit pee\\ncepeensd\\nGAT or Cyarmcmbahamin, 6 8 Coompsen Corrnene comomund fur wechuabren trom aromas entry\\n(cute 08 aah, 00g and tree Be Cmece 2 Nmeet OA NRTA, SACD LT RET PENOCYN\\ngo and va fermabien rep Wee Viarer 81) soe co Pret a WA SOT\\nEred OMA eyrnees seeatated WRN macros yk aremean for Gaprent< pee, MOR SA\\na emvened wn congener wow\" tra pamarsa Tein SHREry, Corwin euserewebun ed OMe NAOT\\nfons LD eneey (ULV) 2.0. inter meney (HCV) 44 Lermety 43 Pe\\nay ete reper pereceeee\\nit hmerenn peivaingain: Wyend waty (gararet) never. CAP wets 7ISIEYS 01\\nsclenbasaiadl\\nLipeting 1Ejemunger WA. viemen G12 tr Pemae 4) Aatpen LAeohers Metheds in Clracel Chereeiry\\ns0N Oe LOOP F073.\\nED OILS BOWER EEE PRREILENT eK Aenea =\\nSoaisho cin Cate! waciooas.\\n=\\n\\na\\n108 Fe 202s ene\\nDT mebesnad Su\\nea3\\neretantenreny', 'thyrocare_0_4557.jpg': '2 . :\\nSf 1 7\\nMg 1 A ECT EEA CAS COLLET Oe\\n- — eotiacs aaa\\n— Ware 1 eee ry\\nTT ay ~ TAT 8 —\\nspenererine ers) ene » we\\nte\\nmes ve oe rt tee a ens enced eS ee\\npe aaeteteees\\nSes creer en ein mae\\nty att a nn\\nos\\nSS ee eee\\nSate\\nSaree a ees ee\\nee es le ee\\ncreme wate ev ree tone\\nee ee ees\\nenean sereem\\nSamer a te ttre memes\\n————— ee\\n. ——\\n\\nTT emad _\\n\\npynapoes)\\n\\n‘seman | AO\\n\\n—\\n\\nOhio ee\\n4\\n.', 'thyrocare_0_4618.jpg': '7.\\n‘Rayreawe CAI\\n‘avi Ctumminat-a08 709 mace ee ‘Toarhs Thguute. Poon\\n\\\\\\n(Cesponste Cffiae : Hapecase Tetmategies tantaed © 0-17/2, THC MMBC, :\\nOm-meoen/asss Comme Oatewthpee\\neR 1b AN KR SEIT A, (2S 700) OeewrLs COLLBCTED aT + ‘\\nmov er (uzane7tim saarena mpeios or Co\\nBh ed 1 ADEA A\\n———— se = a\\n‘Wows, MRDDOTICTRIRNNE (73) cua ” ed\\nyous Temcnaee 14) Ck s wwe 4512\\n‘ROMMED STRGRATING NOROONE TIN CLA 21a emuved 0.95.9\\name: SUBEESTEVS TrRONORNLCY\\nten ction! enecintem, ‘\\n4 -\\nOMNE LURWEEEECENT WOTUNO ABRAY\\nSERN LANERERDCENT WOTUND ABSAT\\nUNERERCENT BEE ABEAY', 'thyrocare_0_4670.jpg': '‘Veyromra CAP h\\n0-37/1,TTC MEDC, Turbhe, ® AccREDTEDW T yrocare’\\n(avi Murmber-400 703 eee ares eememmemnnes Tiarh Tiryroad, Thank: Thysooame\\nConpenate Office : oyrocare Yochmaiagien United @ 0-37/1, TTC MIOC, Tortie, tant itaemiee- G0\\n© 022 - 39000 / 4125 52 OAKES einer con QGuentqncenens °F\\nREPORT\\nnee > ASHI 1A SENGUPTA (257/41) SADWUE COLLECTED AT:\\noar.ev : Ser (7824357519), RALPARA MRDICOS AMD CITY\\n* LAB, RIHUTOU ROAD .MOJAL ASSAM 782035, 702635\\n‘yest axon 1 RAROGYAM A\\nTOTAL TRIIODOTHYRONINE (13) cuta Ly pad 60-200\\nTOTAL THYROXINE (74) (rary 5 wad 4512\\nTHYRORD STGAATING HORMONE (TSH) CLA 214 Urs 0.3-5.5\\nBs hint arama ge Be es on a acocktin\\nCommentn : SUGGESTING THYRONORPULCY\\nPeanse envretate with clinical conditions.\\names:\\n‘TB - CROWETITIVE CENT LUMINESCENT IMMUNO ASSAY\\n90 - COMPETITIVE CHEDEE LIBENESCENT PPCUNO ASSAY\\n— Seen, eannereamnres CHEE LISUREESCEST MPG ASSAY', 'thyrocare_0_4683.jpg': '_ BAP\\n‘Wgrese\\neat M200 FOS Re dc, Thee Thread. Tan\\na\\n Caepenate Cefn : Ramee tacberetagion Uneinn @ 0-47/3, TIC MBC, Tete, MN\\nOm-meewsan sn Sens Beep\\neee 2 AEWA OR SEAT A (ISTAD SAPLE COLLECTED OF\\na cor (7224957539), 5AL PORE, ENDED OUD CSTY\\nLAB BOESTOU ROME ORAL AURIS FEDETE, FORME\\nas © AAR A\\n——_——_ —_—_ i\\nTerr ene Tecouogy VALLE VOTO GEPEREREE GATE\\n\"FORM, WRNDOOTIeRDeeeE (7) cata fod wre 00-200 —\\n‘vous Terenune (74) CAA > werd 4912\\n‘QHERSED STICLATIEG HORPHCEE (TEr1) CLA au waved O65\\nRN STRAT Oe\\nGmeanta) )« SueenmTens TrrrmonorMLcy\\n“on enevetete with eiutanl eencibons.\\na\\n: Coeme SENESCENT WENO ASSAY\\nEN LAREN REED AMBAT\\nAERC WHT ABTAY\\n| 1', 'thyrocare_0_4748.jpg': 'Lo a\\nveae: oa\\n1 EE Ca wees emaser a + .\\n: — iaotas—o\\n: ¢ emomeee ncaa\\nroan a a\\n\\n[ieee toned case ry we\\nSaas\\n\\na\\n= Se\\n\\nve wearer:\\naap\\neae ees ato aves = memes NOME Cort, merc agers OAC\\nfeet forsee mae oN\\nCeatets_near areRe CUM UE A re Me\\neen O42 cle ot _\\n‘Sete tage «\\nber\\nalnepeeed\\n(are Dale Coenen 6 carpe eet erm ard pence Son eat ar\\nDaren mer aoe tage ind Ne ene OOM er re are rt en\\nret cs wonton ome tree rare bis a rnd ns renee mera\\nStagees Oa seer meee am naan rome Io Saget petend vane one\\nSe orcad egress monn ears Sas pee oe\\neRe Ce Se (LN ER mer mer CHS Leer Oa\\nee gate ee epee ere\\nSome etree ea Nene eee RE ents CAP meee FINO\\n\\nes nana\\ncap OA ENS OL) br Cem ALAMIAN LARIMER © sree harry\\nmy\\nOG EERE PE ae\\naemeae .\\nwane me , 75\\npert fs\\netemeneey', 'thyrocare_0_4790.jpg': \"or _. ecap, Th\\neo fe\\n@-3771, THC PEC, Tarte, ® ———e Ou $e\\n‘Panel Pretest Fd ate ‘Tove: Togeane. Teta\\nOm- mew /aa5D CureEE Buhntenee Gel '\\nREPORT\\nty ¢ AEN OR SE QLPTA (25070) SALE COLLECTED AT +\\nBd 1 AARNE A\\n;\\noe ~ eamowoer “vais __ ware eavmanen nase\\nSe wenconenieee a =O ~ ~e tom ‘\\n‘youn, Remonwe (74) cit : wwe 4517\\n‘WUE STPRRATINS HORMONE CTO CLA 214 ns\\nne U\\nih eietans enna. .\\nCDE UReeERCENT DOMINO AmEAT :\\nee LaDERENCEITT HETUND AaSAY\\n AEENCRNT DURTO AEEAY if\", 'thyrocare_0_4979.jpg': 'a , ars Th a\\nTH, RAA/36, Raghunathour, :\\n) Rabeate-700 059 Te\\n(Garparete Cifce : Wayrecare Techaslogies insted © 0-37/3, THC MAC, hatin, lant\\n© ee. 2090 0000/6125 2525 0 2091066086 wednen oreo a\\nREPORT\\n\\nLeap 1 ASIN SENGUTTA (S87) SALE COLLECTED AT T\\n=a + SBE (7824357519) KALPODA WIRDRODS AD CB\\nTOA MAROC (ABSIMLITOL ROAD OIA AGEAA\\n\\n}\\nAASALINE PHOSPHATASE PHOTOMETRY @ w es\\nARUN - TOT PHOTOMETRY 0s? or) ’\\nGRURUEN -DERECT PHOTOMETRY 018 we ‘\\nSURE (BIDET) CALCULATED: on mie >\\nGIOIA GLUTEN, TRANSFERASE (G61) PHOTOMETRY “3 w <<\\nMGPARTATE AMINOTRANSFERASE (SGOT PHOTOMETRY BI w ie\\nMANBE TRAGAMBUSE (SGPT) PHOTOMETRY 369 w .\\nOROTER - TOTAL. PHOTOMETRY 14 om ‘\\n(AE - SERN PHOTOMETRY 3.93 owe a\\n‘SERN ABQLOBULIN RATIO CALCULATED 12 fate\\nspam acon a _PHOTOMETRY 3.21 =', 'thyrocare_0_5074.jpg': 'y.\\nfeet phamiet-000 703 on ™ ‘Tear Theat. Yo\\n(Copeate gine: reser Tedmatayies Untied © 957/1, THC MMBC. Wain .\\n. Qen-sscene 74125 25S serene, Bien eiemeem (\\neR |) AEM ER SLICCITA (259/04) RAE COLLET Tt\\nae ma (7024 M7810, SAL POA ECO ED COT\\nwait ASKED 1 AACUT AE A ve ~™e\\na a __WaETS mavenence eanee _ 4\\nJews PNODOTITADIENE (73) cua ied oma ome\\nai cata 5 ved 4.512\\n‘REED STROAATING HORMONE (TSH) COLA Pat ot 09-55\\n——————— eee a\\nGpemneee: suesestme nrmonomwncy\\ncian eitedaad eoecthesor.\\nis\\nCoens UUmeneeCENTT wee ASBAY ‘\\nCERNE LATERECENT ECUND ADEA\\nRCE HORIND ASAT', 'thyrocare_0_511.jpg': 'a8: .\\n(va Pranbas-400 703 ae ‘oe Taped a\\n«. Capenate far: Ryponan Nndostags taal © 0-22, TH RG, Relig :\\nOen-2enee 2555 Ome BubeP ie :\\nwe 5 ANODL KR SEMANA (25H) SAPLE COLLECTED AT\\neae? 1s Le aaa ORNS\\noe ae 1 AABQGTI A\\neT _-\\n=e Oy Se __ ‘\\nowe MaDDCHORONE (73) cuts ~ pariorie\\nyoue Remcnne (74) Cuba 5 we Su\\nPARED STRRAATING HomrNe TSH) CLA as\\neens\\nints einieas epetoees.\\n(ompe WESCENT BONNE HOEKT\\nQpe UNRERCENT DOLD AIBAY', 'thyrocare_0_517.jpg': \"7. TI\\nfavs feemines-200 705 atte i ran Tee. ee\\nhb\\nExpect Oiftae : Hapouen Tochostayfes tinaed © O-A1/2, THC RENE, Btls :\\nOMl-MEEE/ATAS ComnNG GumPenone Or '\\nad 4 AMA KA SEAT A (250/90) SALA COLASCTED AY +\\namor vm PP green EY\\naay ade 1 ARORA A .\\na oo ee\\nTear masts _ Tecmovoey VALUE ANTS MOPWRENKS RANSE__\\n‘Found, MENODOTHVRONENE (13) cua beg —\\n‘von Trevecicare (74) cite 2 ailpeee\\nRORAED STRRAATING HORMONE CT CLLA 2.14 waved 05S\\nee ee ee\\nQummets: ‘SUREES TING THTRONORILLY\\n7 eurvaiate with Gintunl eoeiens.\\nje\\n{CORFE LUPTERCENT BESUNO ASSAY\\nCRE LAENEDCENT DORSED ASSAY\\nNEROCINT HORINO ABEAY\", 'thyrocare_0_532.jpg': '4a a 5 ‘al\\nwh: Foe re\\nmy\\npl das\\ntg Pe a Sa woe couse at + °\\n_ Loe ents ae\\nbe 1 psec Nene ose\\n\\\\ oe\\n| romneer a an\\n eneemn een) rer » wv\\n=\\nTia wes\\nang ren\\n= saree\\n—\\nsemen nw ee rare en poms so are treet core OI\\nfrneent fabless\\nSamte aitarpas Delorean res ies\\nbh sar] vst we\\neres ed\\not wets\\nties ees cow er\\nSais oe a\\nSS Se ae\\nSSemeeen oe ree, ce, ee\\nfpr ye ga cg omega ea\\n(eames on a NEA CN, pew mes AL A Rent Ht\\nare ath eee pager eorcvem\\nSn eet ee ree omins\\ncave womans:\\nTcTange wa. veams 015 ha Aapes LAs nu cone cheers\\nmeaner\\n\\\\ REN sa arOR mem fen\\n—_e\\nhE Ach Eb Riot ,\\nbP Pay SB hs\\nCS\\n* -', 'thyrocare_0_5338.jpg': \"7—- CAP Th\\nTree\\neavt Wtaradeat-408 709 aes Thar Tigra. Re\\nwt\\nCapenste Cine : Vayrocten Tedeactagies Wiad @ 0-37/3, THC AMD, Tein, Sa\\nOel-m0eN/ A555 Cm Bulges OF '\\nwen 1 ABN ER SEMITA (257) SAMPLE COLETI AT cary\\naw soar UR peUTOU SAD SOAS AMMO TEE OCIS x\\nTER sD + AOSTA A .\\n_\\nns —=\\nee\\nFER AD ___Tecnotony wait NTS REFORENCE RANGE\\nowe WecOOTmONeNE (79) cua ” we «m0\\nROMOKDE (74) ca 5 wwe 4.512\\nRenew sTUMTG nommone rm) CLA at _einl 00S _—\\nGaemments 1 SUEHESTING THIRONOROMLLY 7\\n' cornciate with citntenl conintens.\\n— s\\n(CoD LLDIBEESCENT BONUNED ASEAY\\nSpNNEE CHR LIPENERCENT POEINO AISAY\\nERE USEITCENT BENNO ABSAT\\nmy ‘\", 'thyrocare_0_5357.jpg': 'Sn a . 6 wR\\n. oe AP oa\\n= —\\n0 A RT EEG CD ORL at\\n- ‘osetepespcanae Cad\\nas VENEER © (VETER) cua 3 —e\\nIa\\nPr mre\\nCw\\nny\\na\\nmae © Seal tn wo ratyons om temas REVO Coren’, eorercumed ager OCA, a or\\naan © trasromeeen Progen 1vON\\npasLL_DALLSOTNAILD. STR AEMANT HOARD Ata\\npase 8-23 cute a wn\\nma Gaps +\\nvarios <r\\nepee)\\non Chl. CONRAN $e tered Campin Bena oy ems ater\\npoe een oo pe nd mena Crane > narra Das etre er oe eo\\nretin onl ote Arai omen an Verne BI nee ets net newrmagea Sarre\\njImpeves OHA eprinree epmatairs man erate wom tw Ragrants purpoce Tenet Pe\\npot bo caaread morgue ar ra pane weeta Nery ta searenan oad oer ea\\naaa We cant EV) OO be mens FL) #4 Natty 48 ogre\\nne ey carne rere pareowener\\nRage et ras pebemapms Sue ome (pune merey CAP memes LORDS OF\\neezeaea setorante\\nwanvarerng raserainpe (0.anea= 917 b Cusss A1,Sstpan LA.asuars neds = cima chemenry\\nmon\\n7A uranaacen weno Manat =\\nOb coed CD.\\nAL Pas REDD Ae\\nat,\\nee) 5', 'thyrocare_0_5503.jpg': \"—_———\\noe .\\n= whe\\ntami ane,\\n- : es\\nar, LY eccemntecennteal CTD CLES OT 1\\nvy (page ren sng som ee\\n? (wammene — a\\ntee ae\\n‘20H VaEEE © (rors: } cana Fy we\\n=>\\na wes\\nCa _maghngbade deed\\n— we\\nben\\nfaves © Tam wet erent wh omen ROMA Canter acter aps 1D LC AORN Dar\\nene 8 ereereemees Pegon OR\\name RBe Cam Uwe rene mss?\\n‘erase ©-13 crea Ey vem\\na age +\\ntee ee\\nCorres wares\\nWaser Bd w cyerecrtetemen 9 8 some, comment cotermind Ma ony Por am ears\\nSom Si mere ower re ce mace eee be renee cree er mar nH\\nStari ne a pe tere a mere one arms Bh Soon oto a erence erent\\nSd ageed OO weewen aaiares aan ener. wee to Sap pepe vents ed\\nae es og wo Te eam nonin ery aren peer one oe\\nAapantamane: (at Sune CC) 4 TS, tee my RCW) A Lemmy aE\\nee gy wee pe ere\\nRag et sre ee irs eee 1g) ere CHP ee NE oT\\neanaanen starase:\\naLSemnUnper LURES 0 br Pease A futgun LALSotere Rew crac heme\\nroa\\nUTADA MEELCN pone Meni a\\nes inde eas,\\n4 tL emebuauatheemeedl\\n_ tem aor Jw\\nFlot enestonead\\nGece angen)\\n=, = ' -\", 'thyrocare_0_5608.jpg': '——— ‘ o 5\\nbos wees\\n0 ae amos GR wes urease\\n» = ea ad\\nSi 5 AEE Seni Sone cane ome\\n= ; ~ iis’ eae\\n| WERREEED D CPOTAL) cw a wore\\nSe BS\\nSir\\nony\\nwe tee mere\\n5 Fete erat eretvannd an Memes ANIA Cartes. sentence moment IPE AIR on oer\\n.S Severmemsen rapa Cory\\nLL JASE SMILE CGI Lorena. neat tes has\\nom oss ry a wm\\nETE mere\\nre\\nRa wr cyarwectaten. = 2 amenee erent eres ned oor herrany hem wee eres\\n5 a as cana, mpgs oe aw erie nee ne rarer er nem ane renee va\\nmean od my terenatan oO roven creer wna ets Sn oh ns mere ee\\npore Gun syreunem ouamntanee wan re ie wantenk tas amram purpose Tenma One\\nMa oceans creer ma me pani meeva way nee arene mae ne eae\\nsami OO Meme ENEVD 4 OH, Inte mee (EY) 4 eee Ot nem\\n2 gas sare pewen own\\nfof araeraan qaibarages tensa canary (rere) wrewe CAP mrrtme rLUMet ot\\nSeana Pa searenar OVENS Sty in Pusan Al nina LA,sters Maines = etretal cheery\\noe nee 33.\\nScene en vee\\na —\\nCTotabeand\\nath Pup sees 080? y 7\\n00D BSS\\nGrodan water)', 'thyrocare_0_5640.jpg': 'y as Th EB\\nRand, Kolkata 700 059 ‘Trash agua\\n(Conpavete Offine : Tarecary Tachnateagans United @ 0 17/2, TTC MIO, hat fant!\\n©] O22 30900000 / 4:25 2525 @ ae91ee Mh ecinenpeecomE\\nmend 2 ASHIN SemGueTaA (S847) games counter 5\\naor sep {7024357319) KALPANA RECRCOS AD COPY\\naT sc 1 RAROGYAM © LAB, BEMUTOL ROAD OGM ASEAN\\n!\\n‘Tear mane TECHNOLOSY veaue Tod\\nMALINE PHOSPHATASE PHOTOMETRY 6? wt G\\nenmusee- TOTAL. Prorome TRY os? ove oan\\nGRsUEM -OIRECT PHOTOMETRY 018 wwe <>\\n- eeUEM (MDIRECT CALCULATED: 0.9 Ll ons.\\nGROW GLUTAMN, TRANSFERASE (GOT) PHorume RY ma w <<.\\nABPARTATE AMINOTRANSFERASE {GOT ) PHOTOMETRY 34 w 2.\\nMANENE TRAMSAMINASE (SGPT) PHOTOMETRY 3s w «\\n. OROTEM - TOTAL PHOTOMETRY Par owe\\n. OU - SERUM PHOTOMETRY 393 ove\\nSERN MBPCLOBULIN RATIO CALCINATEO 1.22 nate\\nnn Peorore (ny 323\\nCtense enveeiate wth clinical conditions. u', 'thyrocare_0_5816.jpg': \"moe aaa\\nThyra\\n‘feed, Kolkata-700 059 ‘Tinh Thysetd,\\nCorporate Office : Teyrocare Vachnologies Limited 0-7/3, TTC MIDC, Tharthe, Mand *,\\n© 622. 3090. 0000 / 4125 2525 @ 8691565066 Gh welines@thnwocare.com coe\\nREPORT\\nee 1 ASHIM SENGUPTA (S8Y/M) SAMPLE COLLECTED AT:\\namr. SY + SELF (7824357519), KALPANA MEDEQOS AND CIV\\nTEST ABKED —s: AAROGYANC LAB, BIMUTOLT ROAD ,HOIAI ASSAM 7O261E 90\\n}\\nTET NAME TECHNOLOGY SCALE. wats nena\\nALKALINE PHOSPHATASE PHOTOMETRY 67 we e-1B\\nGALIRUBIN - TOTAL PHOTOMETRY 0.57 n/a Orit @\\nGSLIRUBEN -DIRECT PHOTOMETRY 0.18 modi <6g '\\nGRIRUBIN (INDIRECT) CALCULATED: 0.39 modi onp--\\nGAOWIA GLUTAMYL TRANSFERASE (GG!) PHOTOMETRY 3 wl <s ?\\nASPARTATE AMINOTRANSFERASE (SGOT } PHOTOMETRY 4 wi <3\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 un <@y '\\nPROTEN - TOTAL PHOTOMETRY 7.14 ond 3\\nALBUMIN - SERUM PHOTOMETRY 3.93 ordi oe\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 fatto 7\\nSen GLOBULIN ; PHOTOMETRY 3.21 yd i.\", 'thyrocare_0_5858.jpg': '* Thyf\\n1, RAA/36, Raghunathpur,\\nKolkate-700 059 ‘Telek Tague\\n(Conparate Office : Teyrecare Technologies Limbed @ 0-37/3, TTC MDC, Tastee, tinal taal\\n§ © 22 - 3090 0000 / 6125 2525 © 9651066066 wellnengmyecencom a\\nigh Ae re mern oe et) SAMPLE COLLECTED AT +\\nmow 2 SELF (7824357319), KALPANA HEDECOS ANDO\\nTOOT AOD: AAROGYANC LAB, BTHUTOLI ROAD ,HGIAL ASEAN\\n1\\nTEST NAME TECHNOLOGY VALUE warts 7\\n‘ALKALINE PHOSPHATASE PHOTOMETRY 67 we 4-8\\nGRLIRUBIN - TOTAL PHOTOMETRY 0.87 mala apa!\\n. WELIRUBIN -DIRECT PHOTOMETRY 0.18 mofdl d\\n\\nGALIRUBIN (INDIRECT) CALCULATED 0.39 naa\\n\\nC GRID GLUTAMYL, TRANSFERASE (GG1) PHOTOMETRY 3 w ems\\nAGPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 3B. wu ; are\\nSLANE TRANSAMINASE (SGPT) PHOTOMETRY 389 wi a.\\n\\nch PROTERN - TOTAL PHOTOMETRY 714 owe 2\\n\\nJ ALBUMEN - SERUM PHOTOMETRY 3.93 owa Hae\\n\\n‘SERUM ALS/GLOBULIN RATIO CALCULATED 1.22 Ratio a\\nbs Sqn GLOBULIN PHOTOMETRY 321 —-\\na, = ee Ss ee', 'thyrocare_0_5879.jpg': 'PRETENSES aT: . m ?\\n0-37/1,77C MIDC,Turthe, 3 ACCREDITED yrocare’\\n(avt Mummber-800 703 wate we. . ‘Thank Treyrard. Thanh Thyreenn.\\nCasperate Cifiee : Vryrennre Yoctmnsbayies Uninet @ 0-37/3, TTC AADC, Tere, tant item ~ i\\nOow- ween 55 Ome, Beieegeyoerr an\\neaneon + ASHEN KR SEmGURTA (25070) SanwUE COLLECTED aT :\\nom. ow 1 sey UZAY RAO A TT aoa\\nTat aie 1 AAROGTAR A\\nFOTAL TRIIODOTHTROFENE (73) cree aS rat 60-200\\n‘TOTAL, THYROXINE (74) Cia $ wya 45-12\\nTAYRORD STRAILATING HORMONE (TS?) CLEA 214 pluyerd 0.35.5\\neee A, 4\\nCucuments | SUBTESTING THYRONORMALCY\\nSQunse enrruiate with cinicel condmiens.\\ntest .\\nWO CONPETITEGE COMPS LUMINESCENT DereUNO ASSAY\\nCHEE LLNGNESCENT WOTUND ASSAY\\nSIUC CPE URGINESCENT WTUND AZSAY', 'thyrocare_0_5896.jpg': '‘ «sian CRRA sN, rows ease an\\n_ ‘ravastzsen aaueain see sao eve\\npram + sanamene Es ~~ alee\\n_—_— = Teens Cel Cs,\\npon conser © Pars: cute » wm\\name he.\\npe mere\\n=\\newe\\na ean\\nrn vat tm erro an Rees ROA Carnie ater tned epee tht eran on oar\\nwan 8 Reverie Soren Fer\\neen DALE ROFL) UTA Wee At PO rnS Aaa\\nrvasent o> 63 ener a roe\\neet thee\\nates erstnnres\\nSED RNS oe Bey et Coton fend on tates Bn ene ats\\nNa eho Se, gue Tne ae my ea ON rete wren ee gore\\nMaren wre ra tren oer en Vr ihn ere ne rege ar\\nsp tapered OMA sprees aviaiod mam eva wenn ta Sagem: pupae, Tamme ne\\nSage be aaawecsnd carenmtes wan ine pana neta Nowe te eames wae Te a\\npT: Drtre wee CEV 4 ON Lee mene SYS HE Ney #8 meee\\nsarees rate carte pruwror eave wearer\\nSeam Of Pema pega mea oman Lereeet) mrwey CAP mente NORBOS OF\\nSen pnekeogeyel\\nRen maveearang CE Dmumeger Pubes 02) fe PUR AJ Rat LALcoNOrD ManneGe m Corneal RerWeny\\npanmaeie Caan. WF 7 ane. 73\\n0 RETINAL rar LINGER” mam Sans\\neee\\n“3\\n‘ad tam aoe Onee rs\\nenum sane nes? hog.\\n788 eum anne 20132\\n. @reeweamrany', 'thyrocare_0_5928.jpg': '” p\\na tasers eee\\ned aioe en\\nad Lar\\n‘\\nSerene) ovr Fy we\\nal\\na\\nID Baye\\na we\\n= we\\nage 9 Ta en 8 renee an Benen HOW aren mitrtnt sgt BU\\namb preter mee Ov\\nShel I rT oe -\\neam os cura ss Pel\\n——\\nee ted\\nOnaga\\n-nniysperntneeet Tivantnebarenhetuneasiegioedatal\\nome nO nam ep tan Bee owe en en TD\\n(pmo odo ve tee mpm ae ame wath A rmngce ersten\\nlege es open ee om eee rome Say et ae\\nCaan Oma mre 9 Mo anes Sd wenn ru Ramee FA ew\\n(een Dan em FAOA 4. r mer C4 8 Seneety On\\narenes ware payee rem\\n{Saar haere eng Weed mame (eee roe caren THC\\n_ Sram creas\\nSmarr Suare B > Sons ALENGES Ueto Rapats © nes amy\\n1 ns\\n- ACE Pe —\\nue\\nle Semabecad tg:\\nwee\\nee)\\na', 'thyrocare_0_6185.jpg': '= .\\n, - , ul\\n» > EEA ETS, ema cRuaEED as ¢ .\\n. ~ SeeelSenmaae\\nsper wnsese retn) cose » on\\nad\\nSR 2 nage\\naU Be\\nRY em\\n‘a 9 Wee ta erat om rte SOM Cart. orca aperet SD A, Oa\\nagen B marerrenner Megan Coe\\nSata CMLL CURE rev\\naren 43 cite Ey) ~~\\ntomes ge\\nPee el\\nCa apres\\nane 00d w romana, 8 6 amen (areas em Mare thapeoy Pan wena oats\\noon ma nn cap ae me ene ae apt Sn at ee PR\\n(awe rao wa trae # roe tae Tow BIL sre oto AF sarecgte re nate\\n(Seb eres te rtrers marcia om marr een ta Bagram: perpen “ase ed\\n(Gases 0 poems meee oe Te pear abn tery tan Pama ee\\nResmerenan Oe Aes (OO 4 ON, te te A 8 EN Nemes a\\nneeg rem henypctonaveanndl\\n(Gamage camera cabana Ned mer geet mers CA meter TON\\nreaean ee\\n. Raney OA Vrms OA) Puna ALAS LAI Rees m cal cNertry\\nmi\\n‘ Te Leemenaiianentae __.\\n\\'\\ndinamo\\nEta Centered hy.\\nVR MD aD i\\nroa\\n9 .\\n\" i', 'thyrocare_0_6214.jpg': '(6 chem cmsrma eoweR om enusET ar +\\ned ean\\n\\na | REC vesee vanes\\n— ru ecy ees\\na ENN © (VeTEL) cate 2 wes\\nrc\\n\\ndated\\na\\nee\\n=e ey\\nman © Yala test anatraee wh Taeeners ADEA Cartan’, Lareertieet opera: ID {L/L oper\\na Rerearerinn rages\\nLL ONALT APES CORE LEU PND SAT Es\\naoe O23 Cora ES) perme\\nwenen Bangs +\\narte teed\\nisles iateimaiaal\\nma 02 wr CreMmCURAANI, wk 8 coomente corvvud Compare Maen Echiteay ars armel owt\\nsoe th tn eat, ie Ha ak 5 Cre Mor OMS Herne, a Te YORE\\n(ranin Od © Wa tarmntien @ Pertnn oeaah Viera 1) and t0 Rnd DA A BOOS\\npupa CAA. upton mnecieart SEN macrervi< arerenn Yor aghast PpCEE, TORR Won\\nqu be aqensnd = conpencian wo ue poneray aed memery rea Huamebun or tne PS\\npraminants WOR satiny {MEV} 4 0%. Inter eeney {CVI 44 Nereis 49 aay\\naD Qually Are progres peripener\\nete Aree pg Nyrel aimee (portal) warey. CAP eee TIO MPLS OF\\ncociewrsilahiutiiaall\\nPOR Spting WE Jupagy Th vanes 1) i CesT Al Rewer Lijcehen Meer m cineca chemenry\\nerlneay Plena, WR SRT\\n[iit AEE ERE. ERRECRODAAT SPYPCAD EPG LOE? PONE Aone -\\npearl Ti aS eM\\n\\n25 em ae eae\\nFl emedentl Ju\\n2008 2033 Ass\\nmrenmmara', 'thyrocare_0_6222.jpg': '- Pu\\na 1 eS eae ee Sinead GER 2\\n8 -_ [ap neiny perp toy—hl\\name | eet ve A\\n_ momeveer wn oe\\nwen eee rere) cua » we\\ner\\nced\\ncoma emcee\\non\\n=o mee\\nein 0 Se wet vend eee Cte ete tne caer OL oo\\neee 0 rrerpeenes Paen or\\nGene Mit SOA COR ween Poms es\\nsemen eu ce oo ~~\\na\\nkee os\\nces tones\\nrr reer nee erent remem Med tn ney en ent es\\nsome enn nak eg es ne Bore ene tae wrt One tn ern pe\\nTaos e emt sore oan row ise ian ss woeges neem\\nSeceees ben ros cosa cern re es rome to tage pope eee ooo\\nSip anmene rena ow weewn ons see sas hitmen carer sews\\n(aaPemAe HR Am (EN) 4 OR te meen (FE Rees 8\\ncape eater eegen saree\\nSete nen rere nee oar Leena rey CaP eee rid ot\\nnr coon.\\nGen peaseeng Maen ice 812 Meee AL een Lapin mats = ce ctemy\\nRackets Rnaatin. SF RD F)\\nSSS\\nao\\n\\nLt ie Bite toe\\n\\n12 hy.\\n\\nel i Pane a\\n\\n. Gratecemey :\\n\\n‘', 'thyrocare_0_640.jpg': '“ = CAP\\niad :. My h\\n/1,TTC MIDC,Turbhe, Ts ACCREDRED T yrocare\\nMumbet-400 703 See eee ‘Think Thyroid. Think Thyoon\\n(Corporate Office : Thoyrecere Techastagies Limited 9 0-377, TTC MAC, Tart, Hed toil - ONTO\\n© 022 - 30900000 / 4125 2525 @ 2691 MENGE Mi eeineugthrourecom Qwemthyouwasen, |\\n: + ASMIM KR SENGUPTA (259/18) RAFFLE COLLECTED AT :\\n(7024.357519),KALPAMA MEDICOS AND CITY\\n\\n~ s Ser LAB,BIMUTOLT ROAD .HOJAI ASSAM 702435, 702038\\nad 1 AAROGYAP A\\n\\n: — aes —\\ntT maser Tectmovosy = VALUE _ UNITS REFERENCE RANGE\\n(Aa, TRIIODOTHYRONINE (T3) CALLA 7 nef 60-200\\nFAL, THYROXINE (74) cua $s vad 4.5-12\\n(ROAD STURAATING HORMONE (TSH) CLA 2.14 wluyerd 0.3-5-5\\nfROND STURAATING HOME\\nmenemtn : SUGGESTING THYROWORMALCY\\nane correlate with cfinical conditiens.\\nPad $\\n= COMPETITIVE CHEN LUMINESCENT IMMUNO ASSAY\\n= COMPETITIVE CHEDH LIDGINESCENT IMUNO ASSAY\\ni eens foes pimemenreeT BAIN ASSAY', 'thyrocare_0_657.jpg': \". ‘\\n1, RAN/36, Raghunathpur, 7\\nMelkate-700 059 Tit:\\nConparate Offee : Typocare Wchastogies Unted @ 37/3, TTC MAO. Yoh, :\\n© 22. 3090 0000/4125 2525 © 9691066065 @ welnen@eyecn ee <\\nes\\nREPORT\\nvA el 2 RSMIM SENGUPTA (S8Y/M) SANPLE COLLECTED AT +\\naw 1 SEF (7824357519) KALPAMA HEDIOOS AND CRY\\n‘Weer AeRED | RAROGYANC LAB.SIMTOU ROAD ROOM JOBAOR\\n}\\nTest nae TECHNOLOGY = VALLE wars. a\\nAAIALINE PHOSPHATASE PHOTOMETRY 67 wh a1\\n4 GRIRUBIN - TOTAL PHOTOMETRY 0.57 me '\\nSELIRUOME -DIRECT PHOTOMETRY 0.18 naa '\\nBAURLEN (MORECT) CALCULATED 09 -— af\\nQIBBU GLUTAMINL TRANSFERASE (GGT) PHOTOMETRY “3 w ¢€ _\\nABPARTATE AMINOTRANSFERASE (SGOT } PHOTOMETRY Ba wi .\\nPAAIINE TRANSAMINASE (SGPT) PHOTOMETRY 389 wi ‘a\\n| PROTER - TOTAL PHOTOMETRY 74 owe 1\\nF AABN - SERUM PHOTOMETRY 393 wa\\nSERUM AA/GLOBULIN RATIO CALCULATED 1.22 ati .\\n“@e. - _____ PHOTOMETRY 321 3\\nStee pein este cnicrel condition’.\", 'thyrocare_0_6698.jpg': 'Y OE I aE PAS OL a\\n—_ ewiacusesa\\nou | eemec ery\\naE Oe COT) aos Pi se\\npe\\nTS len singel\\nTeeny\\nalas\\nere\\nnO Rial Nom hated Beare AOVIA Cartan. storia apie! 1D LLJOPLD, a bar\\nm © Saranasven rogram (roe?\\n04 P1RAS PORTE CEP LUST ONAL ae =\\nan O03 cole Eeyy one\\naf el\\nat ers owe\\ned\\notal w cronereaeiemen, = 6 Ceners coun reread Sue or Aen te arenes any\\nmayne pynnenrinnr-oheenerengiomomaersne\\nDoes wae ve trees Otero aa Viste 1? wed ond ne eee OOO\\nsoeres GOA eyemnogs naamcueand ath macreryee creme Nor Sagraats purpane, nate ed\\ncacmmmes ncocganoee on re pone cavee way. one erent Ok\\nsea: Dee Amn ECV) 4 HTN. nk oan REV) 4 enemy 8 egy\\natts cent progress poreceaen\\nSet eomenain pabvcnegate: Npnd corey (GANA!) ervey. CAY momen ISORS 42\\neter\\nPASTRinG GENET RA Wine Bi 2 fe ome Alain Li tefabiere Manartai wm glmonl congener\\nPROT Pucata, bei Pies 3.\\n<em LRREIT BORD cana? _\\nA LEE LE.\\nAE Pe AG HOD\\n2S Fale OU EY\\n83 ou.\\n\" oie ene y', 'thyrocare_0_6716.jpg': '- . >\\nPeveuwe CA Th\\npm remee-s08 rad _e ‘Teak Thun. Toon\\nOmipevate Capen : Teyremnen tetaatiagfes ttntane @ B17/1, THC Annie, Tati :\\nOe. epee 35.55 Somes Gedewtyeam Ge\\npen AEG ER SEPA A (250/90) CAMPLE COLLECTED AY 1 sam cate\\nmae . oor (rear a ene noe\\nnr a= 1 ARIAT A\\na Hef :\\nFee cS. yecmmouogy VALUE ware anranaerce aasaa\\nWORE VRRODOTIORONINE (3) rer ” ~~ om Ut”\\nvawwn. Tremcumet (74) cae ry we 4512\\n‘RAREND STROAATING HORMONE (TS*1) CLA Paty auret 03453\\nee TR eee ee __—\\nGpemsents: Suesestees NrnoNCMECY\\ncamratane wiht citabatl candies.\\n8\\n. CHEE LPUNERCENT PRIMO ABEAY\\nCNN LASERTSCENT DOMINO AMAT\\nECHO PORNO ANBAY', 'thyrocare_0_6723.jpg': 'y CRncennen at : . .\\n0-37/1,TTC MIDC,Turbhe, ® ACCREOMEDW yt Ocal ¢\\nfrei Proreibet-400 703 iow se—oemenes Thar Thypund. Think Tysons.\\n\\nCorporate fcr: Yorocer Yoesheges Lied @ 0-37/1, TTC MAD, Nt, Mink onta =AONOD =i\\n© 022. 30900000 / 4175 525 © 96918E0KS Mh weinemPeyccarecom Quentmweens,\\nwaned + ASHI KML SENGUPTA (251/90) ‘SAMPLE COLLECTED AT:\\no.or 1 SE (7024357519), KALA MEDICS AND CITY\\n; (AB BBOUTOU ROAD .MOIAL ASSAM TEARS POMS\\n‘art nD + AAROGYAN A\\na = _—_ —\\n‘TEsY maneE TECHNOLOGY VALUE UNITS REFERENCE RANGE\\nvey Hiss\\n‘TOTAL TRIIODOTHYRONINE (3) CLA * rg/@ 60-200\\nTotan THMROxie (74) Cia 5 va 45-12\\nTIYROED STBQRLATING HORMONE (TSH) CLA 214 werd 0.3-5.5\\n‘RARDIN STPRAATING HORNE NS\\nCeasments : SUGGESTING THYROWORMALCY\\n(Peance corratate with clinical conditions.\\nCeethed :\\n$B COMPETITIVE COHEN LLRMNNESCENTT DHHUND ASSAY\\nan, ARMNOTITENE CHEPT LIBGMESCENT I@4UND ASSAY', 'thyrocare_0_6743.jpg': '— §& ecap, Th :\\nYear SeatareDW\\nO-FI/1,TIC MDC, Tarte, 2] bacespommch di 2\\n(tae raete-400 703 —e sealinauildaal\\n-\\n— \"\\n_— Coperate Cepe: Ramnere etnaiegies tind © 8-7/2, TH MAC,\\nOmM-mean/a555 Cuma Bwtenityeee a\\neet 1 ABNOA ER SENGUPTA (ZSVAIN an0U8 COULECTER AT\\nmae iw (AIST AAPA HOON AND CITY\\nLARSPOROA ROAD JOGA AMA PERCH OES\\nOR 6SEED 3 AAROGTI A.\\nee\\nene soe _TOCHROLOST WAAR UNITS RVURORCE OAR\\nFema werooonemonmn 3) CLLA BY aS) ‘\\n‘vane, Rennie (741 ca : as\\n{Speumantn 1 SURRESTING TRONOROMACY\\nsalah adel ooelRbene,\\ne CHEE LPERERCENT PENNS ASAT\\nAE UNEDEDCENT POENED AISAY\\nANEDORNT BORED ADEAY ,', 'thyrocare_0_6884.jpg': '| veccesens a1 ‘\\nDoreen Lae Thyrocare’\\nfevi turmine!-400 703 ae ae Tracemmmmnnces Trunks Toyrand. Thirds Thamar.\\nConpovane Office ; Tayrocare Vochantegjes Lintind @ 0-17/3, TTC MMOC, Tarte, Rav henta- aOOND = 5\\n© OV2- 3.0000 / 4175 575 O NETINEOS Mrinengyoweces Quemieweses\\nwore 2 ASHIA KR SENGUPTA (259/01) SAMPLE COULSCTED AT 1\\n— sey (7R241S 7519) KALPANA MIROICOS AMD CITY\\n; (AB. BDIUTOLE ROAD OIAL ASSAM 7UIA35, FEDS\\n‘yest nana 1 AAROGTAR A\\n—_ ee\\n\\nTOTAL TRIODOTHYROMINE (13) Cola % my 60-200\\n\\nTOTAL THYROXINE (14) Cla 5 wd 4.512\\n\\nTHAROND STIPLLATING HORMONE (TSH) CLA 214 wuss 0.3-5.5\\n\\nUe ee\\n\\nCommenta : SUGGESTING THYRONORMALCY\\n\\nPeanee correlate with clinical condiiens.\\n\\n(emthed:\\n\\nTR - COMPETITIVE CHEMIE LUMINESCENT INPAUNIO ASSAY\\n| BO COMPETITIVE CEPI LIDENNPSCENT BAHUND ASSAY\\n\\nme Ne ee cl', 'thyrocare_0_7075.jpg': 'fz CAP Th\\ntrea\\nteva tramber-<00 703 —e Tat Tayi\\nSxpomar fhe: Vggoans tctentagin tint 9 OE, TIC MAG .\\nOGN-nmam/an55 Cm BwhestymrnD\\ncod 0) AA CR SEIT (250/00) Te, een sanncce Am CITY\\nanew vee LaeOOA) OOD SIAL ARAN FODOTE FOO\\nse = ann\\n_ ee\\nwerana _TecHmaeny _veuist _ ORTS SERS OS __.\\nJoma mcconenceme LIA ied ae ee\\nen cua ry we 4512\\ncnripeeph ish cota a rites 04S\\nae cere ron\\nRy civil ean.\\nape swrescenn woune AasaY\\neran EMRE HESS AOLAT\\n caEERCENT DONIC AOEAY\\nae', 'thyrocare_0_7082.jpg': 't\\n7\" scape, Th\\neee ‘\\nDTTC MDC Tha, i] endl\\nWat Pamiet-a08 703 wette Tok et\\n-1\\nCuparate Ofer: Vaysoese tedhnsiagjas linia’ © 0-17/2, T1C MAIC, Tate, Mell\\nOm. nme a555 On Bwheephaoee\\nea 1 ABIDE ER SENGUPTA (259/01) SALE COLABCTOB AT 1\\nane oe {7R4 357519] LALPREA MEDICS AND CTY *\\nUB DORFIOL ROAD OMA DORIA PED FURIE\\nan oe 1 AAROGYAR A ic\\na _____\\nwae _TOCMNOLONT VALUE WONT EOFERENCE ROSE\\nFou wacoonrncme (Ts) CLA x we om\\n‘ota, Rene (14) cia : eee\\nQqumments: SUREESTING TRONDRMLCY\\nearrakity cin cated exiiatons.\\niJ\\n(CHEB LUPIRNESCENT DUCUND ASSAY\\nCANE LNNESCEDIT BOUND ASSAY\\nppemmrener DERE? ADGAY .', 'thyrocare_0_7083.jpg': '_— .\\n\\n1 EOE CR a madaan etpetoel !\\n\\nDead Seowties saa\\n2 A va eT\\nE ___ emer oun are\\n\\n| maneeeeun eo creras; reer » =e\\n=>\\nButed\\n\\nja yng\\n\\nmemcem\\n~via\\nern 9 tas ta eset Sere AINA Cir, andr nerd ON\\ntae b mreoseme mays toon\\nSat, Tatermmmtis Gur urwenun rev se\\nen cra ss owe\\net enpe\\nSS ee\\nome eae\\nee Tile raat, = scones corel rerpeine nd putvecen oar et tee\\nSee me eee ws ce Pace enon rere Son non re rite\\nSeccesapetmee omren cme wos tise nna ns meeps ameaere\\nSeugued ous trees aaevens cer nare ee rem ta eeprom” popes oats Pare\\ninietaemessrpwae oe pe omee areas wnwey ate mereaen ow er ae\\ndeerme a uty FACE PN. te meen I A ety\\nees gate wee mene rene\\n\\nCage secre petty es ee ter eres CF mentee HH OF\\n\\n< —\\n\\naera Rann DAS baie ALNBOA LARS Sat Shc ey\\n\\nCongr\\nRe A RL pom sane -\\n25 de Ale eee\\neee P\\nwememepe\\nv iJ', 'thyrocare_0_7109.jpg': \"q\\nnm 5 .\\n, Moteate- 700 059 ‘Think Tiquetts 9\\nCenporete Offer : Tprocare Technologies Unmined @ D-37/2, TTC MIOC, Tartine, au tani :\\nG © 022 . 3090 0000 / 4125 2525 @ 0691966066 ah watnes@~yrocere com rei\\nREPORT :\\n_e 1 ASHIM SENGUPTA (S8Y/M) Sane COLLECTED AT + ba)\\now. ov + SEU (7824357519) KALPANA WEDICOS Aub cHRe I\\nTent ABNER: AAROGYANC LAB, BIRUTOUE ROAD HOUAI ASGAM\\nf '\\n“<\\nFaw massa . TECHNOLOGY __vauue wars. ne\\nALKALINE PHOSPHATASE PHOTOMETRY 67 we +e\\nGRUBER - TOTAL PHOTOMETRY O87 mala esse:\\n. CUIAB -OIRECT PHOTOMETRY 0.18 moe e\\n, BALIRUBIN (INDIRECT) CALCULATED 0.39 meld :\\nGAOIMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY “3 w «aq\\n, ABPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33. uw 7m\\nPAAMENE TRANSAMINASE (SGPT) PHOTOMETRY 33.9 uw € a\\nPROTEN - TOTAL PHOTOMETRY 7.14 ove ni '\\nABUMEN - StRUM PHOTOMETRY 3.93 awe Lam\\n‘SERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio _=\\n- SRE @LORULIN 2 a, “PHOTOMETRY 3.21 =\\n.. (tense earvatete with clinical conditions.\\n1 =\", 'thyrocare_0_7219.jpg': 'Pnecussen at : . A\\n0-37/1, TTC MIDC, Ture, % ACCREDITED” Thyrocare*\\nVeavi Mumbet-400 703 dwn ais eee Thank Thyyrond. Thank Thyoosee,\\nConpesate Cifice: Toyrocare Toctosiegfen Untied @ 0-37/1, TTC MHOC, Rate, fia heme OOD\\n© 022 «3089000 / 4175 TE O HANKEG MB ecnene yore com Quentaenel |”\\nCo 2 ASMID KA SENGUPTA (25/61) SANPLE COLLECTED AT +\\neur. OY : SEF (7124357519), KALPANA MIBDICOS AND CITY\\n* c LAB, BEMUTOU ROAD ,MOJAL ASEAN 702695, 703408-\\n\\nvest amen 1 AAROGYAM A\\n\\nTOTAL TRIIODOTHYRONINE (73) CLA 6 agi 60-200\\n\\nTOTAL THEROSGNE (74) Cha 5 wa 45-12\\n\\nTHYROID STPRAATING HORMONE (TSH CLA 24 wy 0.3-5.5\\n\\nee wa OE eee\\n\\nComets t SUGGESTING THTRONORMALCT\\n\\nPeanes eorreiate with clinical conditions.\\n\\n(eeted t\\n\\nTS -COIPETITNE CHEME LUMINESCENT IMMIUNO ASSAY\\n\\nFe COMPETITIVE CHIEMH LIDEINESCENT BELO ASSAY\\ncee nanemenmeres CHEE LEEOCENT PTUNO ASSAY\\n\\n_', 'thyrocare_0_757.jpg': \"aE ;\\n(an Wamel-400 703 we ” ae pie Tae\\n' Cayentn Gifu: yee tetas tntos © 900, TAG ‘\\nO@-meem/at55 Onn Buhettpe\\neS 1 ROMA I SENQUPTA (250700) SALE COLLECTED AT\\nmw ow LABOUR AOD FOR iy\\na 1 AARON A ~\\n2\\n=e no Se TE.\\n‘Joma EDDC RORCIN (13) cua * we\\n‘vome Remonse (74) cota : ee\\npone ren GLIA 2 ates OHSS\\n; sia ciated ennditiens.\\n(Qume UsmescenT BEE AamAY\\nUDEREUCENT PORUED ARLAY\\nEVO DURIND ADEAT\", 'thyrocare_0_7571.jpg': '7:\\nO-37/1,T7C PDC Tarte, ® —\\n(tae Premninel-400 703 ates Thnk Tid. Pee\\n=)\\nCenposets Cian: Toyocnre Ttechnctngies thetind © 0-12/3, THC MIRC, Tait,\\nOn2-mem/o5 55 OM Subenpeypesen\\nf\\noe 1 ASEM KR SEMAIPTA (25070) GAMPLE COLLECTOR AT +\\nme i= (7U0 57310) ALA MEDICS AND CIT\\n(UB. BDJTOL ROAD HOOAL AGGAN FEA FEMS\\nTan ee 1 AAOGYNN A -—\\n_—\\noe  _ __ eee —\\n= TECHNOLOST VALUE MEETS REVERENCE RASIOR\\nTr OT en me\\n‘Fouas. MEIQOCTIMRONENE (73) cus ” wt Om\\nYana Persone 14) as ; paar\\nQqeamantn : SUBEESTING TITRONORMALCY ‘\\nequvehate with clmical conditbens.\\nny is\\n(CORSE LREESCENT POTUNO ASSAY\\nCHEDEE LINENESCENT IPOTUNO ASSAY\\nLENICENT ROUND AOTAY', 'thyrocare_0_7601.jpg': 'ROCHOED AT: . p Th\\nnyroanre Pe 2CA rocare? |\\n“37/1, TTC MIDC,Turtne, ok ACCREDITED W” Mi Cc\\nevi Munnbet-400 703 te ‘Thanh Thyroed. Thank There.\\n‘Cenperete Often : Veeyrecere Vedimatagion Usninead @ 0-57/1, TTC WMHOC, Rertetes, Meat ttheentiel -\\nO?- mA /IABD 0261960 B erieeety~ner ae\\naad 6 ABOTM Mm SEDCAUPTA (250708) SAPLE COLLECTED AT\\n(7a24357519) RALPAMA PEEENCOS A000 CITY\\nwv iia LAB,GDAUTOL] ROAD .HOIAL Adaaet FE2AIS, FUDSIS\\nSat sae 1 AAROGYAR A\\nTota. TARODOTIAROFINE {T>) Cle tad nad = =60-200\\n‘Towss Teymoxmer (14) CAL * loan!\\nTHNROND STIULATING HORMONE (TSH) CLA ay ways O58\\ncorunele t SVORESTIE TrHYRONORSALCY\\n(GRenTs earveiate with atinieal conditens.\\neee! +\\n‘7B = CRONPETITIVE Crepe LisenescenT PUNO ASSAY\\nCHEME LIDURESCENT DEIN ASEAY\\ni __', 'thyrocare_0_7635.jpg': \"°. 11, RAV36, Raghunethpur,\\np Rotate 700 059 ‘Tete Tagen\\nCanperate Office : Tiepecare Tochnetogies Lionted 9 0-37/%, TTC MDC, Rettie,| a\\n| © 022 - 3090 0000 / 4125 2525 © 9691960066 8 welnenPimpecenecom =\\n1 REPORT\\neee 1 ASHIM SENGUPTA (Sev/™) cane cociacene arg\\noev 1 ser (7824357519) AADANA HEDICOS AND O\\n‘Tat aaKED 3 AAROGYAM C LAB,ODAFTOU ROAD WOM AMBAOE ‘\\n/ '\\nTeor mama TECHNOLOGY _ _ VALUE wars a\\n‘ALKALINE PHOSPHATASE PHOTOMETRY 67 we S\\nORIWSN - TOTAL PHOTOMETRY 0.57 med ores,\\nBALERUBIN -DIRECT PHOTOMETRY 0.18 mold\\nBREWS (INDIRECT) CALCULATED. 0.39 wave 2\\nGROTMA GLUTAMTL TRANSFERASE (GG1) PHOTOMETRY com] wm < we\\nRBPORTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY Ba wm «a\\nSLAUINE TRANSAMINASE (SGPT) PHOTOMETRY 9 w ae\\n' PROTEM - TOTAL PHOTOMETRY 714 owe 4\\n5 SLBUMEN - SERUM PHOTOMETRY 3.93 owe oa\\n' ‘SPRL ALB/GLOBULIN RATIO CALCULATED 4.22 atte .\\n4 gun aon _ PHOTOMETRY 3.21 Py J\\ni Phemse canrainte with clinica! conditions.\", 'thyrocare_0_7758.jpg': 'a TI\\n7 a 1\\nD-97/1,77C MDC. torte, 2] BSAC 2\\nte Peemel-<80 703 aren Thanh eg. Tee\\n(Copanete Ciftn : Wapenee tateactagfen tintied © 0-27/2, TIC MOC, an\\nOm-meam/anns Gen Bwhesttpue\\n—« 1 ABM 1 SEMGLIPTA {250 /) ‘OAFWLE COLLECTED AT 1\\na. oF te CENSOR ioe sand AORN STATS\\nvers | RCNA\\n8 -\\ntermes © _TeQWOLOST VALI UNITE MFERONER PASE\\n‘Few mNCOOTOVROHEN (72) cua ial = ee i\\nFaw RODE (74) cute s we\\nvc Wowwnone (Vs) GLIA 204 saved 0945\\ncy\\nGraastes SeREETENG NernoMORNLCY\\nits nkaed wantin,\\n2\\nCame useeescesr peemnO AsEAY ‘\\nQa UDEDEERCENTT WOUND AOEAY\\nAURRECINT BORIND AEEAY', 'thyrocare_0_7791.jpg': '4\\n1\\n‘Towers 11, RAA/36, Raghunathpur,\\nReed, Kolkata-700 059 ‘Think Thysald.\\nCarperate Office : Tryrocare Technologies Limited @ D 37/3, TTC MIDC, Turbhe, ftevt Mumbet\\n© O22 3090 0000/6125 2525 @ Be9186b06b MM welines@Pthyrocare.com @:\\nAAPOR 2 ASHIM SENGUPTA (SBY/#) SAMPLE COLLECTED AT 3\\na. oY 1 SELF (7824357519), KALPANA MEDIOOS AND CITY\\nEST ASKED 1 AAROGYAM C LAB, BIHUTOLT ROAD , HOJAL ASSAM 702438, 70\\n!\\nST NAME TECHNOLOGY VALUE units\\nLKALINE PHOSPHATASE PHOTOMETRY 67 UA aS-\\nWLIRUGIN - TOTAL PHOTOMETRY 0.5? masa O2-1.2\\nMLIRUBIN -DIRECT PHOTOMETRY 0.18 mo/di <0\\nMLIRUBIN (INDIRECT) CALCULATED 0.39 masa o-os\\nJAMPMA GLUTAMYL TRANSFERASE (GG) PHOTOMETRY 43 wi <s C\\nSPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY waa wi <3\\nLANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 wt <a.\\nROTEIN - TOTAL PHOTOMETRY 714 ond S.27aR\\nLBUMIN - SERUM PHOTOMETRY 3.93 ont 4\\nERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Ratio as-.\\nPRUM GLOBULIN PHOTOMETRY 3.24\\njanes Corretate with clinical conditions.', 'thyrocare_0_7805.jpg': '‘\\n §& ecap, Th\\nb  ctammnd\\n(ton tombel-c00 705 Bn, That Tyas\\n; Cperatrifn: Papen Technctegin tained © 6-1/1, THC ANB i\\nOM. mNeN/A55S CuNNNE Sumas\\nee + AGRE OR SEMASTA (2510) ‘SALE COLLECTED AT\\npoll ww (7AISTEEPL CALA MICAS AOD CHT\\nLARA AD 2 JOA PODS OS\\n= 1 ARDEA\\na ____\\nwren Tt Nl ————e\\nFoun mmononenCrIE (73) cua he) ~ om\\nWoun, Pence (74) cua . -—\\nERED STPTTIE nme TH CLA zy eet 088\\n1 SUREETRNG THFROMOROWA.CY\\ntah ciniad comers.\\n(Qusn upenescenT pou sae\\nGre UNENEBCEITT POUND ABA\\ned\\nreons', 'thyrocare_0_8214.jpg': \"Mavi themeet-400 703 he ‘There Thysens. Thanh Teqnemaits'\\ni\\n‘Cenpecate CgPee : Tagreneme tetnatnggas Unetand © 0-47/2, THC AMMO. Tete, Mt\\nO@2-MEEE/ UB SS © wee whee\\nfeaen | ameune aa sENGUETA LEVI SaseLa COLLECTED AT\\nne. ov . oe (7e2a287519) KALPORA MBOAEIIG AND CITY\\nLAR SRETOU BORD OIA, AGOAM TERRI, PODER\\nvat 2 AARNE a P.\\n—_— ; iia: “awed en eon\\nFaw TRBOOCTHAONENE (73) ~ ett ” wa 60-200\\nFame, TeMmcouNe (74) cata 5 we 4.512\\n‘REED STRORATING HORMONE TIN CLA 244 envet 03-45\\nRema STHRAATING MONMONE THN SEN —___---__\\nGeemeente 1 SUEEEETHES MnONOREMLCY\\nt ensrenste wits Ania etter.\\na\\n(ewe UstEEaCENT DETUNO ADEAY\\n0 LADERINECENTT WENO ASSAY\\nOEE LUNEDCEDT DENIED ABBAY 5\", 'thyrocare_0_8231.jpg': 'waa\\na leat anand cm emsaiataslld\\n4 - Cumann amram mince AO CY\\naap | ween eT\\n——————— —_ ——_______—\\nre mae ET\\nepee rem) prey Fa Py\\nsteer toga\\nea ye\\nRORY hye\\non-call Leeda\\nfom 1B ear\\n‘Samra 0 Tas tak 0 wernt wh fom AOMAE Cares, urs as agnenl LD LLIN © OE\\nae 0 Rarersaster Pres OH\\nSak PLT APD AML UROL PD\\nre 2 cts Bs oye\\n‘axcermman tage |\\nfens. 111-Fib op\\nCae egptaree\\npromedyofpeyiorin owe TT noche een lienetodaeadeioerelncaetemeteal\\nCae kw Oe SO AE OR Scots ET OM en oO em Re ee\\nae Od a IE mE eR Viaree BIL ne ind ur eres neo\\nRd ayUrTE OA Sree emOte eM mare es See Io See” RTOM TNA Pt\\nSap TTL 2 CCEA OA PERE SUCEE RET) BRD IR NN OK Te\\n‘Apanmaamns: We BOE ICV) AON er suey LV) SAS Seer Oa\\nRee Ey Ene pap sr\\nCatage Sen mabeiepts Neare weer (pera nrey CAP seer HNN 1\\nBeene tow:\\n(Cane a apertng ME romerge . eme 212 7 Sere ALLaee Unters Meret ine arerY\\nSuneecy nee 97\\n\\nu OOS WARK ne sana\\naith dct! eantioce.\\n\"I Tocceanebesnen\\n32 eb 2000 8-37 toy,\\n2h Be ,\\nADR\\n‘', 'thyrocare_0_8251.jpg': \"/ *\\n, 81, BAA/36, Raghunethour, .\\nKolieete-700 059 ‘Tek ;\\n(Conparete Offer : Tryrocare Tachnotogias \\\\ienned & 0-37/3, TTC MOC, Testsin, lnad .\\n* © 622. 2090 0000 / 4125 2525 @ 9691066066 a welnee@Uerecem.comn +\\n‘ REPORT :\\nwee 3 ASHIM SENGUPTA (SBv/M) SA0PLE COLLECTED AT 1\\nmow + SBF {7824357519}, KALPAMA PEDIOOS A0ID Ci\\n7a sD + AAROGYAM © ‘LAB, RISUTOU ROAD HORA AGEASL ;\\n\\n’ '\\n\\n7 Tes masa _ TECHNOLOGY = VALUE wars an\\nALKALINE PHOSPHATASE PHOTOMETRY 67 uw i.\\nGRUIRUBM - TOTAL PHOTOMETRY 0.57 mae ;\\n\\n_ SUA DIRECT PHOTOMETRY 0.18 mah h\\nGMLIRUBIN (INDIRECT) CALCULATED 0.9 wae\\nGHIA GUUTAPTYL TRANSFERASE (GG1) PHOTOMETRY m3 wi ed\\nABPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY ma w 4\\n(ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 w oa\\n\\n' PROTEM - TOTAL PHOTOMETRY 7.14 geal oi\\n\\n‘ BUEN - SERUM PHOTOMETRY 3.93 one fae\\n‘SERUM ALB/GLOBULIN RATIO CALCULATED 1.22 jatte iz\\namamcnm - SHOTORETRY 321 -\\n\\ni Shanes eoyvetate with clinical conditions.\\n\\n-\", 'thyrocare_0_8265.jpg': 'ae\\n-\\n_—ner ametel RR Oe\\nend — <a\"\\n8 taeene pvoorety\\na. a\\nspenvmne cw) cus 2 owes\\na\\nears\\nARGC BR ye\\nLars\\n— ew\\n(ana 0 eat 8 ond Sones AOA tes, retin pt DL\\nfren fringe\\n(Oka ete 08 ere ee\\n— we owe\\n——:\\nSTR en\\nel\\nSe ir etereen esmencine es\\nene ie een\\nei romcea ee Roars censors\\nSamsnigen ae ee eae\\nrmenerccr et eo Sa ec en Ste oe,\\n(enna be ane (9 oe eg ae en\\npa eats ene payee ween\\n(Ge tneen pee 9s ane gre ere CP mee TH\\n——\\nect ree nee = man seen tanner comer\\nomen\\nAn urpenan sen a _.\\n—\\nLe Ra BNP Seat\\noxafn anne 2837 ,7%\\nSe ee ad\\n_ a \\'', 'thyrocare_0_8302.jpg': '} eee AT t Th pr\\nGolkate-700 059 Thnk a\\nConparate Offer: Tyrocer Tachnslogies Limdnad @ D-37/3, TTC MOOK, tthe, .\\ng © 022. 2090 0000 / 4125 2525 @ sol mEOEs ans\\n‘ REPORT\\n7 woe 2 ASHIM SENGUPTA (SBv/m) SAMPLE COLLECTED AT +\\nww + SER (7824357519), KALPAMA HEOIOOS AND COU\\nFORE RENED = AAROGYAC LAB,BIMUTOL ROAD HORAL ASEAN :\\n1\\n- EBT MANE TECHNOLOGY VALUE wats ~\\n‘ALKALINE PHOSPHATASE PHOTOMETRY 7 we a\\n. GRLIRUGIN - TOTAL PHOTOMETRY 0.57 ma :\\nGRUB -OIRECT PHOTOMETRY 0.18 md a\\n5 BALRUBIN (INDIRECT) CALCULATED 0.39 née if\\nQIOMIA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY ce] w € :\\n: AGPARTATE NAINOTRANSFERASE (SGOT } PHOTOMETRY 31 wi in\\nSLNIME TRANSAMINASE (SGPT) PHOTOMETRY m9 w van\\n. proven - TOTAL PHOTOMETRY 74 one 4\\nJ BUN - SERUM PHOTOMETRY 3.93 gwd .\\n‘SERA ALB/GLOBULIN RATIO CALCULATED 12 Ratio :\\nspam qos ______PHOTOMETRY 3.21 Es', 'thyrocare_0_8310.jpg': 'ap Sapa\\nTr eaLmmtnuenend amwemynnn ss\\n-_ (renames Or\\n‘= Wem | eeseane =o\\n—E—E— on =\\nsqueeme cum) cose e we\\n=.\\nie\\n— omen\\nar a\\nman 9 seme a ered es A Cee mean ee 10 AO Oe\\neee Beare ae roe\\neet at nets Sen rele ree es\\nware ote mm -~\\np—— re\\ncae opt\\nSer Cll acre eee et are ar te eee te ee an\\nSacer en ee\\nSangeet were nee nee cage pee ee\\nproton epee tpn une ReaD Geen SO SERENE\\nAenee em  ISE E e ce Ye eer ge\\neae atte eres epee ee\\nSa a a Core ae ee ene AP mene 8m\\nmeme saearase\\n(Suan emeaeaneng MNase 07 ee A eter LAr mtn te cy\\nSint eee ome\\nSn ee\\n—\\namo _ =\\nscape 2am 10.39 hey\\nee .\\n—\\nwoemenran\\noad', 'thyrocare_0_838.jpg': 'ita\\nae May\\n_ anc ‘fen LET Os\\n7 1 (CRUE AUER RENCE 1 PE\\neae ieee ——-\\nwee\\nae Sr __\\neneme (roe; cua x we\\nfntenace Gap |\\nwe «ye\\nen od tede bel\\nEE ye\\ncoronary\\nVane b Weed 8 erent wt mers AONE Caren, cert ape ALLL\\nne B Rareertamer mae ON\\naie AS ery re Par mae\\neae OE cote so owe\\netenes ge:\\nire fre\\nCame ngreeanee\\nfemme pepe ee OT eer irene healt neakaat oaekertd\\neve eet ek gon nd nee mS rm ON eNO eR EE\\nRemwe 00 sve tema orm fee Ce BLL net ind a race Me\\nSetapered Is sroem maneed an mare ee women te SaQreM. pepe \"So AN\\nSuen ame © cme oo poner metcn wry Se Fume Se OO\\nApe: We amas FRC) 4 OR Yee mente RO) 44 rete #1 Oe\\nCREA ely eet opt care\\n(Catnge t Rereen pete Spire sents (par meee CAP eres INN OT\\naes eee\\n(an peta eee Bee BL» fen AL Eeee aren ean © ees meiry\\n‘Rpacatedes Raety seer 9 AT\\n\\\\ OID VE AIRED Pees A\\na\\nuemen\\nOe teteted\\nDe Leetenedeanid\\nPate earay\\n1 7', 'thyrocare_0_8394.jpg': \"; Pnecensun av:\\nTayrecsre CAP 9\\n0-37/1,TTT MEDC, Twrthe, Fe) AccREDATEDW” Thyro\\n\\nfevi Phemibe-400 703 Shoe ws — ‘Thar Thepotd. Thanh Thyseenre. °\\n\\nCapormts Offer : Tayrnmmre Tochunstagios Unies @ 0-57/3. TTC MDC, Tathin, iv\\n© a2. 5800 4175 AO SON eNENS Eh eotrROt perc nt\\n\\nLoad 1 ASHE KR SEMGLPTA (73470) SAMPLE COLLSCTED AT TF\\n\\nom. ov 1s LODGE PL RAPA MORE A CE\\n\\nvast som + AAROGYAR A\\n\\nFat one TeomoLoay VALU HOTS MOPERRNCE RASOEE\\n\\nll = ‘ _ Mars cerenence ers\\n\\n‘Fora. TAROOOTHYROIENE (73) cue ” wea 60-200\\n\\n‘Tomas, THmONCN (74) cota 5 wad 45-12 '\\n\\nTRACED STROAATING HORMONE (TSH) CLA 244 werd 35S\\n\\nTHROW STRMAATIG HORMONE ST\\n\\nGemmmanta | | SUSCESTING THYROWORMALCY\\n\\n(GRanee carratate with ciinical condiiens. .\\n\\nmeas 8\\n\\nCRMPETETINE CHUL LUNIMESCENT OTUND ASSAY\\nCare Laneeersceer penn ASSAY\\nHENS LADENESCENT DETUNO ASSAY z\", 'thyrocare_0_8491.jpg': \"a\\nfhe\\na ' coe om\\noe (emma eweemarnm ar\\n: - eel\\nee amen ——\\nee\\nEERE Hem) cote ry we\\n—\\nond\\n= ead\\nee)\\nrns\\neer 9 ta tat 5 renee om eres Als ries artes meee DL\\nane O Rrreoeene Pare OH\\nae naires Den rie Pee et\\nwan O42 cree on ~~\\nbare ed\\nreed oem\\nSee le remem, = paren errs ene Med rears ta met es\\nanand yieemperneeareenenpeianrrrmnangonyon nears\\nCire recente mene orem rw ie ae etal os meeps wn\\nGeprcemwes bat rere eee ae oven ven to eget: hero aaa Pn\\nScrat c one co opera warn way See eran eae re\\ney\\nPeet ra kenatonoalpaceeel\\nSage re aa Se ane Or ty COP mate EN OS\\nemanate\\n(Gerenarees emry Pita OL: » am AAs Aafia maats = sina cherry\\nro\\n——_—_——S—S\\nCTT nteged\\nPe deutered ie ‘\\nrem\\nBokaro in\", 'thyrocare_0_8748.jpg': ',.... .\\nWayrewre CAP\\navi Dhemnet-200 703 seve Wot oem ‘Teer: Tera. Tata These.\\n.\\nConpumentan Cine : Payreqeeds Haphamanegies Limes POH, TIN RAMEE, Peale |\\n© O2- mW AN DD Snes BwhenStyuaN\\ncanon, 1 AMHEDL RB SENAITA (2577) SALA COLLECTED AY 1\\na 1 see (7226187519, RALPOA MEDICOS AnD CY\\nLAR RIDGUTOLE ROAD ODA AAG TUDOR, FRDSES\\na sa F AAPEAET AN A\\n‘Fear ene TecmoLony | VALUE ere SOFERGRCE RANGE\\nYous, TRNGDCTHT MONEE CT?) ce 7 nwa 40-200 —\\nFores, TerRcoINe (74) cA 3 wa 45-12\\nOROED STWRAATING HORMONE (TSH) 0 C.L.1A Par) med 0.355\\nree Eee weal 7 snd i\\nGqemments 1 SUBSESTING NIRONORLCY\\nSQanne cuvraiate wh antes! eanaiens. -\\n.\\n(CENT LUMEESCEIT eEUND ASEAY\\n(PE LamerersCeNT Peed ASEAY\\nEE LIEDCINNT WORIND AREY', 'thyrocare_0_8749.jpg': \"-.\\nCAP TI ..\\nO-R/1,THC eC. Tate, Bs fe OT\\n= man saws man tigll\\n*\\n.-Cpnsne ive : Veypeneve Tatenstagien thetoad © 0-5/9, THC NAIC, cen.\\nOat-mmen/annr Onna Swieetpnes Gill\\nREPORT\\ntad 2 AMD KR SEAIETA (25070) ‘SALE COLLECTED AT\\npants prs Ce nt Aaa ASSAD\\nase AEE IS\\noo ny\\nar wom romney vat TT ee\\nFoun ManCDONeRCNE (7 cua x we oe .\\n‘Vounn Rencume (74) rome s we «+2\\n‘RERED ETEMLATING HORMONE TTI) CLEA 2 sawed O>5S |\\n‘ 2 SURERETIS THRONOROIALCY ‘\\n. cm icine enendatore.\\na\\n(COPE NeRETECEITT BHTUNO ASSAY\\nGUE EICERT POTD AOEAY\\nAIRC RETIN ADEA\\noy '\", 'thyrocare_0_9047.jpg': '0D\\n‘gg\\n11, RAA/36, Raghunathpur, :\\naad, Kothete- 700 059 ‘Tha Tega.\\nConparate Office : Teyrecare Yechnsiogies Limited © D 37/3, TTC MIOC, Tarte, Mand\\n© O22 - 3090.0000 / 4125 2525 © 9691066006 2 wetrem@enyracere.com\\nREPORT\\n cantand 1 ASMIM SENGUPTA (Sav/M) SADIPLE COLLECTED AT; |\\nom. ov 1 SELF (7824357519) KALAMA WEDICOS am CE\\nvant sommD 1 AAROGYAM C LAB, BIPASTOU ROAD HODAS AGA\\n3\\nPa\\n‘JasT nase ° TECHNOLOGY VALUE wears\\nALKALINE PHOSPHATASE PHOTOMETRY 67 vA 7.\\nOme - TOTAL PHOTOMETRY 0.57 ma ota\\nSRUEN -OIRECT PHOTOMETRY 0.18 rar <end\\nORSRUBE (INDIRECT) CALCULATED 0.39 mad e\\nGAPWAA GLUTAMYVL TRANSFERASE (GGt) PHOTOMETRY 4 mw <%\\nABPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 33.8 wi «mg\\nMANINE TRANSAMINASE (SGPT) PHOTOMETRY 39 w ae\\nPROTEM - TOTAL PHOTOMETRY 7.14 ove mie 1\\nALUN - SERN PHOTOMETRY 3.93 awa sy\\nSERUM ALB/GLOBULIN RATIO CALCULATED 1.22 Gate Bout\\nwmacum PHOTOMETRY _ 3.21 rye. F\\n7 Ptanse carvatete with clinical conditions.', 'thyrocare_0_9076.jpg': \"ROCRISED AT :\\nTSS P . “CAI\\nee hcrewe Wy acer, Thyrocare\\nevi Mumnbet-400 703 aoe, ae rene ‘Think Tryrond. Thins Tryrwenre.\\nCurporate Offien : Teyrecuve Tochnstagien Uieniind @ 0 37/3 TTC MIO. Teeter, tant tteenbes - SOSOR:~\\n© 022 - 30800000 4175 5 OREN EOE SE erienEroLee com Qwaretemennent:\\ncoal 4 ASHE KR SENGUPTA (2597) Saneie COLLECTED AT +\\na. a : ser 17824357519), KALPANA MEDEOODS AND CITY\\nLAB. ODOUTOLT ROAD ,MOAAL ARAM 7ED428, 703028\\n\\nwer saxem 1 AAROGVAN A\\neee Yecneovogy VALUS UNITS SETERENCE ANGE\\nTOTAL TRIIODOTHYRONINE (13) CLL 7 agit 60-200\\nTOTAL Treenoxueee (74) CoA . wah 45-12\\nTHYROED STRCULATING HORMONE (TSH) Cota 214 wed 0.95.5\\nee ee - auras 3\\nCummmants : SUGGESTING THYRONORMALCY\\nPeause carvelate with ciintcel condhions.\\nethene:\\n{FB - COOETITEVE CHEE LUMICESCENT IHOUNO ASSAY\\n\\n= COMPETITIVE CHES LUMENESCENT WHUND ASSAY '\\ni Saees ome urmencen rene es 3\\n\\nTy\", 'thyrocare_0_9108.jpg': 'SEED AT : ,\\nare . 2 CAP\\nne Gy LGAe. Thyrocar\\npurnibet-200 703 ae eee ‘Thank Thyvesd. Think Theyroem\\nCorporate Offinn : Teyvecare Yotmetagian timed @ 0-37/2, TTC MMOC, Raritan, Steet heen ~\\n© 022. S000 4175 25 ORT EEORL OB rinem@yroure com =e\\n\\n2 ASHEN KA SENGUPTA (2597) SawLa COLLECTED AT +\\n\\nve 1 ser {7024397910}, WALPAMA OEDICOS AND CITY\\nLAB RIAUTOL OAD ,OJAL ARBAM 7E2AR, 702698\\n\\nae 1 AAROMEAR A\\nae reomovoey value Users mapenenec manesm\\na TREDODOTHYRONIeE (13) CLA 7 ne 60-200\\nua. FREYROXNOE (74) CAA 5 ws 4512\\nROED STIMULATING HORMONE (TS) CatA 2 te mura 0.3-5.5\\nERD 1 DURGESTHEG THYRONMORMALCY es\\na0 carvatate with Clantcel condone.\\nomeaital\\nCOOSPETITEVE CHEST LUNNESCeNT 1UNO ASSAY\\nSOOWUTTTEGE CHEN LINUNERCE ITT EmED ASSAY\\n SARTCH CPE LASTNESCENT WETUTED ASBAY', 'thyrocare_0_912.jpg': 'ae : i x\\nRareure =\\nD-37/1, TTC PDC, Turthe, 3] ACCREOMEOW Thyroc By\\nevs Mumnie-<00 703 ee. oe Thine: Thyrend, Thanh Teysoeuse.\\nConponste Offian : Veprocare Yorbntagios United @ 0-17/2, TTC MIDC, Tertins, Sens Atel - AN\\n© 022. N80 457 TO BENNER B eeteneoue ce\\ni! 2 ASHI KA SEMCAPTA (259/04) SAMPLE COLASCTED AT ¢ pa\\nmECOR AND\\n\\non. ow se Zar SSS RATA,\\n\\nvan sao 1 AAROGTAR A\\n\\nFoTM, TROOO TYROSINE (73) CLL ~~ aed 60-200\\n\\n‘Totes, Trevmnou (74) C11 3 us 12\\n\\nTEED STRULATING HORMONE (tse) CLA 2.14 wierd 0.3-5.3\\n\\nROD STRAT Oe wa Ue Ue eee\\n\\neeeNts 1 SUBSESTING TTTRONORMALCY\\n\\nPewuee enrvetate with cintent conawsons.\\n\\nPetes\\n\\nWW -COTETINE CORRE LUMINESCENT [POU ASSAY\\n\\nCoane LasUEEESCENT DERN AEEAT\\nCHEN LANERCENT DONS ABSAY :', 'thyrocare_0_9207.jpg': \"‘<a\\n\\\\-\\nBl, RAA/36, Raghunethpur, Ae\\n1, Kotkate-7O0 O59 ‘Think Thgaete\\nCemparste Office : Tryrecare Technologies nined @ D 37/3, TTC MHOC, Tartine, tnd\\n. © 022. 3090 0000 / 4125 2525 @ 9691066066 watineu@uwrecerecom ‘\\nae.\\n1 REPORT\\nLand 1 ASHIM SENGUPTA (Sav/™) SA0PLE COLLECTED AT >\\namr. ov : seer (7824357519), KALPANA WROICOS AMD CPE J\\n‘yest aaxep 1 AAROGTROe LAB.SIMUTOU ROAD MODAL ABRAM -\\n’\\n|\\n‘TEST MADE TECHNOLOGY value wars aga\\nMRALINE PHOSPHATASE PHOTOMETRY 67 un ~ a\\nGALIRUBIN - TOTAL PHOTOMETRY Os? mia Oda,\\nORLIRUOIN -OIRECT PHOTOMETRY o.1a moe «<\\nOLIRUSI (INDIRECT) CALCULATED 0.39 mela ss\\nGROWIA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY uD mw <&!\\nABPARTATE AMINOTRANSFERASE (SGOT } PHOTOMETRY 33.1 wi <n .\\nALANINE TRANSAMINASE (SGPT) PHOTOMETRY 38.9 uA <a\\nPROTEM - TOTAL PHOTOMETRY 7.14 one =\\nALBUMEN - SERUM PHOTOMETRY 3.93 one as\\nSBRUM ALBYGLOGULIN RATIO CALCULATED 1.22 Ratio ae\\nearaet qceuu __ PHOTOMETRY 328 ~s\\nManse cervelete with clinical conditions. '\", 'thyrocare_0_9445.jpg': '. 0 SRS SRR, ROTH aah aT et\\nant -m_ CARER eet, ae ed DURAN SPN EAE\\n<p 1 eee ee\\n— tomcat\\n‘Seg mE © (ror) ce » we\\n=\",\\ner\\npe\\nwee sees\\n[a\\nares ott eee tees cl me, werent ene nm Sa\\npent Partagas\\nSee tent an reo rane\\n=e\\nSet\\n——\\nres oe, ime es\\nSie sae\\nSerces cease a ate oe\\nleoromae eee oe tw ee ee\\neee ens sae See ae\\n(eet He tite ONO He oni Aw Nemes oe\\nee\\nree nm ee ens\\nmesos narree.\\n| 1 — cat neaeaen\\nSSSaeren\\n2 sUTHLD Ye uremia, see\\n——\\n‘ara men owe\\nEL Diets A ie 1\\nib deb BE Be\\noie \"', 'thyrocare_0_9447.jpg': \"i\\n| DI TC Tine, ] some Thyron a0\\nVine Poul 408 703 aon Tash i Ra\\nWO rts ctv amine nanemeblasdbiuainene 3:\\nOei-mmem/c5 55 Oia Beep Oe ;\\nAEPORT\\n=e + GRA OO SENGUPTA (25100) SANOUE COURCTED AY +\\nme a (7EQARS7S1G WALA RENO AND CI\\nLA NOAOU GOAD OOS AUEAN TEAS PDE\\nas 1 AROS A\\n———\\n= ee\\nng 1 CLA w rr (q\\name OVE 6) cuts 5 pounce\\nnome (Ta) CLA 2M mand 0555\\na\\nth dante eondines. '\\n(IE URESCENT POR ASAT\\nTens mene eae\", 'thyrocare_0_9575.jpg': '7—- ~\\n(tant Praeiee-200 703 eee To Teese, Pea .\\nval\\nCarporste Cifoe: Vayama Yashnstagies Uasned © 0-37/1, THC MDC, Ro\\nOM. mea / NET OMAK Bubeapty O\\nct 1 AGMA ER SEMCLOTA (257/8) BAWLE COLLECTED AT +\\nann 1 ser Pepe get any\\nvanvsamap =| MAD “~~ _\\ntl\\nwren Tunmmomy Nal _ wears Serene ae __\\nToms. TRECOOIRONIE (73) CLA n wd 6-00 \"\\n‘Toma enone (74) bug - eee\\nPAREN STRNATNCNONONE (Tm) CLA Mts OFS\\nGeumments | SUDEESTING THITRONORELCY .\\n. cosvetehe eth eBaical eonebont.\\nif\\nCormre LUNUNESCENTT WORUNO ASSAY\\nCOPE LNEEDCENTT WETUNO ABKAY\\nCNG LUENCENT PORNO ABSAY\\nsla\\na', 'thyrocare_0_9691.jpg': 'J roc a:\\nD-37/3,11C mac, Turbhe, ® ACCREOTEOW yrocare\\nWoe Pumber-00 703 ssh i ome ‘Thar Taped. Third Thywmsome.\\nCompesate Office : Torpocare Technslagian United © 0-7/3, STC MIOC, Wether, nd Montes\\n© 022- MHD0K /4175 2575 OMFINOS Darien Ptresece Quenthpaween,\\n\\nnee 2 ASMIML ACR SENGUPTA (257/18) ‘SAMPLE COLLECTED AT :\\n\\neap.0¥ ear. (7026357519) KALPARA MEDICOS AAD COTY\\n\\n‘Test aanaD 1 AAROGYAM A\\n\\net : —_\\nvest woe TECHNOLOGY VALUE (UNITS REVERENCE RANGE\\nvesrae a ore\\n‘TOTAL TRIIODOTHYROMINE (13) CUA % ngidl 60-200\\n\\nTOTAL THYROXINE (T4) Cle by wd 4.512\\n\\nTAIROAD STPGAATING HORMONE (TSH) C.LIA 214 wed 0.3-5.5\\n\\nTROD STRAT HO\\nComments 1 SUGGESTING THYRONORMALCY\\n\\n(Phense corratate with clinical condriens.\\n\\n(emthet:\\n\\nTe- COWETITINE (CHERE LUMINESCENT DOMINO ASSAY\\n\\n2h, CRMSTITREE CUTE LUSEMESCENT IMIUND ASSAY ‘', 'thyrocare_0_9833.jpg': ':\\nCHE AS 1\\ncare . 2 CAI\\n—————— Wy =xGae- Thyrocare\\nPemint-200 703 een ae vere ‘Trent: Thyrosd. Thank: Theyrensre\\n@ O22 . 900000 / 1 OARS 88 rire ae er\\n. pe ag TT\\n— = wares SETS Aon we re\\nCTA ES Soe rc pee\\nTae. TRIBODOTHTRONNE (13) cite 76 wn 60-700\\nTak. TUOTROMIE (54) CA s heal O42\\nVRE? STORLATING HORMONE cre CLA a 1 _ wes 0.35.5\\nnein: DUCES TRO THTrRONOAMAL CY\\neee Gerratats with einies! conditbers\\neiieaat 2\\n| COUPETTTIVE Cont LUNIEESCENT LUND ASSAY\\n‘ (CHEN LOPEEESCE esl WET ASSAY\\nY CoG LuemeCcEnT Pern ABSAY'}\n"
     ]
    }
   ],
   "source": [
    "print(\"Ground Truth Data:\", ground_truth_data)\n",
    "print(\"Extracted Data:\", extracted_data)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bf8bb5b1-fd84-41a2-b031-8196822bf908",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "bbbdc638-f461-40e0-a2c1-74653eb6f1d7",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7272905d-cfb8-4093-b5a9-c68e14a5440d",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "ad4e505d-8c25-4f8a-9bea-7710c33fcd30",
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "7a3092d5-5b91-4a25-b01a-65681a4e8561",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python [conda env:base] *",
   "language": "python",
   "name": "conda-base-py"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
